<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Amoxicillin: Pediatric drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Amoxicillin: Pediatric drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Amoxicillin: Pediatric drug information</div><div class="clear"></div><div id="topicText"><div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
(For additional information <a class="drug drug_general" data-topicid="8673" href="/d/html/8673.html" rel="external">see "Amoxicillin: Drug information"</a> and <a class="drug drug_patient" data-topicid="10888" href="/d/html/10888.html" rel="external">see "Amoxicillin: Patient drug information"</a>)<br/><br/>For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="list canbnlist drugH1Div drugBrandNames" id="F52865906"><span class="drugH1">Brand Names: Canada</span>
<ul>
<li>AG-Amoxicillin;</li>
<li>APO-Amoxi;</li>
<li>APO-Amoxi Sugar Free [DSC];</li>
<li>Auro-Amoxicillin;</li>
<li>DOM-Amoxicillin;</li>
<li>JAMP-Amoxicillin;</li>
<li>Novamoxin;</li>
<li>PMS-Amoxicillin;</li>
<li>Polymox;</li>
<li>PRO Amox-500;</li>
<li>PRO-Amox-250</li></ul></div>
<div class="list_set htclist drugH1Div drugBrandNames" id="F1045040"><span class="drugH1">Therapeutic Category</span>
<ul>
<li>
<span class="list-set-name">Antibiotic, Penicillin</span></li></ul></div>
<div class="block don drugH1Div" id="F53462365"><span class="drugH1">Dosing: Neonatal</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>General dosing:</b> Limited data available; optimal dose not established:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>High-dose regimen (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1','lexi-content-ref-7100823','lexi-content-ref-27941119','lexi-content-ref-25842223','lexi-content-ref-25842221','lexi-content-ref-870440']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1','lexi-content-ref-7100823','lexi-content-ref-27941119','lexi-content-ref-25842223','lexi-content-ref-25842221','lexi-content-ref-870440'])">Ref</a></span>):</i></p>
<p style="text-indent:-2em;margin-left:6em;">Preterm and term neonates:</p>
<p style="text-indent:-2em;margin-left:8em;">1.5 to &lt;2 kg: 75 mg/kg/day in divided doses every 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">≥2 kg: 100 mg/kg/day in divided doses every 12 hours.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Traditional-dose regimen: </i>Preterm and term neonates: Oral: 30 mg/kg/day in divided doses every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-AAP.2021','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-AAP.2021','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="7d7a9210-2077-4d28-9ff9-de0dd7bc57d2">Otitis media, acute, Group A or B streptococcus</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, acute (AOM), Group A or B streptococcus:</b> Neonates: Oral stepdown therapy following parenteral treatment: Oral: 30 to 40 mg/kg/day in divided doses every 8 hours for 10 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="dfbc3246-1bad-4350-b592-9b67ea2ffd98">Pneumococcal infection prophylaxis for anatomic or functional asplenia</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Pneumococcal infection prophylaxis for anatomic or functional asplenia:</b> Neonates: Oral: 20 mg/kg/day in divided doses twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33275684','lexi-content-ref-24855431']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33275684','lexi-content-ref-24855431'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0b887c7a-255f-4ba6-9db6-bbcbd2dc543e">Urinary tract infection, prophylaxis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Urinary tract infection, prophylaxis (hydronephrosis, vesicoureteral reflux):</b> Neonates: Oral: 10 to 15 mg/kg/day once daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-16427220','lexi-content-ref-Domonoske.1','lexi-content-ref-16716788','lexi-content-ref-17483966']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-16427220','lexi-content-ref-Domonoske.1','lexi-content-ref-16716788','lexi-content-ref-17483966'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block dop drugH1Div" id="F134538"><span class="drugH1">Dosing: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>General dosing:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Infants, Children, and Adolescents:</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Standard-dose regimen:</i> Oral: 40 to 45 mg/kg/day in divided doses every 8 hours; maximum dose: 500 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-AAP.2021','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-AAP.2021','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>High-dose regimen:</i> 80 to 90 mg/kg/day divided every 12 hours; a maximum dose has not been established; however, some experts suggest a maximum daily dose of 4,000 mg/<b>day</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1','lexi-content-ref-AAP.2021']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1','lexi-content-ref-AAP.2021'])">Ref</a></span>).</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c74e9b7c-3d24-4a43-8fa5-6da3c93d72db">Anthrax</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Anthrax:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Infants, Children, and Adolescents (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24777226']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24777226'])">Ref</a></span>):</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Postexposure prophylaxis, exposure to aerosolized spores:</i> Oral: 75 mg/kg/day in divided doses every 8 hours for 60 days after exposure; maximum dose: 1,000 mg/dose.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Cutaneous, without systemic involvement:</i> Oral: 75 mg/kg/day in divided doses every 8 hours; maximum dose: 1,000 mg/dose. Duration of therapy: 7 to 10 days for naturally acquired infection, up to 60 days for biological weapon-related exposure.</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Systemic, oral step-down therapy:</i> Oral: 75 mg/kg/day in divided doses every 8 hours as part of appropriate combination therapy to complete 60-day course; maximum dose: 1,000 mg/dose.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="d6b46673-8570-4914-ad98-b96bd4dd105b">Endocarditis, prophylaxis before invasive dental procedures</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Endocarditis, prophylaxis before invasive dental procedures:</b> Limited data available: <b>Note:</b> Recommended only in patients who are at highest risk for infective endocarditis (IE) or adverse outcomes (eg, history of IE, cardiac valve repair using prosthetic valves or material, unrepaired cyanotic congenital heart disease [CHD], left ventricular assist device or implantable heart, repaired CHD with prosthetic material or device during first 6 months after procedure, pulmonary artery valve or conduit placement [eg, Melody valve, Contegra conduit], repaired CHD with residual defects at the site or adjacent to site of prosthetic patch or device, heart transplant recipients with cardiac valvulopathy) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26373317','lexi-content-ref-33853363','lexi-content-ref-28315732']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26373317','lexi-content-ref-33853363','lexi-content-ref-28315732'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants, Children, and Adolescents: Oral: 50 mg/kg as a single dose administered 30 to 60 minutes prior to dental procedure; maximum dose: 2,000 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33853363']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33853363'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="9938d465-584f-48f7-8083-e90bc984c47e">Exit-site or tunnel infection, peritoneal dialysis catheter</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Exit-site or tunnel infection, peritoneal dialysis catheter:</b> Infants, Children, and Adolescents: Oral: 10 to 20 mg/kg/dose every 24 hours; maximum dose: 1,000 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22851742']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22851742'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8b8d4809-3f39-4624-a159-df262570daf3">
<i>Helicobacter pylori</i> eradication</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Helicobacter pylori</b></i>
<b> eradication:</b> Limited data available: <b>Note:</b> Use as part of an appropriate combination regimen; usual duration of therapy is 14 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28541262']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28541262'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Standard-dose regimen:</i></p>
<p style="text-indent:-2em;margin-left:6em;">Weight-directed dosing: Children and Adolescents: Oral: 50 mg/kg/day in divided doses every 12 hours; maximum dose: 1,000 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21701406','lexi-content-ref-28653787','lexi-content-ref-27629844','lexi-content-ref-21558964','lexi-content-ref-25171023','lexi-content-ref-19330931']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21701406','lexi-content-ref-28653787','lexi-content-ref-27629844','lexi-content-ref-21558964','lexi-content-ref-25171023','lexi-content-ref-19330931'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Fixed dosing (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28541262']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28541262'])">Ref</a></span>): Children and Adolescents:</p>
<p style="text-indent:-2em;margin-left:8em;">15 to &lt;25 kg: Oral: 500 mg twice daily.</p>
<p style="text-indent:-2em;margin-left:8em;">25 to &lt;35 kg: Oral: 750 mg twice daily.</p>
<p style="text-indent:-2em;margin-left:8em;">≥35 kg: Oral: 1,000 mg twice daily.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>High-dose regimen:</i></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Note: </b>For use in combination with a proton pump inhibitor and metronidazole when susceptibility is unknown or when <i>H. pylori</i> isolate is resistant to clarithromycin AND metronidazole. Fixed (weight-band) dosing based on a target dose of ~75 mg/kg/<b>day</b> divided twice daily; maximum dose reported: 100 mg/kg/<b>day</b> divided twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28541262','lexi-content-ref-21407111']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28541262','lexi-content-ref-21407111'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Children and Adolescents (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28541262','lexi-content-ref-21407111']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28541262','lexi-content-ref-21407111'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:8em;">15 to &lt;25 kg: Oral: 750 mg twice daily.</p>
<p style="text-indent:-2em;margin-left:8em;">25 to &lt;35 kg: Oral: 1,000 mg twice daily.</p>
<p style="text-indent:-2em;margin-left:8em;">≥35 kg: Oral: 1,500 mg twice daily.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0676402d-6bcc-48b1-a3ce-53f79c692b71">Lyme disease</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Lyme disease (</b>
<i>
<b>Borrelia</b></i>
<b> spp. infection):</b> Infants, Children, and Adolescents: Oral: 50 mg/kg/day in divided doses every 8 hours; maximum dose: 500 mg/dose. Duration of therapy depends on clinical syndrome; treat erythema migrans and borrelial lymphocytoma for 14 days, carditis for 14 to 21 days, arthritis (initial, recurrent, or refractory) for 28 days, and acrodermatitis chronica atrophicans for 21 to 28 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33251700']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33251700'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5285a396-852e-4b3d-b4b0-d754f216f7be">Osteoarticular infection, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Osteoarticular infection, acute (eg, septic [bacterial] arthritis, osteomyelitis): </b>
<i>Step-down therapy following parenteral treatment (targeted therapy for susceptible pathogen):</i> Limited data available:</p>
<p style="text-indent:-2em;margin-left:4em;">Infants, Children, and Adolescents: Oral: 80 to 120 mg/kg/day in divided doses every 6 to 8 hours; maximum daily dose: 4,000 mg/<b>day</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32123023','lexi-content-ref-28708801']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32123023','lexi-content-ref-28708801'])">Ref</a></span>). Minimum total duration (IV plus oral therapy) is 2 to 3 weeks for septic arthritis and 3 to 4 weeks for osteomyelitis; however, duration should be individualized based on several factors including causative pathogen, response to therapy, and normalization of inflammatory markers (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28708801','lexi-content-ref-34350458']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28708801','lexi-content-ref-34350458'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a96b8104-65d0-48ba-b460-4308464e6db6">Otitis media, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, acute (AOM):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>High-dose regimen: </i>
<b>Note: </b>Preferred in the United States and when activity against penicillin nonsusceptible <i>Streptococcus pneumoniae</i> is desired (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23439909','lexi-content-ref-31505007','lexi-content-ref-21334779']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23439909','lexi-content-ref-31505007','lexi-content-ref-21334779'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Infants ≥3 months and Children: Oral: 80 to 90 mg/kg/day in divided doses every 12 hours. Maximum dose has not been established for AOM; however, 4,000 mg/<b>day</b> has been suggested (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23439909','lexi-content-ref-Bradley.1','lexi-content-ref-20042912','lexi-content-ref-9951971','lexi-content-ref-18754699','lexi-content-ref-14742786','lexi-content-ref-15930204','lexi-content-ref-AAP.2021']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23439909','lexi-content-ref-Bradley.1','lexi-content-ref-20042912','lexi-content-ref-9951971','lexi-content-ref-18754699','lexi-content-ref-14742786','lexi-content-ref-15930204','lexi-content-ref-AAP.2021'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Standard-dose regimen:</i>
<b>Note: </b>Only for use in areas where rates of penicillin nonsusceptible <i>S. pneumoniae</i> are known to be low or if an isolated pathogen is penicillin-susceptible (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1','lexi-content-ref-9951971','lexi-content-ref-15286214','lexi-content-ref-31505007','lexi-content-ref-21334779','lexi-content-ref-33419114']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1','lexi-content-ref-9951971','lexi-content-ref-15286214','lexi-content-ref-31505007','lexi-content-ref-21334779','lexi-content-ref-33419114'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">Infants ≥3 months and Children: Oral: 40 to 50 mg/kg/day in divided doses every 8 to 12 hours. Maximum daily dose: 1,500 mg/<b>day </b>(<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-9493813','lexi-content-ref-9951971','lexi-content-ref-14742786','lexi-content-ref-8416502','lexi-content-ref-8414799','lexi-content-ref-8295812','lexi-content-ref-9764549','lexi-content-ref-33419114']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-9493813','lexi-content-ref-9951971','lexi-content-ref-14742786','lexi-content-ref-8416502','lexi-content-ref-8414799','lexi-content-ref-8295812','lexi-content-ref-9764549','lexi-content-ref-33419114'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Duration of therapy:</i> For patients with severe or recurrent AOM, tympanic membrane perforation, or who are &lt;2 years of age, treat for 10 days; for patients ≥2 years of age with mild to moderate, nonrecurrent disease without tympanic membrane perforation, shorter durations of 5 to 7 days may be sufficient (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23439909','lexi-content-ref-28002709','lexi-content-ref-20824827','lexi-content-ref-31876601','lexi-content-ref-NICE.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23439909','lexi-content-ref-28002709','lexi-content-ref-20824827','lexi-content-ref-31876601','lexi-content-ref-NICE.2'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8a8bcaa3-71a0-4cba-b543-1410405bd5ef">Peritonitis, prophylaxis for peritoneal dialysis patients requiring invasive dental procedures</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Peritonitis, prophylaxis for peritoneal dialysis patients requiring invasive dental procedures:</b> Infants, Children, and Adolescents: Oral: 50 mg/kg as a single dose administered 30 to 60 minutes before dental procedure; maximum dose: 2,000 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-22851742']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-22851742'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ed599b2f-52de-47cd-b7d2-d706008b1db0">Pneumonia, community-acquired</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Pneumonia, community-acquired:</b></p>
<p style="text-indent:-2em;margin-left:4em;">Infants ≥3 months, Children, and Adolescents:</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Empiric therapy for presumed bacterial pneumonia</i>: Oral: 90 mg/kg/day in divided doses every 12 hours; maximum daily dose: 4,000 mg/<b>day </b>(<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21880587']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21880587'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Group A Streptococcus, mild infection or step-down therapy</i>: Oral: 50 to 75 mg/kg/day in divided doses every 12 hours; maximum daily dose: 4,000 mg/<b>day</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21880587']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21880587'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Haemophilus influenzae, mild infection or step-down therapy</i>: Oral: 75 to 100 mg/kg/day in divided doses every 8 hours; maximum daily dose: 4,000 mg/<b>day </b>(<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21880587']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21880587'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>Streptococcus pneumoniae, mild infection or step-down therapy (penicillin minimal inhibitory concentration [MIC] ≤2 mcg/mL)</i>: Oral: 90 mg/kg/day in divided doses every 12 hours <b>or</b> 45 mg/kg/day in divided doses every 8 hours; maximum daily dose: 4,000 mg/<b>day</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21880587']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21880587'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>S. pneumoniae, elevated penicillin MIC (penicillin MIC = 2 mcg/mL)</i>: Oral: 90 to 100 mg/kg/day in divided doses every 8 hours; dosing based on pharmacokinetic modeling to optimize pharmacodynamic target attainment (time over MIC) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-20975453','lexi-content-ref-21880587']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-20975453','lexi-content-ref-21880587'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Duration of therapy: For outpatient treatment of uncomplicated disease in patients who respond to therapy, 5 days of therapy is likely adequate (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33683325','lexi-content-ref-32525203','lexi-content-ref-35040920']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33683325','lexi-content-ref-32525203','lexi-content-ref-35040920'])">Ref</a></span>). Longer duration (eg, total course of 7 to 10 days) may be necessary in patients with complicated disease or who do not respond quickly to therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1','lexi-content-ref-35579504','lexi-content-ref-32525203']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1','lexi-content-ref-35579504','lexi-content-ref-32525203'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="dfbc3246-1bad-4350-b592-9b67ea2ffd98">Pneumococcal infection prophylaxis for anatomic or functional asplenia</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Pneumococcal infection prophylaxis for anatomic or functional asplenia (eg, sickle cell disease [SCD]): </b>
<b>Note:</b> The decision to discontinue antibiotic prophylaxis after 5 years of age in children with SCD who have not experienced invasive pneumococcal infection and have received recommended pneumococcal immunizations should be individualized (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33275684','lexi-content-ref-NHLBI.1','lexi-content-ref-AAP.2021']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33275684','lexi-content-ref-NHLBI.1','lexi-content-ref-AAP.2021'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants (as soon as SCD diagnosed or asplenic) and Children &lt;6 years: Oral: 20 mg/kg/day in divided doses every 12 hours; maximum dose: 250 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33275684','lexi-content-ref-17826619','lexi-content-ref-24855431']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33275684','lexi-content-ref-17826619','lexi-content-ref-24855431'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children ≥6 years and Adolescents: Oral: 250 mg every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-17826619','lexi-content-ref-24855431']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-17826619','lexi-content-ref-24855431'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c1713969-1e40-4699-a4e8-d53af9b95043">Rhinosinusitis, acute bacterial; uncomplicated</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Rhinosinusitis, acute bacterial; uncomplicated: Note:</b> While IDSA guidelines consider amoxicillin/clavulanate as the preferred therapy, AAP guidelines allow amoxicillin for uncomplicated, mild to moderate infections in patients who do not attend daycare and who have not received antibiotics within the last month (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23796742','lexi-content-ref-22438350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23796742','lexi-content-ref-22438350'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Standard-dose regimen</i>: <b>Note: </b>Recommended in areas where &lt;10% of <i>Streptococcus pneumoniae </i>are penicillin-nonsusceptible.</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥2 years and Adolescents: Oral: 45 mg/kg/day in divided doses every 12 hours.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>High-dose regimen:</i>
<b>Note: </b>Recommended in areas where ≥10% of <i>S. pneumoniae </i>are penicillin-nonsusceptible.</p>
<p style="text-indent:-2em;margin-left:6em;">Children ≥2 years and Adolescents: Oral: 80 to 90 mg/kg/day in divided doses every 12 hours; maximum dose: 2,000 mg/dose.</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="002747a1-d12d-413d-9efb-492e8da1743e">Streptococcus, group A; pharyngitis/tonsillitis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Streptococcus, group A; pharyngitis/tonsillitis:</b> Children and Adolescents: Oral: 50 mg/kg/day once daily or in divided doses every 12 hours for 10 days; maximum daily dose: 1,000 mg/day (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19246689','lexi-content-ref-22965026','lexi-content-ref-AAP.2021']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19246689','lexi-content-ref-22965026','lexi-content-ref-AAP.2021'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0b887c7a-255f-4ba6-9db6-bbcbd2dc543e">Urinary tract infection, prophylaxis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Urinary tract infection, prophylaxis (hydronephrosis, vesicoureteral reflux):</b> Infants ≤2 months: Oral: 10 to 15 mg/kg once daily; some suggest administration in the evening (drug resides in bladder longer); <b>Note:</b> Due to resistance, amoxicillin should not be used for prophylaxis after 2 months of age (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-16427220','lexi-content-ref-16716788','lexi-content-ref-17483966']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-16427220','lexi-content-ref-16716788','lexi-content-ref-17483966'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="68ea4564-c2b6-429c-8a8b-e8846ecb9178">Urinary tract infection, treatment</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Urinary tract infection, treatment: Note:</b> Recommended only when pathogen has been proven susceptible (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1'])">Ref</a></span>). Duration of therapy should be individualized based on patient age, severity/extent of infection, and clinical response; typical duration is 7 to 14 days, though it may be as short as 3 to 5 days (eg, for uncomplicated cystitis in patients ≥2 years of age) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31958969','lexi-content-ref-29292282','lexi-content-ref-32364593','lexi-content-ref-34860955','lexi-content-ref-25477258']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31958969','lexi-content-ref-29292282','lexi-content-ref-32364593','lexi-content-ref-34860955','lexi-content-ref-25477258'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Infants: Oral: 50 to 100 mg/kg/day in divided doses every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25477258']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25477258'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">Children and Adolescents: Oral: 50 to 100 mg/kg/day in divided doses every 8 hours; maximum dose: 500 mg/dose (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25477258','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25477258','lexi-content-ref-manu.1'])">Ref</a></span>); for uncomplicated cystitis, may consider 30 mg/kg/day in divided doses every 8 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Bradley.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Bradley.1'])">Ref</a></span>).</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dorp drugH1Div" id="F51064768"><span class="drugH1">Dosing: Kidney Impairment: Pediatric</span>
<p style="text-indent:-2em;margin-left:2em;">There are no dosage adjustments provided in the manufacturer's labeling; however, the following guidelines have been used by some clinicians (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Aronoff.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Aronoff.1'])">Ref</a></span>): Oral:</p>
<p style="text-indent:-2em;margin-left:4em;">Infants, Children, and Adolescents:</p>
<p style="text-indent:-2em;margin-left:6em;">Mild to moderate infection: Dosing based on 25 to 50 mg/kg/day divided every 8 hours:</p>
<p style="text-indent:-2em;margin-left:8em;">GFR &gt;30 mL/minute/1.73 m<sup>2</sup>: No adjustment required.</p>
<p style="text-indent:-2em;margin-left:8em;">GFR 10 to 29 mL/minute/1.73 m<sup>2</sup>: 8 to 20 mg/kg/dose every 12 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">GFR &lt;10 mL/minute/1.73 m<sup>2</sup>: 8 to 20 mg/kg/dose every 24 hours.</p>
<p style="text-indent:-2em;margin-left:8em;">Hemodialysis: Moderately dialyzable (20% to 50%); ~30% removed by 3-hour hemodialysis: 8 to 20 mg/kg/dose every 24 hours; give after dialysis.</p>
<p style="text-indent:-2em;margin-left:8em;">Peritoneal dialysis: 8 to 20 mg/kg/dose every 24 hours.</p>
<p style="text-indent:-2em;margin-left:6em;">Severe infection (high dose): Dosing based on 80 to 90 mg/kg/day divided every 12 hours:</p>
<p style="text-indent:-2em;margin-left:8em;">GFR &gt;30 mL/minute/1.73 m<sup>2</sup>: No adjustment required.</p>
<p style="text-indent:-2em;margin-left:8em;">GFR 10 to 29 mL/minute/1.73 m<sup>2</sup>: 20 mg/kg/dose every 12 hours; do not use the 875 mg tablet.</p>
<p style="text-indent:-2em;margin-left:8em;">GFR &lt;10 mL/minute/1.73 m<sup>2</sup>: 20 mg/kg/dose every 24 hours; do not use the 875 mg tablet.</p>
<p style="text-indent:-2em;margin-left:8em;">Hemodialysis: Moderately dialyzable (20% to 50%); ~30% removed by 3-hour hemodialysis: 20 mg/kg/dose every 24 hours; give after dialysis.</p>
<p style="text-indent:-2em;margin-left:8em;">Peritoneal dialysis: 20 mg/kg/dose every 24 hours.</p></div>
<div class="block dohp drugH1Div" id="F51064769"><span class="drugH1">Dosing: Hepatic Impairment: Pediatric</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block doa drugH1Div" id="F134516"><span class="drugH1">Dosing: Adult</span><p>(For additional information <a class="drug drug_general" data-topicid="8673" href="/d/html/8673.html" rel="external">see "Amoxicillin: Drug information"</a>)</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Usual dosage range: Oral:</b> 500 mg to 1 g every 8 to 12 hours.</p>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="60e9d2ac-8a42-4447-963b-6e516db3e471">Actinomycosis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Actinomycosis (alternative agent) (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> For initial therapy of mild infection or step-down therapy following parenteral treatment of severe infection (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Brook.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Brook.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> 500 mg 3 to 4 times daily <b>or</b> 1 g 3 times daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Brook.1','lexi-content-ref-6584159','lexi-content-ref-29513846']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Brook.1','lexi-content-ref-6584159','lexi-content-ref-29513846'])">Ref</a></span>); higher doses of 4 to 6 g/day in divided doses have been utilized in case reports (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23722146','lexi-content-ref-25045274']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23722146','lexi-content-ref-25045274'])">Ref</a></span>). Optimal duration is uncertain; some experts suggest total durations of 2 to 6 months for mild infection and 6 to 12 months for severe or extensive infection (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Brook.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Brook.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="c74e9b7c-3d24-4a43-8fa5-6da3c93d72db">Anthrax</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Anthrax (alternative agent [susceptible strains only]<b>) </b>(off-label use): </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Consult public health officials for event-specific recommendations. A high index of suspicion for emergent beta-lactam resistance during therapy is warranted (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24447897']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24447897'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Inhalational (postexposure prophylaxis):</i>
<b>Oral:</b> 1 g every 8 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24447897']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24447897'])">Ref</a></span>); duration depends on anthrax vaccine status and series completion, age, immune status, and pregnancy/breastfeeding status. For those who have not previously received anthrax vaccine, duration ranges from 42 to 60 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31834290']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31834290'])">Ref</a></span>). Some experts favor longer durations of prophylaxis (eg, total of 3 to 4 months) for patients who are immunocompromised or remain unvaccinated (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Wilson.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Wilson.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Note:</b> Anthrax vaccine should also be administered to exposed individuals (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31834290','lexi-content-ref-24447897']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31834290','lexi-content-ref-24447897'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Cutaneous, without systemic involvement, treatment:</i>
<b>Oral:</b> 1 g every 8 hours; duration is 7 to 10 days after naturally acquired infection and 60 days following biological weapon-related event. <b>Note:</b> Treat patients with extensive edema or cutaneous lesions of the head or neck with a parenteral regimen recommended for systemic involvement (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24447897']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24447897'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="62048737-388a-4ebd-8440-756ad8552430">Bronchiectasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Bronchiectasis:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Treatment of pulmonary exacerbations in patients <b>without</b> beta-lactamase-positive H. influenzae or Pseudomonas aeruginosa:</i>
<b>Oral:</b> 500 mg 3 times daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-7012996']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-7012996'])">Ref</a></span>) <b>or</b> 1 g 3 times daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-3129390']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-3129390'])">Ref</a></span>) for up to 14 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28889110']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28889110'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Prevention of pulmonary exacerbations: </i>
<b>Note: </b>Reserve for patients with ≥3 exacerbations per year who are <b>not</b> colonized with <i>P. aeruginosa</i> and not candidates for long-term macrolide therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Barker.2018','lexi-content-ref-28889110']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Barker.2018','lexi-content-ref-28889110'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Oral:</b> 500 mg twice daily; dosing based on expert opinion (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Barker.2018']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Barker.2018'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="7b5dfb59-ffef-4a47-a0b0-636358e3c277">Cervical infection in pregnancy due to <i>Chlamydia trachomatis</i></span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Cervical infection in pregnancy due to <i>Chlamydia trachomatis</i> (alternative agent) (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Reserve for patients who are pregnant who cannot use preferred agents (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> 500 mg 3 times daily for 7 days with test of cure ≥4 weeks after treatment (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-34292926','lexi-content-ref-Hsu.1','lexi-content-ref-11408852']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-34292926','lexi-content-ref-Hsu.1','lexi-content-ref-11408852'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="142a8701-080d-49cd-9f46-814412cd152f">Endocarditis, prophylaxis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Endocarditis, prophylaxis before invasive dental procedures (off-label use):</b>
<b>Oral:</b> 2 g 30 to 60 minutes before procedure; if inadvertently not given prior to the procedure, may be administered up to 2 hours after the procedure. <b>Note:</b> Reserve for select situations (cardiac condition with the highest risk of adverse endocarditis outcomes and procedure likely to result in bacteremia with an organism that can cause endocarditis) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33853363']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33853363'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="8b8d4809-3f39-4624-a159-df262570daf3">
<i>Helicobacter pylori</i> eradication</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<i>
<b>Helicobacter pylori </b></i>
<b>eradication:</b>
<b>Oral:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Clarithromycin triple regimen:</i> Amoxicillin 1 g twice daily in combination with clarithromycin 500 mg twice daily, plus a standard-dose or double-dose proton pump inhibitor; continue regimen for 14 days. <b>Note:</b> Avoid use in patients with risk factors for macrolide resistance (eg, prior macrolide exposure or local clarithromycin resistance rates ≥15%, which is assumed in the United States) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28071659','lexi-content-ref-27102658']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28071659','lexi-content-ref-27102658'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Concomitant regimen:</i> Amoxicillin 1 g twice daily in combination with clarithromycin 500 mg twice daily, either metronidazole or tinidazole 500 mg twice daily, plus a standard-dose proton pump inhibitor twice daily; continue regimen for 10 to 14 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28071659']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28071659'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Sequential regimen (alternative regimen):</i> Amoxicillin 1 g twice daily plus a standard-dose proton pump inhibitor twice daily for 5 to 7 days; followed by clarithromycin 500 mg twice daily, either metronidazole or tinidazole 500 mg twice daily, plus a standard-dose proton pump inhibitor twice daily for 5 to 7 days; some experts prefer the 10-day regimen due to the lack of data showing superiority of the 14-day sequential regimen in North America (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28071659','lexi-content-ref-Lamont.2023']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28071659','lexi-content-ref-Lamont.2023'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Hybrid regimen (alternative regimen):</i> Amoxicillin 1 g twice daily, plus a standard-dose proton pump inhibitor twice daily for 7 days; followed by amoxicillin 1 g twice daily, clarithromycin 500 mg twice daily, either metronidazole or tinidazole 500 mg twice daily, plus a standard-dose proton pump inhibitor twice daily for 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28071659']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28071659'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Levofloxacin triple regimen (salvage regimen):</i> Amoxicillin 750 mg 3 times daily in combination with a double-dose proton pump inhibitor twice daily plus levofloxacin 500 mg once daily; continue regimen for 14 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33524402']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33524402'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>High</i>-<i>dose dual therapy (alternative salvage regimen)</i>: Amoxicillin 750 mg 4 times daily <b>or</b> 1 g 3 times daily; in combination with a double-dose proton pump inhibitor twice daily for 14 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28071659','lexi-content-ref-33524402']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28071659','lexi-content-ref-33524402'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="0676402d-6bcc-48b1-a3ce-53f79c692b71">Lyme disease</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Lyme disease (<i>Borrelia</i> spp. infection) (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Erythema migrans:</i>
<b>Oral:</b> 500 mg 3 times daily for 14 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33251700']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33251700'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Carditis (initial therapy for mild disease [first-degree atrioventricular block with PR interval &lt;300 msec] or step-down therapy after initial parenteral treatment for more severe disease once PR interval &lt;300 msec):</i>
<b>Oral:</b> 500 mg 3 times daily for 14 to 21 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33251700']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33251700'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Arthritis without neurologic involvement:</i>
<b>Oral:</b> 500 mg 3 times daily for 28 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33251700']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33251700'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="a96b8104-65d0-48ba-b460-4308464e6db6">Otitis media, acute</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Otitis media, acute (alternative agent):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Some experts recommend amoxicillin/clavulanate over amoxicillin alone due to the frequency of otopathogens that produce beta-lactamases (eg, <i>H. influenzae</i>, <i>Moraxella catarrhalis</i>) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Limb.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Limb.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> 500 mg every 8 hours <b>or </b>875 mg every 12 hours (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-WHO.2','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-WHO.2','lexi-content-ref-manu.1'])">Ref</a></span>). Some experts use 1 g every 8 hours for patients at high risk of severe infection or resistant <i>Streptococcus </i>
<i> pneumoniae</i>. Duration is 5 to 7 days for mild to moderate infection and 10 days for severe infection (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Limb.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Limb.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="61dc4516-3280-419e-a0fd-0e93be129181">Periodontitis, severe, plaque-associated</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Periodontitis, severe, plaque-associated (off-label use):</b>
<b>Oral:</b> 500 mg every 8 hours in combination with metronidazole for 14 days or until clinical resolution, whichever is longer; use in addition to periodontal debridement (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-28303587','lexi-content-ref-Chow.2020','lexi-content-ref-23297772']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-28303587','lexi-content-ref-Chow.2020','lexi-content-ref-23297772'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="164222d6-88e9-415d-ad0e-8fe154087ff0">Pneumococcal prophylaxis in patients at high risk</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Pneumococcal prophylaxis in patients at high risk (off-label use): </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b>For select patients at high risk (eg, patients with functional or anatomic asplenia, sickle cell disease, or allogeneic hematopoietic cell transplant recipients with chronic graft-vs-host disease or hypogammaglobulinemia) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19747629','lexi-content-ref-27925427']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19747629','lexi-content-ref-27925427'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> Dose not well-defined: 500 mg twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33275684']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33275684'])">Ref</a></span>); based on recommendations in pediatric patients &gt;5 years of age, may consider 250 mg twice daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24855431']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24855431'])">Ref</a></span>). Some experts recommend 250 mg once daily. Duration varies based on patient-specific factors (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27925427']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27925427'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="ed599b2f-52de-47cd-b7d2-d706008b1db0">Pneumonia, community-acquired</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Pneumonia, community-acquired:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> For empiric therapy in outpatients without comorbidities or risk factors for antibiotic-resistant pathogens <b>or</b> oral step-down therapy following initial parenteral therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31573350','lexi-content-ref-File.2']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31573350','lexi-content-ref-File.2'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> 1 g 3 times daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31573350','lexi-content-ref-9636854','lexi-content-ref-11157603']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31573350','lexi-content-ref-9636854','lexi-content-ref-11157603'])">Ref</a></span>); for initial empiric therapy, some experts prefer use of amoxicillin in combination with an antibiotic that targets atypical pathogens (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-File.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-File.1'])">Ref</a></span>). Duration is for a minimum of 5 days; patients should be clinically stable with normal vital signs before therapy is discontinued (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31573350']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31573350'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="7b595739-8c04-4fd6-a7d4-afa7aea8d75f">Prosthetic joint infection, chronic suppression</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Prosthetic joint infection, chronic suppression (off-label use):</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> For infection caused by beta-hemolytic streptococci, penicillin-susceptible <i>Enterococcus</i> spp., or <i>Cutibacterium </i>spp. (following pathogen-specific IV therapy in patients undergoing 1-stage exchange or debridement with retention of prosthesis) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Berbari.2018','lexi-content-ref-23223583']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Berbari.2018','lexi-content-ref-23223583'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> 500 mg 3 times daily (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23223583','lexi-content-ref-26246256']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23223583','lexi-content-ref-26246256'])">Ref</a></span>); duration depends on patient-specific factors (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Berbari.2018']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Berbari.2018'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="1437b55a-5145-4c15-bba4-c28709c37109">Rhinosinusitis, acute bacterial</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Rhinosinusitis, acute bacterial: </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b>In uncomplicated acute bacterial rhinosinusitis, initial observation and symptom management without antibiotic therapy is appropriate in most patients. Reserve antibiotic therapy for poor follow-up or lack of improvement over the observation period (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25832968','lexi-content-ref-26785402']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25832968','lexi-content-ref-26785402'])">Ref</a></span>). For initial therapy of nonsevere infection in patients without risk factors for pneumococcal resistance or poor outcome (eg, ≥65 years of age, recent hospitalization or antibiotic use, multiple comorbidities, high endemic resistance) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25832968','lexi-content-ref-Patel.2018']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25832968','lexi-content-ref-Patel.2018'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral:</b> 500 mg every 8 hours <b>or</b> 875 mg every 12 hours for 5 to 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25832968','lexi-content-ref-22337680','lexi-content-ref-8760738','lexi-content-ref-Patel.2018']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25832968','lexi-content-ref-22337680','lexi-content-ref-8760738','lexi-content-ref-Patel.2018'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5fe294fd-4626-4e48-9579-84675accedc8">Skin and soft tissue infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Skin and soft tissue infection:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Erysipelas, treatment of mild infection or step-down therapy after initial parenteral therapy:</i></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Oral:</b> 500 mg 3 times daily <b>or </b>875 mg twice daily; total duration is 5 days, with extension to 14 days for slow response, severe infection, or immunosuppression (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-Spelman.1','lexi-content-ref-manu.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-Spelman.1','lexi-content-ref-manu.1'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Erysipeloid (localized cutaneous Erysipelothrix rhusiopathiae infection):</i></p>
<p style="text-indent:-2em;margin-left:6em;">
<b>Oral:</b> 500 mg 3 times daily for 5 to 10 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24973422','lexi-content-ref-Reboli.1']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24973422','lexi-content-ref-Reboli.1'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="f1fe1cc4-2394-4b14-b840-3f8d607a121f">Streptococcal pharyngitis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Streptococcal pharyngitis (group A):</b>
<b>Oral:</b> 500 mg twice daily <b>or </b>1 g once daily for 10 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-19246689','lexi-content-ref-22965026']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-19246689','lexi-content-ref-22965026'])">Ref</a></span>).</p></div>
</div>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="5ac615e6-688a-461c-8a9f-5e7703d06ac9">Urinary tract infection</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Urinary tract infection: </b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note: </b>Not recommended for empiric therapy given decreased efficacy compared to first-line agents and high prevalence of resistance (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-21292654']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-21292654'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Asymptomatic bacteriuria (≥10<sup>5</sup> CFU per mL) in pregnancy (eg, group B Streptococcus):</i>
<b>Oral:</b> 500 mg every 8 hours <b>or</b> 875 mg every 12 hours for 4 to 7 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31977795','lexi-content-ref-Hooton.2','lexi-content-ref-31506700']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31977795','lexi-content-ref-Hooton.2','lexi-content-ref-31506700'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Cystitis, acute uncomplicated or acute simple cystitis (infection limited to the bladder without signs/symptoms of upper tract, prostate, or systemic infection) due to Enterococcus spp.:</i>
<b>Oral:</b> 500 mg every 8 hours <b>or</b> 875 mg every 12 hours for 5 days (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26369973','lexi-content-ref-Hooton.1','lexi-content-ref-21308555']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26369973','lexi-content-ref-Hooton.1','lexi-content-ref-21308555'])">Ref</a></span>).</p></div>
</div>
<p style="text-indent:-2em;margin-left:2em;margin-top:2em;">
<b>Dosage adjustment for concomitant therapy:</b> Significant drug interactions exist, requiring dose/frequency adjustment or avoidance. Consult drug interactions database for more information.</p></div>
<div class="block dora drugH1Div" id="F50991757"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">The renal dosing recommendations are based upon the best available evidence and clinical expertise. Senior Editorial Team: Bruce Mueller, PharmD, FCCP, FASN, FNKF; Jason A. Roberts, PhD, BPharm (Hons), B App Sc, FSHP, FISAC; Michael Heung, MD, MS.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>Altered kidney function:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Oral: </b></p>
<table border="1" frame="border" rules="all">
<caption>
<b>Amoxicillin Dose Adjustments in Kidney Impairment</b></caption>
<colgroup><col align="center"/>
<col align="center"/>
<col align="center"/>
<col align="center"/>
</colgroup><thead valign="middle">
<tr>
<th align="center">
<p style="text-indent:0em;">GFR (mL/minute)</p></th>
<th align="center">
<p style="text-indent:0em;">If the normal recommended dose is 250 to 500 mg every 8 hours<sup>a</sup></p></th>
<th align="center">
<p style="text-indent:0em;">If the normal recommended dose is 875 mg to 1 g every 12 hours<sup>b</sup></p></th>
<th align="center">
<p style="text-indent:0em;">If the normal recommended dose is 1 g every 8 hours<sup>b,c</sup></p></th></tr></thead>
<tfoot valign="middle">
<tr>
<td align="left" colspan="4">
<p style="text-indent:-2em;margin-left:2em;">
<sup>a</sup>Golightly 2013; Szeto 2017; manufacturer's labeling; expert opinion</p></td></tr>
<tr>
<td align="left" colspan="4">
<p style="text-indent:0em;">
<sup>b</sup>Expert opinion</p></td></tr>
<tr>
<td align="left" colspan="4">
<p style="text-indent:0em;">
<sup>c</sup>Keller 2015</p></td></tr>
<tr>
<td align="left" colspan="4">
<p style="text-indent:-2em;margin-left:2em;">
<sup>d</sup>Dialyzable (30% to 47% with low flux filters [Davies 1988; Francke 1979]). If utilizing a 24-hour dosing interval, administer dose after dialysis or give an additional dose after dialysis on dialysis days.</p></td></tr></tfoot>
<tbody valign="middle">
<tr>
<td align="center">
<p style="text-indent:0em;">≥30</p></td>
<td align="center">
<p style="text-indent:0em;">No dosage adjustment necessary</p></td>
<td align="center">
<p style="text-indent:0em;">No dosage adjustment necessary</p></td>
<td align="center">
<p style="text-indent:0em;">No dosage adjustment necessary</p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;">10 to 30</p></td>
<td align="center">
<p style="text-indent:0em;">250 to 500 mg every 12 hours</p></td>
<td align="center">
<p style="text-indent:0em;">500 mg every 12 hours</p></td>
<td align="center">
<p style="text-indent:0em;">1 g every 12 hours</p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;">&lt;10</p></td>
<td align="center">
<p style="text-indent:0em;">250 to 500 mg every 12 to 24 hours</p></td>
<td align="center">
<p style="text-indent:0em;">500 mg every 12 to 24 hours</p></td>
<td align="center">
<p style="text-indent:0em;">500 mg every 12 hours</p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;">Hemodialysis, intermittent (thrice weekly)<sup>d</sup></p></td>
<td align="center">
<p style="text-indent:0em;">250 to 500 mg every 12 to 24 hours</p></td>
<td align="center">
<p style="text-indent:0em;">500 mg every 12 to 24 hours</p></td>
<td align="center">
<p style="text-indent:0em;">500 mg every 12 hours</p></td></tr>
<tr>
<td align="center">
<p style="text-indent:0em;">Peritoneal dialysis</p></td>
<td align="center">
<p style="text-indent:0em;">250 to 500 mg every 12 hours</p></td>
<td align="center">
<p style="text-indent:0em;">500 mg every 12 hours</p></td>
<td align="center">
<p style="text-indent:0em;">500 mg every 12 hours</p></td></tr></tbody></table></div>
<div class="block doha drugH1Div" id="F50988898"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer's labeling.</p></div>
<div class="block arsc drugH1Div" id="F56238112"><span class="drugH1">Adverse Reactions (Significant): Considerations</span>
<div class="collapsible">
<span class="collapsible-title">Antibiotic-associated (non–Clostridioides difficile) diarrhea</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">GI effects range from antibiotic-associated [non–<i>Clostridioides difficile]</i>
<b> diarrhea</b> (AAD), <b>nausea</b>, and <b>vomiting</b>. Most cases of AAD are mild and self-limiting. However, <i>Clostridioides difficile</i> may account for as many as &gt;20% of cases in children, adolescents, and adults (discussed separately) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003987','lexi-content-ref-29408016','lexi-content-ref-17385141']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003987','lexi-content-ref-29408016','lexi-content-ref-17385141'])">Ref</a></span>). Diarrhea is less common with amoxicillin or ampicillin alone than with amoxicillin/clavulanic acid (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-11821511','lexi-content-ref-25404399','lexi-content-ref-31561959','lexi-content-ref-25964726','lexi-content-ref-28827186']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-11821511','lexi-content-ref-25404399','lexi-content-ref-31561959','lexi-content-ref-25964726','lexi-content-ref-28827186'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Mechanism</i>: Dose- and time-related; antibiotic disruption of indigenous gut microbiota (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-850084','lexi-content-ref-32518780']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-850084','lexi-content-ref-32518780'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset</i>: Varied; mean time to onset of AAD is 3 to 18 days for adult patients and 2 to 6 days for pediatric patients. The majority of AAD cases occur<i> during</i> (versus after) antibiotic therapy in pediatric patients (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003987']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003987'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Risk factors:</i></p>
<p style="text-indent:-2em;margin-left:6em;">• High-dose amoxicillin regimens</p>
<p style="text-indent:-2em;margin-left:6em;">• Longer duration of therapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25964726','lexi-content-ref-32518780']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25964726','lexi-content-ref-32518780'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Longer length of hospitalization or ICU stay (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30020891','lexi-content-ref-32518780']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30020891','lexi-content-ref-32518780'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Age (younger pediatric patients &lt;2 years and older adults) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-27003987','lexi-content-ref-32518780']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-27003987','lexi-content-ref-32518780'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Longer duration of proton pump inhibitor use (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-32518780']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-32518780'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Parenteral nutrition (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30020891']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30020891'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Combined administration of antibiotics (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30020891','lexi-content-ref-31118710']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30020891','lexi-content-ref-31118710'])">Ref</a></span>)</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Clostridioides difficile diarrhea</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<i>Clostridioides difficile</i> infection (CDI) has occurred, including <b>
<i>Clostridioides difficile</i> associated diarrhea</b> (CDAD) and <b>
<i>Clostridioides difficile</i> colitis</b>.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Mechanism</i>: Dose- and time-related; related to cumulative antibiotic exposure. Amoxicillin may cause disruption of the intestinal microbiota resulting in the overgrowth of pathogens, such as <i>C. difficile</i> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29689301','lexi-content-ref-29462280','lexi-content-ref-21653301']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29689301','lexi-content-ref-29462280','lexi-content-ref-21653301'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset</i>: Varied; may start on the first day of antibiotic therapy or up to 3 months postantibiotic (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25157757','lexi-content-ref-32069358','lexi-content-ref-22146873']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25157757','lexi-content-ref-32069358','lexi-content-ref-22146873'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Risk factors:</i></p>
<p style="text-indent:-2em;margin-left:6em;">• Antibiotic exposure (highest risk factor), especially prolonged use (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-29053792','lexi-content-ref-21653301','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-29053792','lexi-content-ref-21653301','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Type of antibiotic (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23478961','lexi-content-ref-32069358','lexi-content-ref-23620467','lexi-content-ref-24324224','lexi-content-ref-27216385']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23478961','lexi-content-ref-32069358','lexi-content-ref-23620467','lexi-content-ref-24324224','lexi-content-ref-27216385'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Long durations in a hospital or other health care setting (recent or current) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-29053792','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-29053792','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Older adults (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-29053792','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-29053792','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Immunocompromised conditions (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-29053792','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-29053792','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• A serious underlying condition (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-29053792','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-29053792','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• GI surgery/manipulation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29462280','lexi-content-ref-27216385']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29462280','lexi-content-ref-27216385'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Antiulcer medications (eg, proton pump inhibitors, H2 blockers) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Chemotherapy (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-CDC.1','lexi-content-ref-29462280','lexi-content-ref-27216385','lexi-content-ref-29272341'])">Ref</a></span>)</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Hypersensitivity and immunologic reactions (immediate and delayed)</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:2em;">Hypersensitivity and immunologic reactions (immediate and delayed) range from <b>skin rash</b> to rare cases of <b>anaphylaxis</b> in adult and pediatric patients (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-cho.2020','lexi-content-ref-34384710','lexi-content-ref-34306301','lexi-content-ref-34271183','lexi-content-ref-33292467']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-cho.2020','lexi-content-ref-34384710','lexi-content-ref-34306301','lexi-content-ref-34271183','lexi-content-ref-33292467'])">Ref</a></span>). Severe cutaneous adverse reactions (SCARs), including <b>Stevens-Johnson syndrome</b> and <b>toxic epidermal necrolysis</b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30051945','lexi-content-ref-31614216']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30051945','lexi-content-ref-31614216'])">Ref</a></span>), <b>drug rash with eosinophilia and systemic symptoms </b>(DRESS) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25369238','lexi-content-ref-33777581','lexi-content-ref-30973334']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25369238','lexi-content-ref-33777581','lexi-content-ref-30973334'])">Ref</a></span>), and <b>acute generalized exanthematous pustulosis </b> (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30121684','lexi-content-ref-26783390']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30121684','lexi-content-ref-26783390'])">Ref</a></span>) have been reported. <b>Aseptic meningitis</b> has also been documented (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-31219042']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-31219042'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Mechanism: </i>Non–dose-related; immunologic. Immediate hypersensitivity reactions (eg, anaphylaxis, urticaria) are IgE-mediated. Delayed hypersensitivity reactions, such as maculopapular rash and SCARs, are T-cell-mediated (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30558872','lexi-content-ref-cho.2020','lexi-content-ref-24073903','lexi-content-ref-28965641']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30558872','lexi-content-ref-cho.2020','lexi-content-ref-24073903','lexi-content-ref-28965641'])">Ref</a></span>). Amoxicillin may trigger a flare of DRESS caused by other drugs, such as carbamazepine and allopurinol (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-20653681']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-20653681'])">Ref</a></span>), possibly through reactivation of HHV-6 (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23936716']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23936716'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Onset:</i> Immediate hypersensitivity reactions: Rapid; occur within 1 hour of administration but may occur up to 6 hours after exposure (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30558872']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30558872'])">Ref</a></span>). Delayed hypersensitivity reactions: Maculopapular rash reactions: Intermediate; occur 7 to 10 days after initiation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-24073903','lexi-content-ref-34384710']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-24073903','lexi-content-ref-34384710'])">Ref</a></span>). Other reactions (including SCARs): Varied; occur after days to 8 weeks after initiation (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25369238','lexi-content-ref-26120552','lexi-content-ref-NICE.1','lexi-content-ref-31614216']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25369238','lexi-content-ref-26120552','lexi-content-ref-NICE.1','lexi-content-ref-31614216'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Risk factors:</i></p>
<p style="text-indent:-2em;margin-left:6em;">• Cross-reactivity between penicillins and cephalosporins and among cephalosporins is mostly related to side chain similarity (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-29408440']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-29408440'])">Ref</a></span>). For cephalexin, ampicillin and amoxicillin share identical or similar side chains, respectively, and cross-reactions have been reported (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-25345303','lexi-content-ref-34293504','lexi-content-ref-27016799','lexi-content-ref-29408440']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-25345303','lexi-content-ref-34293504','lexi-content-ref-27016799','lexi-content-ref-29408440'])">Ref</a></span>). Additionally, cross-reactivity between benzylpenicillin and aminopenicillins (eg, amoxicillin, ampicillin) may occur (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-33500632']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-33500632'])">Ref</a></span>).</p>
<p style="text-indent:-2em;margin-left:6em;">• Viral infections (eg, Epstein-Barr virus [infectious mononucleosis], cytomegalovirus, HHV 6 and 7) (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-30558872','lexi-content-ref-28965641']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-30558872','lexi-content-ref-28965641'])">Ref</a></span>)</p>
<p style="text-indent:-2em;margin-left:6em;">• Epstein-Barr virus (EBV): Reported incidence of skin rash is higher in patients with an acute EBV infection concomitantly treated with amoxicillin (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-23589810']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-23589810'])">Ref</a></span>), although not all studies have shown similar results (<span class="ref-callout-list"><a aria-label="list of references" class="ref-callout-list-link" lexi-content-ref-id="['lexi-content-ref-26893522','lexi-content-ref-29617685']" onclick="event.preventDefault(); window.mobileOpenReferences &amp;&amp; mobileOpenReferences(['lexi-content-ref-26893522','lexi-content-ref-29617685'])">Ref</a></span>).</p></div>
</div>
</div>
<div class="block adr drugH1Div" id="F134479"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">1% to 10%: Gastrointestinal: Diarrhea, nausea, vomiting</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Dermatologic: Acute generalized exanthematous pustulosis (Choon 2018), erythema multiforme, erythematous maculopapular rash (Koosakulchai 2021), exfoliative dermatitis, pruritus, skin rash (Katoh 2021), Stevens-Johnson syndrome (Yang 2020), toxic epidermal necrolysis (Yang 2020), urticaria (Koosakulchai 2021)</p>
<p style="text-indent:-2em;margin-left:4em;">Gastrointestinal: <i>Clostridioides difficile</i> colitis, <i>Clostridioides difficile</i>-associated diarrhea, hemorrhagic colitis, melanoglossia, mucocutaneous candidiasis, staining of tooth</p>
<p style="text-indent:-2em;margin-left:4em;">Genitourinary: Crystalluria</p>
<p style="text-indent:-2em;margin-left:4em;">Hematologic &amp; oncologic: Agranulocytosis, anemia, eosinophilia, hemolytic anemia (Rossi 2010), immune thrombocytopenia, leukopenia, neutropenia (Curtis 2017), thrombocytopenia</p>
<p style="text-indent:-2em;margin-left:4em;">Hepatic: Cholestatic hepatitis (Kim 2011), cholestatic jaundice, hepatitis (acute cytolytic), increased serum alanine aminotransferase (Kim 2011), increased serum aspartate aminotransferase (Kim 2011)</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Anaphylactic shock, anaphylaxis (Piotin 2021), angioedema (Koosakulchai 2021), drug reaction with eosinophilia and systemic symptoms (De La Cruz 2021), hypersensitivity angiitis (Garcia-Porrua 1999), nonimmune anaphylaxis, serum sickness-like reaction (Mohsenzadeh 2020)</p>
<p style="text-indent:-2em;margin-left:4em;">Nervous system: Agitation, anxiety, aseptic meningitis, behavioral changes, confusion, dizziness, hyperactive behavior (reversible), insomnia, seizure</p></div>
<div class="block coi drugH1Div" id="F134495"><span class="drugH1">Contraindications</span>
<p style="text-indent:-2em;margin-left:2em;">Serious hypersensitivity to amoxicillin (eg, anaphylaxis, Stevens-Johnson syndrome) or to other beta-lactams, or any component of the formulation</p>
<p style="text-indent:-2em;margin-left:2em;">
<i>Canadian labeling:</i> Additional contraindications (not in US labeling): Infectious mononucleosis (suspected or confirmed)</p></div>
<div class="block war drugH1Div" id="F134476"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Superinfection: Prolonged use may result in fungal or bacterial superinfection.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Disease-related concerns:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Infectious mononucleosis: A high percentage of patients with infectious mononucleosis develop an erythematous rash during amoxicillin therapy; avoid use in these patients.</p>
<p style="text-indent:-2em;margin-left:4em;">• Renal impairment: Use with caution in patients with renal impairment; dosage adjustment recommended.</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>
<i>Dosage form specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;">• Benzyl alcohol and derivatives: Some dosage forms may contain sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol; large amounts of benzyl alcohol (≥99 mg/kg/day) have been associated with a potentially fatal toxicity (“gasping syndrome”) in neonates; the “gasping syndrome” consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension, and cardiovascular collapse (AAP ["Inactive" 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol derivative with caution in neonates. See manufacturer's labeling.</p>
<p style="text-indent:-2em;margin-left:4em;">• Chewable tablets: May contain phenylalanine; see manufacturer's labeling.</p></div>
<div class="block foc drugH1Div" id="F134488"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Capsule, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 250 mg, 500 mg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension Reconstituted, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 125 mg/5 mL (80 mL, 100 mL, 150 mL); 200 mg/5 mL (50 mL, 75 mL, 100 mL); 250 mg/5 mL (80 mL, 100 mL, 150 mL); 400 mg/5 mL (50 mL, 75 mL, 100 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 500 mg, 875 mg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet Chewable, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 125 mg, 250 mg</p></div>
<div class="block geq drugH1Div" id="F134472"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">Yes</p></div>
<div class="block fee drugH1Div" id="F134497"><span class="drugH1">Pricing: US</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Capsules</b> (Amoxicillin Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">250 mg (per each): $0.13 - $0.25</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">500 mg (per each): $0.19 - $0.39</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Chewable</b> (Amoxicillin Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">125 mg (per each): $0.37</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">250 mg (per each): $0.74</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Suspension (reconstituted)</b> (Amoxicillin Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">125 mg/5 mL (per mL): $0.04</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">200 mg/5 mL (per mL): $0.09</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">250 mg/5 mL (per mL): $0.06</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">400 mg/5 mL (per mL): $0.10</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>Tablets</b> (Amoxicillin Oral)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">500 mg (per each): $0.50</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">875 mg (per each): $0.87</p>
<p style="text-indent:0em;">
<b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>
<div class="block dinfoc drugH1Div" id="F52865907"><span class="drugH1">Dosage Forms: Canada</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.  [DSC] = Discontinued product</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Capsule, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Polymox: 250 mg, 500 mg</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 250 mg, 500 mg</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Suspension Reconstituted, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Polymox: 125 mg/5 mL (150 mL); 250 mg/5 mL (150 mL)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 125 mg/5 mL (100 mL, 150 mL); 250 mg/5 mL (75 mL, 100 mL, 150 mL)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Tablet Chewable, Oral: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Generic: 125 mg [DSC], 250 mg</p></div>
<div class="block exp drugH1Div" id="F57631813"><span class="drugH1">Extemporaneous Preparations</span>
<p style="text-indent:0em;display:inline">
<b>Note:</b> Due to ongoing shortages of commercially available liquid preparations, the FDA has provided guidance regarding extemporaneous preparation using tablets or capsules for individual patients (FDA 2022).</p>
<p style="text-indent:-2em;margin-left:2em;">
<b>50 mg/mL Oral Suspension:</b></p>
<p style="text-indent:-2em;margin-left:4em;">
<b>Note:</b> Use dedicated or disposable equipment, follow appropriate cleaning procedures, and avoid dust (ie, by wetting with vehicle and mixing carefully) to avoid contamination of compounding area since product is beta-lactam.</p>
<p style="text-indent:-2em;margin-left:4em;">A 50 mg/mL oral suspension may be made with capsules or tablets and Ora-Blend or other oral suspension vehicle of choice. To prepare 100 mL, calculate the number of tablets or capsules needed to equal amoxicillin 5,000 mg; if using tablets, crush required number of tablets in a mortar and reduce to a fine powder; if using capsules, empty the contents of required number of capsules into a mortar. Add ~10 mL of vehicle (Ora-Blend, Ora-Blend SF, or other oral suspension of choice) and mix carefully to form a smooth paste. Add incremental amounts of vehicle to final volume of 100 mL, mixing thoroughly after each addition. Package in a tight, light-resistant container and label "shake well" and "refrigerate." Suspension may be stored for up to 14 days refrigerated.</p>
<div class="reference">Allen LV. Amoxicillin 50 mg/mL oral suspension. <i>US Pharm</i>. 2022;47(12):59-60.</div>
</div>
<div class="block admp drugH1Div" id="F52612229"><span class="drugH1">Administration: Pediatric</span>
<p style="text-indent:0em;display:inline">Oral: May be administered on an empty or full stomach; may be mixed with small amount of formula, milk, cold drink, or juice; administer dose immediately after mixing; shake suspension well before use.</p></div>
<div class="block adm drugH1Div" id="F134492"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:-2em;margin-left:2em;">
<b>Oral:</b> Administer around-the-clock to promote less variation in peak and trough serum levels.</p>
<p style="text-indent:-2em;margin-left:2em;">Suspension: Shake well before use; may be mixed with formula, milk, fruit juice, water, ginger ale, or cold drinks; administer dose immediately after mixing.</p></div>
<div class="block sts drugH1Div" id="F134506"><span class="drugH1">Storage/Stability</span>
<p style="text-indent:0em;display:inline">Capsule, tablet, oral suspension (prior to reconstitution): Store at room temperature. Reconstituted oral suspension remains stable for 14 days at room temperature or refrigerated (refrigeration preferred) (<b>Note:</b> Canadian oral suspension storage recommendations may vary; refer to manufacturer’s labeling). Unit-dose antibiotic oral syringes are stable at room temperature for at least 72 hours (Tu 1988).</p></div>
<div class="block usep drugH1Div" id="F53565398"><span class="drugH1">Use</span>
<p style="text-indent:-2em;margin-left:2em;">Treatment of infections of skin and soft tissue, GU tract, or upper or lower respiratory tract due to susceptible organisms (FDA approved in all ages); combination therapy of <i>Helicobacter pylori</i> (FDA approved in adults); has also been used for the treatment of Lyme disease and acute osteoarticular infection; prophylaxis of bacterial endocarditis, prophylaxis of pneumococcal infection in patients with sickle cell disease or asplenia, prophylaxis of peritonitis in patients undergoing dental treatment or treatment of exit-site or tunnel infections in patients with peritoneal dialysis catheters, urinary tract infection prophylaxis, and postexposure prophylaxis and treatment of anthrax.</p></div>
<div class="block mst drugH1Div" id="F134569"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Amoxicillin may be confused with amoxapine, Augmentin</p>
<p style="text-indent:-2em;margin-left:4em;">Amoxil may be confused with amoxapine</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">International issues:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Fisamox [Australia] may be confused with Fosamax brand name for alendronate [US, Canada, and multiple international markets] and Vigamox brand name for moxifloxacin [US, Canada, and multiple international markets]</p>
<p style="text-indent:-2em;margin-left:4em;">Limoxin [Mexico] may be confused with Lanoxin brand name for digoxin [US, Canada, and multiple international markets]; Lincocin brand name for lincomycin [US, Canada, and multiple international markets]</p>
<p style="text-indent:-2em;margin-left:4em;">Zimox: Brand name for amoxicillin [Italy], but also the brand name for carbidopa/levodopa [Greece]</p>
<p style="text-indent:-2em;margin-left:4em;">Zimox [Italy] may be confused with Diamox which is the brand name for acetazolamide [Canada and multiple international markets]</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13298741"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">
<b>Substrate</b> of OAT1/3</p></div>
<div class="block dri drugH1Div" id="F134481"><span class="drugH1">Drug Interactions</span><br/><br/><div class="clear"></div><p xmlns=""></p><div class="inner" xmlns=""><p style="text-indent:0em;display:inline"><b>Note</b>: Interacting drugs may <b>not be individually listed below</b> if they are part of a group interaction (eg, individual drugs within “CYP3A4 Inducers [Strong]” are NOT listed).  For a complete list of drug interactions by individual drug name and detailed management recommendations, use the Lexicomp drug interactions program by clicking on the “Launch drug interactions program” link above.</p><p xmlns=""></p></div>
<p style="text-indent:-2em;margin-left:2em;">Acemetacin: May increase the serum concentration of Penicillins.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Allopurinol: May enhance the potential for allergic or hypersensitivity reactions to Amoxicillin.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Aminoglycosides: Penicillins may decrease the serum concentration of Aminoglycosides. Primarily associated with extended spectrum penicillins, and patients with renal dysfunction. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Bacillus clausii: Antibiotics may diminish the therapeutic effect of Bacillus clausii.  Management: Bacillus clausii should be taken in between antibiotic doses during concomitant therapy.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">BCG (Intravesical): Antibiotics may diminish the therapeutic effect of BCG (Intravesical). <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">BCG Vaccine (Immunization): Antibiotics may diminish the therapeutic effect of BCG Vaccine (Immunization). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Cholera Vaccine: Antibiotics may diminish the therapeutic effect of Cholera Vaccine.  Management: Avoid cholera vaccine in patients receiving systemic antibiotics, and within 14 days following the use of oral or parenteral antibiotics.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Dichlorphenamide: Penicillins may enhance the hypokalemic effect of Dichlorphenamide. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Fecal Microbiota (Live) (Oral): May diminish the therapeutic effect of Antibiotics.<i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Fecal Microbiota (Live) (Rectal): Antibiotics may diminish the therapeutic effect of Fecal Microbiota (Live) (Rectal). <i> Risk X: Avoid combination</i></p>
<p style="text-indent:-2em;margin-left:2em;">Immune Checkpoint Inhibitors (Anti-PD-1, -PD-L1, and -CTLA4 Therapies): Antibiotics may diminish the therapeutic effect of Immune Checkpoint Inhibitors (Anti-PD-1, -PD-L1, and -CTLA4 Therapies). <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Khat: May decrease the serum concentration of Amoxicillin. Management: Consider administering amoxicillin before, or 2 hours after, khat chewing to avoid reductions in amoxicillin bioavailability.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Lactobacillus and Estriol: Antibiotics may diminish the therapeutic effect of Lactobacillus and Estriol. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Methotrexate: Penicillins may increase the serum concentration of Methotrexate. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Mycophenolate: Penicillins may decrease serum concentrations of the active metabolite(s) of Mycophenolate. This effect appears to be the result of impaired enterohepatic recirculation. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Probenecid: May increase the serum concentration of Penicillins.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Sodium Benzoate: Penicillins may diminish the therapeutic effect of Sodium Benzoate. <i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Sodium Picosulfate: Antibiotics may diminish the therapeutic effect of Sodium Picosulfate.  Management: Consider using an alternative product for bowel cleansing prior to a colonoscopy in patients who have recently used or are concurrently using an antibiotic.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Tetracyclines: May diminish the therapeutic effect of Penicillins.<i> Risk C: Monitor therapy</i></p>
<p style="text-indent:-2em;margin-left:2em;">Typhoid Vaccine: Antibiotics may diminish the therapeutic effect of Typhoid Vaccine. Only the live attenuated Ty21a strain is affected.  Management: Avoid use of live attenuated typhoid vaccine (Ty21a)  in patients being treated with systemic antibacterial agents. Postpone vaccination until 3 days after cessation of antibiotics and avoid starting antibiotics within 3 days of last vaccine dose.<i> Risk D: Consider therapy modification</i></p>
<p style="text-indent:-2em;margin-left:2em;">Vitamin K Antagonists (eg, warfarin): Penicillins may enhance the anticoagulant effect of Vitamin K Antagonists. <i> Risk C: Monitor therapy</i></p></div>
<div class="block dic drugH1Div" id="F134498"><span class="drugH1">Dietary Considerations</span>
<p style="text-indent:0em;display:inline">Some products may contain phenylalanine.</p></div>
<div class="block pri drugH1Div" id="F5720643"><span class="drugH1">Pregnancy Considerations</span>
<p style="text-indent:0em;">Amoxicillin crosses the placenta (Muller 2009; Zareba-Szczudlik 2017). Maternal serum concentrations are significantly greater than the umbilical cord, placenta, and amniotic fluid concentrations when amoxicillin is administered orally prior to delivery (Buckingham 1975; Zareba-Szczudlik 2017).</p>
<p style="text-indent:0em;margin-top:2em;">Due to pregnancy-induced physiologic changes, some pharmacokinetic parameters of oral amoxicillin may be altered. Renal clearance is increased in the second and third trimester compared to postpartum values. In addition, oral absorption is decreased during labor. Maternal adipose tissue and the presence of anemia may influence maternal serum and amniotic fluid concentrations. Although minimum inhibitory concentrations can be reached, higher oral doses (or a parenteral antibiotic) may be needed based on the specific maternal infection or if treating an infection of the fetus and/or placenta (Andrew 2007; Buckingham 1975; Zareba-Szczudlik 2017).</p>
<p style="text-indent:0em;margin-top:2em;">As a class, penicillin antibiotics are widely used in pregnant patients. Based on available data, penicillin antibiotics are generally considered compatible for use during pregnancy (Ailes 2016; Bookstaver 2015; Crider 2009; Damkier 2019; Lamont 2014; Muanda 2017a; Muanda 2017b).</p>
<p style="text-indent:0em;margin-top:2em;">Amoxicillin may be used for the management of <i>Bacillus anthracis </i>in pregnant patients when penicillin susceptibility is documented. Maternal infection with <i>B. anthracis </i>may cause preterm labor, fetal infection, fetal distress, or fetal loss. Maternal death may also occur. Amoxicillin is an alternative agent for the treatment of cutaneous anthrax without systemic involvement and for the postexposure prophylaxis of <i>B. anthracis</i> during pregnancy<i>.</i> The dose and duration of amoxicillin therapy in pregnant and postpartum patients is the same as in nonpregnant adults. Adjustments in dose for pregnancy are not recommended until additional pharmacokinetic data become available (Meaney-Delman 2014).</p>
<p style="text-indent:0em;margin-top:2em;">Untreated chlamydial disease can cause pelvic inflammatory disease, ectopic pregnancy, and infertility. In addition, treatment of maternal disease usually prevents transmission to the neonate during birth. Due to concerns of chlamydia persistence following exposure to penicillin class antibiotics, amoxicillin is an alternative antibiotic for the treatment of chlamydial infections in pregnancy (CDC [Workowski 2021]).</p>
<p style="text-indent:0em;margin-top:2em;">Amoxicillin is used for the treatment of Lyme disease. Vertical transmission from mother to fetus is not well documented; it is unclear if infection increases the risk of adverse pregnancy outcomes. When treatment for Lyme disease in pregnancy is needed, the indications and dosing of amoxicillin are the same as in nonpregnant patients (IDSA/AAN/ACR [Lantos 2021]; Lambert 2020; SOGC [Smith 2020]).</p>
<p style="text-indent:0em;margin-top:2em;">Untreated urinary tract infections (UTIs) during pregnancy are associated with an increased risk of developing pyelonephritis, low birth weight, and preterm labor. Amoxicillin may be an option for the treatment of UTI during pregnancy (de Rossi 2020; IDSA [Nicolle 2019]).</p>
<p style="text-indent:0em;margin-top:2em;">Amoxicillin is used in the management of <i>H. pylori </i>eradication. <i>H. pylori </i>is associated with hyperemesis gravidarum and may be linked to other adverse maternal and fetal outcomes. Treatment in patients with mild or no symptoms is generally delayed until after delivery; however, amoxicillin may be considered as part of a treatment regimen when otherwise appropriate (Cardaropoli 2014; Nguyen 2019; Zhan 2019).</p>
<p style="text-indent:0em;margin-top:2em;">Amoxicillin can also be used in the management of preterm prelabor rupture of membranes (PROM); treatment with antibiotics is used to prolong pregnancy and decrease maternal and newborn infections (ACOG 217 2020). Amoxicillin may also be used in certain situations prior to vaginal delivery in patients at high risk for endocarditis (ACOG 199 2018).</p>
<p style="text-indent:0em;margin-top:2em;">Amoxicillin is considered compatible for the treatment airway diseases in pregnant patients (ERS/TSANZ [Middleton 2020]).</p></div>
<div class="block mopp drugH1Div" id="F53565399"><span class="drugH1">Monitoring Parameters</span>
<p style="text-indent:0em;display:inline">With prolonged therapy, monitor renal, hepatic, and hematologic function; observe for change in bowel frequency; monitor for signs and symptoms of hypersensitivity, including anaphylaxis.</p></div>
<div class="block pha drugH1Div" id="F134475"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Inhibits bacterial cell wall synthesis by binding to one or more of the penicillin-binding proteins (PBPs) which in turn inhibits the final transpeptidation step of peptidoglycan synthesis in bacterial cell walls, thus inhibiting cell wall biosynthesis. Bacteria eventually lyse due to ongoing activity of cell wall autolytic enzymes (autolysins and murein hydrolases) while cell wall assembly is arrested.</p></div>
<div class="block phk drugH1Div" id="F134494"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Absorption: Oral: Rapid with or without food; delayed absorption may be seen in some neonates and infants &lt;60 days of age (Mir 2020).</p>
<p style="text-indent:-2em;margin-left:2em;">Distribution: Readily into liver, lungs, prostate, muscle, middle ear effusions, maxillary sinus secretions, bone, gallbladder, bile, and ascitic and synovial fluids; poor cerebrospinal fluid penetration (except when meninges are inflamed).</p>
<p style="text-indent:-2em;margin-left:4em;">V<sub>d</sub>:</p>
<p style="text-indent:-2em;margin-left:6em;">Neonates, including preterm (GA: 25 to 42 weeks; PNA: ≤9 days): 0.65 ± 0.13 L/kg (Pullen 2006).</p>
<p style="text-indent:-2em;margin-left:6em;">Infants ≥3 months of age and children ≤5 years of age: 1.44 ± 0.37 L/kg (Canafax 1998).</p>
<p style="text-indent:-2em;margin-left:2em;">Protein binding: ~20%.</p>
<p style="text-indent:-2em;margin-left:2em;">Bioavailability: Oral suspension: Neonates (GA: 37 to 43 weeks; PNA: 6 to 12 days): 75% (range: 60% to 101%) (Lönnerholm 1982).</p>
<p style="text-indent:-2em;margin-left:2em;">Half-life elimination:</p>
<p style="text-indent:-2em;margin-left:4em;">Preterm and term neonates (GA: 25 to 42 weeks; PNA: ≤9 days): 5.2 ± 1.9 hours (Pullen 2006).</p>
<p style="text-indent:-2em;margin-left:4em;">Adults: 61.3 minutes.</p>
<p style="text-indent:-2em;margin-left:2em;">Time to peak:</p>
<p style="text-indent:-2em;margin-left:4em;">Preterm and term neonates (PNA: &lt;5 days): Oral suspension: ~4 hours (Cohen 1975; Weingartner 1977); reported mean range: 2 to 6 hours (Keij 2019).</p>
<p style="text-indent:-2em;margin-left:4em;">Adults: Capsule, oral suspension: 1 to 2 hours; chewable tablet: 1 hour.</p>
<p style="text-indent:-2em;margin-left:2em;">Excretion: Urine (60% as unchanged drug); lower in neonates (Cohen 1975; Weingartner 1977).</p></div>
<div class="block phksp drugH1Div" id="F54868136"><span class="drugH1">Pharmacokinetics: Additional Considerations (Adult Data Unless Noted)</span>
<p style="text-indent:-2em;margin-left:2em;">Anti-infective considerations:</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Parameters associated with efficacy</i>:</p>
<p style="text-indent:-2em;margin-left:6em;">Time dependent; associated with time free drug concentration (<i>f</i>T) &gt; minimum inhibitory concentration, goal: ≥40% to 50% (bactericidal) (Andes 1998; Craig 1996; Craig 1998; Gustafsson 2001).</p>
<p style="text-indent:-2em;margin-left:8em;">Expected drug exposure in normal renal function:</p>
<p style="text-indent:-2em;margin-left:10em;">Infants ≥3 months of age and children ≤4 years of age, C<sub>max</sub> (peak):</p>
<p style="text-indent:-2em;margin-left:12em;">15 mg/kg/dose 3 times daily, steady state: 7.9 ± 3.5 mg/L (Fonseca 2003).</p>
<p style="text-indent:-2em;margin-left:12em;">25 mg/kg/dose twice daily, steady state: 10.6 ± 5.1 mg/L (Fonseca 2003).</p>
<p style="text-indent:-2em;margin-left:10em;">Adults, C<sub>max</sub> (peak):</p>
<p style="text-indent:-2em;margin-left:12em;">125 mg, single dose (125 mg per 5 mL suspension): 1.5 to 3 mg/L.</p>
<p style="text-indent:-2em;margin-left:12em;">250 mg, single dose (capsule or 250 mg per 5 mL suspension): 3.5 to 5 mg/L.</p>
<p style="text-indent:-2em;margin-left:12em;">400 mg, single dose (chewable tablet): 5.18 ± 1.64 mg/L.</p>
<p style="text-indent:-2em;margin-left:12em;">400 mg, single dose (400 mg per 5 mL suspension): 5.92 ± 1.62 mg/L.</p>
<p style="text-indent:-2em;margin-left:12em;">500 mg, single dose: 5.5 to 7.5 mg/L.</p>
<p style="text-indent:-2em;margin-left:12em;">875 mg, single dose: 13.8 ± 4.1 mg/L.</p>
<p style="text-indent:-2em;margin-left:4em;">
<i>Postantibiotic effect</i>:</p>
<p style="text-indent:-2em;margin-left:6em;">
<i>H. influenzae:</i> &lt;1 hour; <i>S. pneumoniae:</i> 0.3 to 5.8 hours; viridans streptococci: 0.7 to 2 hours<i> (</i>Davies 2000; Dubois 2000; Lee 2000).</p></div>
<div class="list fbnlist drugH1Div drugBrandNames" id="F134499"><span class="drugH1">Brand Names: International</span><div class="ibn-search drugBrandNames"></div>
<div class="collapsible-indication brand-names-accordion drugBrandNames"><span class="collapsible-indication-title">International Brand Names by Country</span><div class="collapsible-indication-wrap-frame drugBrandNames"><div class="collapsible-indication-wrap drugBrandNames">For country code abbreviations (<a class="graphic graphic_table" href="/d/html/116421.html" rel="external">show table</a>)<br xmlns=""/><br/><ul>
<li>
<span class="countryCode">(AE)</span> <span class="country">United Arab Emirates</span><span class="countrySeparator">: </span><span class="drugName">Amoxidin | Amoxil | Amoxipen | Amoxycillin | Amoxydar | Danoxillin | E mox | Flemoxin | Glomox | Hiconcil | Hipen | Hymox | Ibiamox | Julphamox | Moxilen | Neomox | Omacillin | Ospamox | Penamox | Princimox | Ranoxyl | Remox | Ultramox</span>;</li>
<li>
<span class="countryCode">(AR)</span> <span class="country">Argentina</span><span class="countrySeparator">: </span><span class="drugName">Almorsan | Amox-g | Amox-g duo | Amoxi duo mar | Amoxi Gno | Amoxi mar | Amoxibiot | Amoxibiot forte | Amoxicilina | Amoxicilina drawer | Amoxicilina duo fecofar | Amoxicilina fecofar | Amoxicilina lacefa | Amoxicilina lemax | Amoxicilina medipharma | Amoxicilina puntanos | Amoxicilina richet | Amoxicilina richet duo | Amoxicilina sant gall friburg | Amoxicilina shabba | Amoxicilina vannier | Amoxicina | Amoxicler | Amoxidal | Amoxidal duo | Amoxifarma | Amoxigrand | Amoxipenil | Amoxipoten | Amoxitenk | Amoxol | Amoxol duo | Ardine | Atrival | Biolabsa | Biolabsa duo | Biotamoxal | Bioxilina | Clofamox | Darzitil | Darzitil duo | Darzitil plus | Dunox | Fabamox | Fada amoxicilina | Fullcilina | Fullcilina duo | Grinsil | Larocilin | Mixcilin | Moxitral | Nobactam | Oximar | Ralipen | Trifamox | Xalotina</span>;</li>
<li>
<span class="countryCode">(AT)</span> <span class="country">Austria</span><span class="countrySeparator">: </span><span class="drugName">Amoxicillin 1a pharma | Amoxicillin hexal | Amoxicillin ratiopharm | Amoxihexal | Amoxilan | Amoxistad | Clamoxyl | Eramox | Ospamox</span>;</li>
<li>
<span class="countryCode">(AU)</span> <span class="country">Australia</span><span class="countrySeparator">: </span><span class="drugName">Alphamox | Amiloxyn | Amohexal | Amoxicillin | Amoxil | Amoxil duo | Amoxycillin | Amoxycillin an | Amoxycillin generichealth | Amoxycillin ps | Amoxycillin ranbaxy | Amoxycillin-dp | Apo amoxycillin | Bgramin | Cilamox | Fisamox | Genrx amoxycillin | Ibiamox | Maxamox | Moxacin | Noumed amoxicillin | Ranmoxy | Yomax</span>;</li>
<li>
<span class="countryCode">(BD)</span> <span class="country">Bangladesh</span><span class="countrySeparator">: </span><span class="drugName">Aldalin | Ambeexin | Amocap | Amocil | Amocin | Amolin | Amotid | Amotid f | Amox | Amoxapen | Amoxicap | Amoxicillin | Amoxicillin e | Amoxicon | Amoxil | Amoxilin | Amoxima | Amoxin | Amoxipan | Amoxisyrup | Amoxon | Antif | Apimox | Apoxy | Aristomox | Avlomox | Bactamox | Bitoxil | Bpmox | Brodamox | Cemoxin | Chemoxilin | Cidamox | Clamox | Demox | Demoxil | Dopen | E mox | Emoxil | Fimoxyl | Flamoxin | Gemoxyl | Genamox | Hectamox | Hi mox | Hiconcil | Hymoxyl | J mox | Jamoxil | Kamoxicillin | Kamoxy | Loxyl | Mimox | Moci | Monamox | Mox | Moxa | Moxacil | Moxapen | Moxatid | Moxicillin | Moxico | Moxilin | Moxin | Moxitid | Moxyvan | Mumox | Mymoxcil | Navamox | Neomox | Neucil | Oclomox | Orgamox | Orixyl | Pamoxil | Pemox | Penmox | Pentamox | Pharmoxyl | Primox | Promox | Q-mox | Remamox | Remoxil | Remoxin | Remoxyl | Roxyl | S-amoxy | Sapox | Seemaxyl | Servimox | Simox | Sinamox | Sk mox | Skymoxin | Stamox | Tycil | Tymox | Tymoxil | Ultramox | Ultrapen | Unimox | Versamox | Xemox | Zimoxyl | Ziskamox</span>;</li>
<li>
<span class="countryCode">(BE)</span> <span class="country">Belgium</span><span class="countrySeparator">: </span><span class="drugName">Amocilline | Amoxi | Amoxicillin ab | Amoxicilline apotex | Amoxicilline bexal | Amoxicilline eg | Amoxicilline Eurogenerics | Amoxicilline merck-generics | Amoxicilline sandoz | Amoxicilline teva generics belgium | Amoxycaps | Amoxypen | Bactimed | Clamoxyl | Clamoxyl-Gsk | Docamoxici | Flemoxin | Hiconcil | Moxaline | Moxitop</span>;</li>
<li>
<span class="countryCode">(BF)</span> <span class="country">Burkina Faso</span><span class="countrySeparator">: </span><span class="drugName">Amoxi denk | Amoxicilline | Amoxicilline sandoz | Amoxicilline ubigen | Amoxicilline winthrop | Amoxirex | Bactox | Clamoxyl | Hiconcil | Imox | Linmox | Ospamox | Penamox | Philco Amoxy | Ranoxyl</span>;</li>
<li>
<span class="countryCode">(BG)</span> <span class="country">Bulgaria</span><span class="countrySeparator">: </span><span class="drugName">Amopen | Medospamox | Ospamox | Ranoxyl | Upsamox</span>;</li>
<li>
<span class="countryCode">(BR)</span> <span class="country">Brazil</span><span class="countrySeparator">: </span><span class="drugName">Amox-ems | Amoxadene | Amoxi-ped | Amoxibel | Amoxibron | Amoxicap | Amoxicilina | Amoxidil | Amoxifar | Amoxil | Amoxil bd | Amoximed | Amoxina | Amoxipen | Amoxitan | Amplal | Amplamox | Ariproxina | Atak | Axepen | Bimoxin | Camoxin | Cibramox | Cilimox | Duzimicin | Farmoxil | Furp amoxicilina | Germoxil | Hiconcil | Hincomox | Ibamoxil | Iquego amoxicilina | Licilon | Lifamox | Medxil | Moxiplus | Nemoxil | Neo moxilin | Novocilin | Ocylin | Penvicilin | Pharmox | Polibac | Polimoxil | Sinot | Syfmox | Trimox | Ultramox | Uni amox | Uniao amoxicilina | Velamox</span>;</li>
<li>
<span class="countryCode">(CH)</span> <span class="country">Switzerland</span><span class="countrySeparator">: </span><span class="drugName">Amoxi | Amoxi mepha | Amoxi-basan | Amoxicillin 1a pharma | Amoxicillin actavis | Amoxicillin cimex | Amoxicillin HelvePharm | Amoxicillin sandoz | Amoxicillin spirig hc | Amoxicillin-biochemie | Amoxicilline axapharm | Amoxicilline sandoz | Amoxicilline streuli | Azillin | Clamoxyl | Flemoxin | Penimox | Spectroxyl | Supramox</span>;</li>
<li>
<span class="countryCode">(CI)</span> <span class="country">Côte d'Ivoire</span><span class="countrySeparator">: </span><span class="drugName">Agram | Amitron | Amodex | Amokod | Amoxal | Amoxi denk | Amoxicap | Amoxicillin | Amoxicillin creacil | Amoxicilline | Amoxicilline bristol myers | Amoxicilline ubigen | Amoxicilline winthrop | Amoxil | Amoxyn | Apo amoxi | Bactox | Bristamox | Linmox | Lyamox | Medomox | Novamox | Ospamox | Penamox | Pneumoccid | Polymoxyl | Pulmoxyl | Ranoxyl | Theomox | Umoxil | Zamocilline</span>;</li>
<li>
<span class="countryCode">(CL)</span> <span class="country">Chile</span><span class="countrySeparator">: </span><span class="drugName">Abiolex | Abiolex duo | Amobiotic | Amoval | Amoxicilina | Amoxipenil | Novamox | Optamox | Solomoxy | Unimox</span>;</li>
<li>
<span class="countryCode">(CN)</span> <span class="country">China</span><span class="countrySeparator">: </span><span class="drugName">A ke lin | A mo jun | A mo xian | Amoxicillin | Amoxy | Amoxycillin | Flemoxin | Jiang bi lin | Lu tai ling | Mai lin guang | Mo sa | Penamox | Ri ao | Xin da bei ning | Ya bao li ke | Yi jun | Yi sa lin | Zai lin</span>;</li>
<li>
<span class="countryCode">(CO)</span> <span class="country">Colombia</span><span class="countrySeparator">: </span><span class="drugName">Adbiotin | Akrimoxy | Aldrimox | Alfacilina | Amicil | Amoxal | Amoxem | Amoxen | Amoxicilina | Amoxicilina bcn | Amoxicilina mk | Amoxidal | Amoxil | Amoxipen | Amoxolqrp | Amoxtrix | Ampitrex | Ampliex | Amprex | Bactroless | Bristamox | Cofradin | Decacilin | Deltmoxi | Eumoxina | Faramox | Infemox | Kiddol | Moxacin | Neogram | Orvimox | Ospamox | Servamox | Solomoxy | Tramotal | Trifamox | Trifamox duo | Tripsopen | Vonamocylin | Weidermicina | Zakmar | Zamox</span>;</li>
<li>
<span class="countryCode">(CZ)</span> <span class="country">Czech Republic</span><span class="countrySeparator">: </span><span class="drugName">Apo amoxi | Ospamox</span>;</li>
<li>
<span class="countryCode">(DE)</span> <span class="country">Germany</span><span class="countrySeparator">: </span><span class="drugName">Amagesan | Amoxi | Amoxi 1a pharma | Amoxi abz | Amoxi basf | Amoxi CT | Amoxi diolan | Amoxi hefa | Amoxi hp | Amoxi saar | Amoxibeta | Amoxibeta T | Amoxicillin | Amoxicillin aristo | Amoxicillin billix | Amoxicillin denk | Amoxicillin dura | Amoxicillin Heumann | Amoxicillin micro labs | Amoxicillin puren | Amoxidoc | Amoxihexal | Amoxillat | Amoximerck | Amoxypen | Byk amoxicillin | Dignoamoxicillin | Dura ax | Easymox | Espa Moxin | Infectomox | Infectomycin | Jephoxin | Jutamox | Ospamox | Phamoxi | Sigamopen | Zamocillin</span>;</li>
<li>
<span class="countryCode">(DO)</span> <span class="country">Dominican Republic</span><span class="countrySeparator">: </span><span class="drugName">Acimox | Aliveg | Amicil | Amitron | Amolix | Amotran | Amoval | Amoxicilina | Amoxicilina cinfa | Amoxicilina lam | Amoxidal | Amoxidin | Amoxifur | Amoxil | Amoxmer | Atenac | Bactamox | Baykid amoxicilina | Binox | Bioxil | Cipamox | Dicilina | Eupen | Grunamox | Inamox | Infemox | Ipoxilina | Linamox | Luframoxil | Magnacyl | Meramox | Modexil | Mopen | Mox | Moxilac | Moxilin | Moxiline | Orbimox | Ospamox | Raudopen | Sumox | Sumox duo | Tracyl | Xilibron</span>;</li>
<li>
<span class="countryCode">(EC)</span> <span class="country">Ecuador</span><span class="countrySeparator">: </span><span class="drugName">Acromox | Amobiotic | Amoval | Amoval duo | Amox | Amoxgran | Amoxicher | Amoxicilina | Amoxicilina la sante | Amoxil | Amoxipen t | Amoxistar | Amoxital | Avamox | Baselmox | Bristamox | Chenamox | Duomox | Ecumox | Grunamox | Julphamox | Libramox | Moxylin | Neomox | Nifamox | Odontocilina | Orquiamox | Ospamox | Oxipen | Proxidal duo | Servamox | Uosomox</span>;</li>
<li>
<span class="countryCode">(EE)</span> <span class="country">Estonia</span><span class="countrySeparator">: </span><span class="drugName">Amocileks | Amopen | Amorion | Amoxicilina aurovitas | Amoxicilina generis | Amoxicillin | Amoxicillin al | Amoxicillin ratiopharm | Amoxicillin sandoz | Amoxilan | Amoxin | Amoxistad | Amoxycillin | Bactox | Eramox | Gonoform | Hiconcil | Moxilen | Ospamox | Penalta | Upsamox</span>;</li>
<li>
<span class="countryCode">(EG)</span> <span class="country">Egypt</span><span class="countrySeparator">: </span><span class="drugName">Alemox | Amoxicid | Amoxicillin | Amoxicillin stada | Amoxil | Amoxycillin | Aramox | Biomox | Delpedox | E mox | Epcimox | Farconcil | Flemoxin | Hicillin | Hiconcil | Ibiamox | Moxacil | Moxipen | Neomoxibact | Organomox | Ospamox | Rivamox | Unimox</span>;</li>
<li>
<span class="countryCode">(ES)</span> <span class="country">Spain</span><span class="countrySeparator">: </span><span class="drugName">Actimoxi | Agerpen | Alfida | Amitron | Amoxaren | Amoxi gobens | Amoxibacter | Amoxicilina alter | Amoxicilina aristo | Amoxicilina aurovitas | Amoxicilina belmac | Amoxicilina bohm | Amoxicilina cinfa | Amoxicilina cuve | Amoxicilina davur | Amoxicilina esteve | Amoxicilina juventus | Amoxicilina kern pharma | Amoxicilina mundogen | Amoxicilina normon | Amoxicilina sandoz | Amoxidel | Apamox | Ardine | Borbalan | Britamox | Bronco tonic | Clamoxyl | Co amoxin | Combitora | Dobriciclin | Hosboral | Remisan | Salvapen | Suamoxil | Tolodina</span>;</li>
<li>
<span class="countryCode">(ET)</span> <span class="country">Ethiopia</span><span class="countrySeparator">: </span><span class="drugName">Amocin | Amoxapen | Amoxi denk | Amoxicillin | Amoxid | Amoxil | Amyn | Asmox | Julphamox | Medomox | Moxipil | Rivamox</span>;</li>
<li>
<span class="countryCode">(FI)</span> <span class="country">Finland</span><span class="countrySeparator">: </span><span class="drugName">Amorion | Amoxicillin Generics | Amoxicillin mip pharma | Amoxin | Amoxipen | Clamox | Imacillin | Penalta</span>;</li>
<li>
<span class="countryCode">(FR)</span> <span class="country">France</span><span class="countrySeparator">: </span><span class="drugName">Amodex | Amophar | Amoxicilline | Amoxicilline almus | Amoxicilline alter | Amoxicilline arrow | Amoxicilline biogaran | Amoxicilline cristers | Amoxicilline hexal | Amoxicilline irex | Amoxicilline ivax | Amoxicilline Merck | Amoxicilline micro labs | Amoxicilline ranbaxy | Amoxicilline ratiopharm | Amoxicilline rpg | Amoxicilline sandoz | Amoxicilline teva | Amoxicilline zydus | Bactox | Bristamox | Clamoxyl | Flemoxine | Gramidil | Hiconcil</span>;</li>
<li>
<span class="countryCode">(GB)</span> <span class="country">United Kingdom</span><span class="countrySeparator">: </span><span class="drugName">Amix | Amoram | Amoxicillin | Amoxident | Amoxidin | Amoxil | Amoxycillin | Amoxycillin almus | Amoxycillin arrow | Amoxycillin berk | Amoxycillin cox | Amoxycillin kent | Amoxycillin sandoz | Amoxydent | Amoxymed | Amrit | Galenamox | Respillin | Rimoxallin | Zoxycil</span>;</li>
<li>
<span class="countryCode">(GH)</span> <span class="country">Ghana</span><span class="countrySeparator">: </span><span class="drugName">Permoxyl</span>;</li>
<li>
<span class="countryCode">(GR)</span> <span class="country">Greece</span><span class="countrySeparator">: </span><span class="drugName">Amospes | Amoxil | Amoximycin | Amoxycillin | Aproxal | Flemoxin | Izoltil | Ospamox | Paradroxil | Triodanin</span>;</li>
<li>
<span class="countryCode">(HK)</span> <span class="country">Hong Kong</span><span class="countrySeparator">: </span><span class="drugName">Amocap | Amolin | Amon-s | Amox | Amoxa | Amoxapen | Amoxicap | Amoxicillin | Amoxigran | Amoxil | Amoxitab | Amoxon-g | Amoxon-p | Amoxon-s | Amoxon-w | Amoxycillin | Amyn | Aroxin | Beamoxy | Edamox | Euromox | Hamoxillin | Hiconcil | Moxarin | Moxcin | Moxen | Moxilen | Moxipen | Moxlin | Neomox | Ospamox | Panmox | Promox | Ranoxyl | Reichamox | Setmoxil | Sinfung | Unicil | Unimox | Vidacillin | Vixmin | Zoramix-f</span>;</li>
<li>
<span class="countryCode">(HR)</span> <span class="country">Croatia</span><span class="countrySeparator">: </span><span class="drugName">Almacin | Amoksicilin | Amoksicilin Belupo | Amoxil | Ospamox | Ospamox bid</span>;</li>
<li>
<span class="countryCode">(HU)</span> <span class="country">Hungary</span><span class="countrySeparator">: </span><span class="drugName">Amoclen | Amogal | Amoxicillin bril | Duomox | Humamoxin | Ospamox</span>;</li>
<li>
<span class="countryCode">(ID)</span> <span class="country">Indonesia</span><span class="countrySeparator">: </span><span class="drugName">Abamox | Amobiotic | Amosterra | Amox | Amoxicillin | Amoxil | Amoxillin | Amoxipen | Amoxsan | Amoxycillin | Arcamox | Berlimox | Broadamox | Bufamoxy | Dexymox | Etamox | Flemoxin | Hiconcil | Holimox | Inamox | Intermoxil | Medimox | Mexylin | Moxlin | Novamox | Novax | Opimox | Ospamox | Pehamoxil | Penmox | Polymox | Rindamox | Robamox | Servamox | Silamox | Sirimox | Supramox | Widecillin | Yusimox | Zemoxil</span>;</li>
<li>
<span class="countryCode">(IE)</span> <span class="country">Ireland</span><span class="countrySeparator">: </span><span class="drugName">Amoxicillin | Amoxil | Clonamox | Galenamox | Geramox | Oramox | Pinamox | Rimoxallin</span>;</li>
<li>
<span class="countryCode">(IL)</span> <span class="country">Israel</span><span class="countrySeparator">: </span><span class="drugName">Amoxi | Hiconcil | Moxypen | Moxyvit | Moxyvit forte</span>;</li>
<li>
<span class="countryCode">(IN)</span> <span class="country">India</span><span class="countrySeparator">: </span><span class="drugName">A-mox | Acemox | Admoxin | Allmox | Almox | Alphamox | Amlox | Amocin | Amodryn | Amodux | Amotex | Amotid | Amox | Amoxi | Amoxicillin | Amoxil | Amoxinga | Amoxipen | Amoxivan | Amoxy | Amoxybid | Amoxycillin | Amoxygull | Amoxylin | Amoxysain | Amoxytop | Amurol | Amx | Amyn | Angemox | Antimox | Aristomox | Arpimox | Atmox | Axn | Bactomox | Baromox | Bemox | Bemoxy | Benimox | Betmox | Bigmox | Biomox | Biomoxil | Bitamox | Blismox | Blumox | Caremox | Cipmox | Comoxyl | Cremox | Damoxy | Danemox | Delamin | Dentomox | Dicimox | Dynamox | Edomox | Efimox | Efmox | Elmox | Epoxin | Erox | Esimox | Euphomox | Finemox | Flemoxin | Galmox | Genmox | Germox | Glamoxin | Gutenmox | Healmox | Hemox | Hexamox | Hipen | Hipen-a | Hipen-p | Hycimox | Hykil | Idimox | Ifimox | Imox | Infemox | Iphamox | Jetmox | Kamoxyl | Lamoxy | Larixin | Libamox | Linmox | Loxyn | Lupimox | Medimox | Menmox | Mentox-p | Merimox | Metamox | Mokcan | Mopen | Mormox | Mox | Mox kid | Mox-sg | Moxcee | Moxcem | Moxene | Moxgard | Moxibact | Moxica | Moxicap | Moxiday | Moxikem | Moxileb | Moxilin | Moxilink | Moxilion | Moxilup | Moximet | Moximon | Moxinta | Moxipal | Moxisar | Moxitas | Moxley | Moxmed | Moxvid | Moxway | Moxxil | Moxybiotic | Moxyco | Moxydil | Moxylar | Moxylife | Moxylite | Moxyzen | Mymox | Natamox | Nepomox | Neumoxes | Nodimox | Nomox | Novamox | O moxy | Octamox | Olymox | Omox | Optimox | Osomox | Ospamox | Pd mox | Pedimox | Pedmox | Peermox | Penom | Pexomox | Phenoxyl | Polymox | Pranmox | Pressmox | Pulmoxyl | Puremox | R-mox | Radimox | Ranoxyl | Raymox | Rekmox | Rizmox | Romexyl | Ronemox | Roscillin-amx | Sinmox | Sirimox | Softmox | Stalmox | Sumox | Sunimox | Suzimox | Swimox | Symoxyl | Synamox | Threomox | Tormoxin | Toxi | Tram | Trimox | Trimox ketone | Twicyl | Unilox | Unimox | Value mox | Vemox | Vermox | Warcilin | Weloxy | Womox | Wymox | Xytid | Z mox | Zamox | Zovax | Zox | Zycillin</span>;</li>
<li>
<span class="countryCode">(IQ)</span> <span class="country">Iraq</span><span class="countrySeparator">: </span><span class="drugName">Acamoxil | Amoxicillin mdi | Amoxycillin | Amoxycillin as | As amoxocillin | As amoxocilline | Jamox</span>;</li>
<li>
<span class="countryCode">(IT)</span> <span class="country">Italy</span><span class="countrySeparator">: </span><span class="drugName">Alfamox | Amoflux | Amosol | Amox | Amoxicillina | Amoxicillina doc | Amoxicillina eg | Amoxicillina hex | Amoxicillina jet | Amoxicillina sandoz | Amoxicillina zentiva | Amoxillin | Amoxina | Erremox | Hydramox | Ibiamox | Isimoxin | Mopen | Moxiren | Neo ampiplus | Neotetranase | Oralmox | Pamocil | Sintopen | Sintoplus | Velamox | Zimox</span>;</li>
<li>
<span class="countryCode">(JO)</span> <span class="country">Jordan</span><span class="countrySeparator">: </span><span class="drugName">Amoxapen | Amoxibel | Amoxil | Amoxydar | Hiconcil | Hymox | Julphamox | Moxepharm | Moxilen | Moxiram | Ospamox | Penamox | Ultramox</span>;</li>
<li>
<span class="countryCode">(JP)</span> <span class="country">Japan</span><span class="countrySeparator">: </span><span class="drugName">Amolin | Amopenixin | Amopicillin | Amopicillin taiyo | Amosepacin | Amox | Amoxicillin | Amoxicillin towa | Amoxycillin | Amoxycillin amel | Amoxycillin fujimoto | Amoxycillin hexal | Amoxycillin merck | Amoxycillin showa | Amoxycillin taiyo | Amoxycillin tatumi kagaku | Amoxycillin towa | Anemolin | Apitart | Chitacillin | Clamoxyl | Delacillin | Efpenix | Hiconcil | Himinomax | Niramitin | Pasetocin | Rimosin | Sawacillin | Sawamezin | Seokicillin | Seokicillin choseido | Unicillin | Widecillin</span>;</li>
<li>
<span class="countryCode">(KE)</span> <span class="country">Kenya</span><span class="countrySeparator">: </span><span class="drugName">Alimox | Ambioxy ds | Amoxi denk | Amoxicap | Amoxicillin | Amoxigen | Amoxigran | Amoxil | Amoximed | Amoxin | Amoxmark | Amyn | Asmox | Biomox | Brumox | Camox | Caremox | Conamox | Elymox | Farconcil | Gestamox | Glamoxy | Imox | Kamox | Kemoxyl | Labmox | Lemoxipen | Medomox | Miloxy | Moxacil | Moxacil forte | Moxilact | Moxileb | Moxper | Mydawa amoxicillin | Neomox | Nesmox | Omacillin | Ospamox | Penamox | Promox | Pulmoxyl | Rivamox | Septimox | Spamox | Tunamox 250 dt | Unimox | Unimox bp | Unixil | Winpen | Z mox | Zeemox</span>;</li>
<li>
<span class="countryCode">(KR)</span> <span class="country">Korea, Republic of</span><span class="countrySeparator">: </span><span class="drugName">A mox | A-cillin | Amocipen | Amonex | Amox | Amox apen | Amoxapen | Amoxicare | Amoxicillin | Amoxicillin donga | Amoxicillin samsung | Amoxis | Amxilline | Ckdamoxicillin | Gomcillin | Huons amoxicillin | Jw amoxicillin | Kymoxin | Moxillin | Pamoxin | Pharma amoxicillin | Umoxen</span>;</li>
<li>
<span class="countryCode">(KW)</span> <span class="country">Kuwait</span><span class="countrySeparator">: </span><span class="drugName">Amoxil | Glomox | Hiconcil | Hymox | Julphamox | Neomox | Omacillin | Ospamox | Remox | Ultramox</span>;</li>
<li>
<span class="countryCode">(LB)</span> <span class="country">Lebanon</span><span class="countrySeparator">: </span><span class="drugName">Amodex | Amoxicillin | Amoxicilline | Amoxidrex | Amoxil | Amoxycillin | Cipamox | E mox | Flemoxin | Gramidil | Hiconcil | Ibiamox | Julphamox | Moxilen | Ospamox | Penamox | Reichamox | Zamocilline</span>;</li>
<li>
<span class="countryCode">(LT)</span> <span class="country">Lithuania</span><span class="countrySeparator">: </span><span class="drugName">Amocilex | Amoclen | Amopen | Amotaks | Amoxicilina Arena | Amoxicilina aurobindo | Amoxicilina generis | Amoxicilina max | Amoxicillina eg | Amoxil | Amoxycillin | Apo amoxi | Azillin | Bactox | Flemoxin | Hiconcil | Moxypen | Ospamox | Pan amoxycillin</span>;</li>
<li>
<span class="countryCode">(LU)</span> <span class="country">Luxembourg</span><span class="countrySeparator">: </span><span class="drugName">Amoxi | Amoxicilline Eurogenerics | Amoxicilline sandoz | Amoxihexal | Amoxypen | Clamoxyl | Flemoxin | Gramidil | Hiconcil | Moxaline | Novabritine</span>;</li>
<li>
<span class="countryCode">(LV)</span> <span class="country">Latvia</span><span class="countrySeparator">: </span><span class="drugName">Amocilex | Amoclen | Amopen | Amoxicilina generis | Amoxil | Amoxycillin | Apo amoxi | Bactox | Clamoxyl | Flemoxin | Hiconcil | Lamoxy | Moxilen | Moxypen | Mymox | Ospamox | Upsamox | Winpen</span>;</li>
<li>
<span class="countryCode">(MA)</span> <span class="country">Morocco</span><span class="countrySeparator">: </span><span class="drugName">A-gram | Alfamox | Amodex | Amoxicilline | Amoxil | Apo amoxi | Aximycine | Bactamox | Bactox | Biomox | Cipamox | Clamox | Clamoxyl | Dispamox | Hiconcil | Neomox | Ospamox | Penamox | Phamox | Pneumoccid | Servamox | Starmox | Streptocid</span>;</li>
<li>
<span class="countryCode">(MX)</span> <span class="country">Mexico</span><span class="countrySeparator">: </span><span class="drugName">Acimox | Acroxil | Amicil | Amiglan | Amobay | Amoxdar | Amoxicilina | Amoxicilina g.i | Amoxicilina gi | Amoxicilina gi ser | Amoxicilina keyer | Amoxifur | Amoxil | Amoxil 12 h | Amoxinovag | Amoxisol | Amoxivet | Ampicel | Ampliron | Amsaxilina | Ardine | Armoxin | Betabiot | Bimoxan | Biovicam | Brenoxil | Brenoxil s | Clifen | Deniren | Dimopen | Doxamil | Examolin | Flemoxon | Genobiotic moxi | Gimalxina | Grunicina | Hidramox | Libiotex | Limoxin | Lorexil-m | Lumox | MicroMox | Mocimed | Moxicilina | Moxiclina | Moxlin | Moxpharma | Ormocyn | Ormocyn t 5 | Pamoxab | Penamox | Penamox 12h | Penticlox | Polymox | Servamox | Solciclina | Vandix | Vizimox | Xalyn-or | Xiprocan</span>;</li>
<li>
<span class="countryCode">(MY)</span> <span class="country">Malaysia</span><span class="countrySeparator">: </span><span class="drugName">Amolin | Amoxicap | Amoxicillin | Amoxigran | Amoxil | Amoxilin | Amoxilla | Amoxitab | Amoxy | Amoxycillin | Amoxycillin Pharmaniaga | Beamoxy | Betamox | Hamoxillin | Ifimox | Moxilen | Moxipen | Ospamox | Ranoxyl | Setmoxil | Symoxyl | Synamox | Z mox | Zamoxil</span>;</li>
<li>
<span class="countryCode">(NG)</span> <span class="country">Nigeria</span><span class="countrySeparator">: </span><span class="drugName">Acimox | Alamox | Amonex | Amoxapan | Amoxicillin marcolivia | Amoxil | Amoxynova | Andersons amoxycillin | Annmox | Avromox | Betamoxin | Chimexbon amoxicillin | Cikamox | Cimoxil | Dramoxicillin | Dramoxilin | Emmox | Fleming | Floximox | Grafclav | Hanbet amoxicillin | Healmoxy | Ipcamox | Jawamox | Kenneth amoxicillin | Kinglion amoxicillin | Krismox | Maryclantin | Miramox | Namox | Nemoxil | Noxil | Rainbow amoxicillin | Ricnos amoxicillin | Vamoxil | Xtramox | Zimamox | Zimox</span>;</li>
<li>
<span class="countryCode">(NL)</span> <span class="country">Netherlands</span><span class="countrySeparator">: </span><span class="drugName">Amoxicilline | Amoxicilline flx | Amoxicilline Merck | Amoxicilline ratiopharm | Amoxicilline sandoz | Amoxicilline sandoz disper | Flemoxin</span>;</li>
<li>
<span class="countryCode">(NO)</span> <span class="country">Norway</span><span class="countrySeparator">: </span><span class="drugName">Amimox | Amoxicillin | Amoxicillin accord | Amoxicillin sandoz | Amoxicilline eg | Amoxillin | Bremide | Imacillin | Imaxi | Infectomox</span>;</li>
<li>
<span class="countryCode">(NZ)</span> <span class="country">New Zealand</span><span class="countrySeparator">: </span><span class="drugName">Alphamox | Amoxicillin actavis | Amoxil | Amoxycillin | Apo amoxi | Moxlin | Noumed amoxicillin | Ospamox</span>;</li>
<li>
<span class="countryCode">(OM)</span> <span class="country">Oman</span><span class="countrySeparator">: </span><span class="drugName">Omacillin</span>;</li>
<li>
<span class="countryCode">(PE)</span> <span class="country">Peru</span><span class="countrySeparator">: </span><span class="drugName">Alcevan | Amoval | Amoxi c | Amoxibiotech | Amoxicilina | Amoxicilina trifarma | Amoxicilina uqp | Amoxiclin | Amoxiclin cl | Amoxidal duo | Amoxidin | Amoxidin 7 | Amoxil | Amoxil 12 h | Amoxilip | Amoxilip 500 | Amoximass | Amoxioral | Amoxipen | Amyn | Apmox | Apo amoxi | Bactamox | Bactiomax | Bioxdrin | Bristamox | Bronco amoxidin nf | Clavoxilin | Clavutrim | Deltamox | Derinox | Farmoxyl | Grunamox | Julphamox | Magnific | Magnimox | Med amox | Moxicel | Novamox | Novaxon | Odontomox | Orabiot | Orabiot duo | Ospamox | Penamox | Pentrax | Pentrax duo | Ranoxyl | Rhamoxilina | Solomoxy | Supermoxil | Supramoxil | Terbomox | Trifamox | Turvex | Velamox | Zezhatos</span>;</li>
<li>
<span class="countryCode">(PH)</span> <span class="country">Philippines</span><span class="countrySeparator">: </span><span class="drugName">Acumox | Altomox | Amelox | Amorex | Amoxicillin | Amoxicillin sandoz | Amoxil | Amoxsteryl | Amoxtrex | Amoxycillin | Amusa | Arimox | Bactigent | Benedex | Betamox | Boie amoxicillin | Bradoxil | Broadmetz | Brumox | Cartrimox | Chrisomox | Cilfam | Clearamox | Coamoxin | Cycamil | Daisamox | Eleomox | Eppitrexil | Essenmox | Evimox | Exbropin | Gexcil | Giacillin | Glamox | Globamox | Globapen | Gorgonio | Grumox | Harbimox | Harvimox | Himox | Infeban | Jamox | Ladoxillin | Lewixin | Littmox | Macromox | Maelenoxyl | Maroxil | Medimoxil | Medvox | Megamox | Moks | Montramox | Moxidre | Moxillin | Moxiped | Moxydril | Moxylor | Neomox | Novamox | Nuevamox | Nuevamoxil | Optimox | Oramox | Pathogram | Pediamox | Pemoxin | Penbiosyn | Pharmamox | Phecymox | Philamox | Polymox | Primex | Promox | Richmox | Rielmox | Roddexil | Semoxicillin | Semoxil | Servimox | Spectra | Stamox | Sumoxil | Supramox | Syncloxil | Telsimox | Teramoxyl | Termox | Trexil | Trigan | Unimox | Usa-amoxicillin | Valmox | Valzimox | Varolox | Vastamox | Vaxman | Vhellox | Vistrep | Vomoxyn | Westfimox | Wyamox | Xazexy | Yugoxil | Zedroxyn | Zymoxyl</span>;</li>
<li>
<span class="countryCode">(PK)</span> <span class="country">Pakistan</span><span class="countrySeparator">: </span><span class="drugName">Adamox | Amfast | Amocillin | Amoxascot | Amoxene | Amoxicap | Amoxidox | Amoxil | Amoxillin | Amoxipen | Amoxycillin | Amoxygen | Amoxylin | Amoxypen | Ampimox | Arcomox | Arpimox | Axalyn | Blomox | Cekamox | Ciloxil | Cipamox | Climox | Concimox | Cosmox | Delmox | Effimox | Elmox | Enmox | Epoxcil | Excellin | Fedroxil | Geomoxin | Glimox | Himoxin | Hizemox | Ibiamox | Imcomox | Jaxcil | Kemyclox | Klox | Maxil | Mb mox | Medimox | Medixil | Moxifil | Moxilium | Moxin | Moxypen | Novomox | Ocemox | Ospamox | Oximox | Pemoxin | Penbro | Penmox | Penoxil | Polyxil | Princimox | Regumoxil | Selmox | Semocillin | Skymox | Stamox | Supramox | Tabrocil | Ultramox | Werimox | Wilmox | Wisep | Wymox | Zeemox | Zekatac | Zoxicillin</span>;</li>
<li>
<span class="countryCode">(PL)</span> <span class="country">Poland</span><span class="countrySeparator">: </span><span class="drugName">Amoclen | Amotaks | Amoxicilline | Amoxycillin | Duomox | Grunamox | Hiconcil | Ospamox</span>;</li>
<li>
<span class="countryCode">(PR)</span> <span class="country">Puerto Rico</span><span class="countrySeparator">: </span><span class="drugName">Amoxicillin | Amoxil | Moxatag | Polymox | Trimox | Wymox</span>;</li>
<li>
<span class="countryCode">(PT)</span> <span class="country">Portugal</span><span class="countrySeparator">: </span><span class="drugName">Amoxicilina | Amoxicilina aurobindo | Amoxicilina generis | Amoxicilina tolife | Amoxil | Amplamox | Bodisan | Cipamox | Clamoxyl | Dilaclan | Moxadent | Moxipen | Oraminax | Ospamox</span>;</li>
<li>
<span class="countryCode">(PY)</span> <span class="country">Paraguay</span><span class="countrySeparator">: </span><span class="drugName">Acimox | Amoval | Amoval duo | Amoxicilina ahimsa | Amoxicilina bional | Amoxicilina caplin point | Amoxicilina cellofarm | Amoxicilina dallas | Amoxicilina eurofarma | Amoxicilina eximfarma | Amoxicilina genfar | Amoxicilina imedic | Amoxicilina la sante | Amoxicilina landerlan | Amoxicilina mintlab | Amoxicilina pasteur | Amoxicilina variquin | Amoxicilina vivele | Amoxiclerc | Amoxidal | Amoxidal duo | Amoxigran | Amoxiland | Amoxilider duo | Amoxilin | Amoxilin lactante | Amoxilin ninos | Amoximedin | Amoxipen | Amoxsul | Anamox | Antibiopen | As biotic amoxicilina | Bactilexin | Bioxilina | Blenopack | Carbomox | Compoxilin | Contex novo | Flogobell biotic | Kefrane | Medamox | Novamox | Novamox duo | Orbenin | Oxibiot | Pentus | Plamodex | Plamodex duo | Sultrex biotic | Trifamox | Trifamox duo | Trixan</span>;</li>
<li>
<span class="countryCode">(QA)</span> <span class="country">Qatar</span><span class="countrySeparator">: </span><span class="drugName">Amoxil | Amoxydar | Amoxydar Forte | Apo-Amoxi | Biomox | E-Mox | Farconcil | Glomox | Hymox | Hymox Forte | Julphamox | Neomox | Omacillin | Ospamox | Penamox | Remox (JPI)</span>;</li>
<li>
<span class="countryCode">(RO)</span> <span class="country">Romania</span><span class="countrySeparator">: </span><span class="drugName">Amoxicilina | Amoxicilina Arena | Amoxicilina atb | Amoxicilina aurobindo | Amoxicilina forte | Amoxicilina sandoz | Amoxicillin sandoz | Duomox | E mox | Ephamox | Moxypen | Ospamox</span>;</li>
<li>
<span class="countryCode">(RU)</span> <span class="country">Russian Federation</span><span class="countrySeparator">: </span><span class="drugName">Amosin | Amoxicillin | Amoxicillin ekobol | Amoxicillin sandoz | Amoxicillin trihydrate (purimox) | Amoxon | Ecobol | Flemoxin | Gramox d | Hiconcil | Ospamox</span>;</li>
<li>
<span class="countryCode">(SA)</span> <span class="country">Saudi Arabia</span><span class="countrySeparator">: </span><span class="drugName">Amoxil | Amoxipen | Amoxydar | Flemoxin | Glomox | Hiconcil | Hymox | Julphamox | Moxidad | Moxidad forte | Neomox | Novamoxin | Omacillin | Ospamox | Penamox | Princimox | Remox | Ultramox</span>;</li>
<li>
<span class="countryCode">(SE)</span> <span class="country">Sweden</span><span class="countrySeparator">: </span><span class="drugName">Amimox | Amoxicillin 2care4 | Amoxicillin aurobindo | Amoxicillin ebb | Amoxicillin mylan | Amoxicillin sandoz | Amoxiferm | Bristamox | Imacillin | Imaxi</span>;</li>
<li>
<span class="countryCode">(SG)</span> <span class="country">Singapore</span><span class="countrySeparator">: </span><span class="drugName">Amox | Amoxapen | Amoxicap | Amoxigran | Amoxil | Amoxycillin | Amyn | Aroxin | Betamox | Inamox | Lamoxy | Moxilen | Moxipen | Ospamox | Promox | Pulmoxyl | Strimox | Symoxyl | Synamox | Unimox</span>;</li>
<li>
<span class="countryCode">(SI)</span> <span class="country">Slovenia</span><span class="countrySeparator">: </span><span class="drugName">Amoksicillin | Amoxil | Hiconcil | Megamox | Ospamox</span>;</li>
<li>
<span class="countryCode">(SK)</span> <span class="country">Slovakia</span><span class="countrySeparator">: </span><span class="drugName">Amoclen | Amoxihexal | Amoxycillin | Duomox | Ospamox</span>;</li>
<li>
<span class="countryCode">(SL)</span> <span class="country">Sierra Leone</span><span class="countrySeparator">: </span><span class="drugName">Amoxil | Emmox | Miral amoxicillin | Sinoamox</span>;</li>
<li>
<span class="countryCode">(TH)</span> <span class="country">Thailand</span><span class="countrySeparator">: </span><span class="drugName">Am moxy f | Amocin | Amox | Amoxa | Amoxapen | Amoxicillin | Amoxillin | Amoximed | Amoxin | Amoxlin | Amoxtrin y | Amoxy | Amoxy I.C | Amoxy-T | Amoxycillin | Amoxylin | Ampno | Amyn | Augxil forte | Augxil G | Auramox | Betamox | Bomox | C-mox | Diamoxycap | Dpf mox | Himox | Ibiamox | Meixil kids | Milamox n | Mox | Mox run | Moxapen | Moxarin | Moxilin | Moxillin | Moxipan | Moxipharm | Moxlin | Moxno | Moxxo | Moxxo forte | Moxycillin | Moxyno | Mymox | Newtamox-My | Oriamox | Pharmox | Pharmoxcillin | Pinnamox | Premox | Pulmoxyl | Py-Amox | Pyramox | Ranoxyl | Sanomox g | Sanomox y | Servamox | Sia mox | Starmox | T.O.Cillin | U-Amox | Unimox | Vamox | Vimoxillin</span>;</li>
<li>
<span class="countryCode">(TN)</span> <span class="country">Tunisia</span><span class="countrySeparator">: </span><span class="drugName">Amoxal | Amoxicilline winthrop | Amoxil | Amoxipen | Amoxydar | Clamoxyl | Hiconcil | Novamox | Penamox | Saifoxyl</span>;</li>
<li>
<span class="countryCode">(TR)</span> <span class="country">Turkey</span><span class="countrySeparator">: </span><span class="drugName">Alfoxil | Amoksilin | Amoksina | Amosin | Atoksilin | Demoksil | Largopen | Moksilin | Remoxil | Topramoxin | Trimosin</span>;</li>
<li>
<span class="countryCode">(TW)</span> <span class="country">Taiwan</span><span class="countrySeparator">: </span><span class="drugName">Amocil | Amocillin | Amolin | Amox | Amoxcin | Amoxi gobens | Amoxicillin | Amoxicilline | Amoxil | Amoxil paediatric | Amoxycillin | Enmocil | Fusomoxillin | Hiconcil | Ibiamox | Moxilen | Sawamezin | Servamox | Yisulon</span>;</li>
<li>
<span class="countryCode">(UA)</span> <span class="country">Ukraine</span><span class="countrySeparator">: </span><span class="drugName">Amospes | Amoxicillin | Amoxil | Bactox | Flemoxin | Hiconcil | Ospamox</span>;</li>
<li>
<span class="countryCode">(UG)</span> <span class="country">Uganda</span><span class="countrySeparator">: </span><span class="drugName">Agoxin | Amoxapen | Amoxicap | Amoxicillin | Amoxikid | Amoxil | Amoxiren | Asmox | Brumox | Classmox | Duramox | Elymox | Farconcil | Hipen | Hiphen | Kam amoxy | Kemoxyl | Medomox | Miloxy | Moxacil | Moxileb | Moxirone | Penamox | Rivamox | Spamox | Unixil | Xomox</span>;</li>
<li>
<span class="countryCode">(UY)</span> <span class="country">Uruguay</span><span class="countrySeparator">: </span><span class="drugName">Amox-g | Amoxi | Amoxicilina | Amoxicilina phs | Amoxidal | Amoxil | Fabamox | Farconcil | Fullcilina | Maxibiotic | Moxifar | Moxtam | Ospamox | Princimox | Servamox | Trifamox duo</span>;</li>
<li>
<span class="countryCode">(VE)</span> <span class="country">Venezuela, Bolivarian Republic of</span><span class="countrySeparator">: </span><span class="drugName">Amoxal | Amoxicilina | Amoxiduo | Amoxilan | Amoxisa | Amylin | Eumoxina | Minoxy | Ospamox | Strimox | Trimoxal | Wellmoxy</span>;</li>
<li>
<span class="countryCode">(VN)</span> <span class="country">Viet Nam</span><span class="countrySeparator">: </span><span class="drugName">Asiamox | Bidimoxy | Franmoxy | Hagimox | Ibaxacin | Pms pharmox</span>;</li>
<li>
<span class="countryCode">(ZA)</span> <span class="country">South Africa</span><span class="countrySeparator">: </span><span class="drugName">Acucil | Adco-amoxicillin | Allmox | Amocillin | Amoxicillin | Amoxicillin hexal | Amoxil | Amoxycillin | Amyn | Auro amoxicillin | Austell amoxicillin | Betamox | C-mox | Ipcamox | Maxcil | Micro-amoxycillin | Moxan | Moxymax | Moxypen | Norimox | Penmox | Promoxil | Ranmoxy | Rolab-amoxycillin | Saltermox | Spectramox | Ultramox | Xeracil | Yomax | Zaloxy | Zoxil</span>;</li>
<li>
<span class="countryCode">(ZM)</span> <span class="country">Zambia</span><span class="countrySeparator">: </span><span class="drugName">Amocillin | Amolin | Amoxen | Amoxi denk | Amoxicap | Amoxicillin | Amoxin | Amoxycillin | Amoxykant | Amyn | Apmox | Camoxy | Dynamox | Elymox | Galmox | Imox | Jetmox | Lamoxy | Miloxy | Moxileb | Moximon | Moxmar | Moxmed | Moxypen | Neomox | Primox | Spamox | Syamoxil | Tormoxin | Umoxil | Unixil | Z mox</span>;</li>
<li>
<span class="countryCode">(ZW)</span> <span class="country">Zimbabwe</span><span class="countrySeparator">: </span><span class="drugName">Adco Amoxycillin | Amocillin | Amoxen | Amoxycillin | Balmox 500 | Imox | Medomox | Miloxy | Ranoxyl | Strimox</span></li></ul></div>
</div>
</div>
</div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference" id="lexi-content-ref-31958969">
<a name="31958969"></a>Afolabi TM, Goodlet KJ, Fairman KA. Association of antibiotic treatment duration with recurrence of uncomplicated urinary tract infection in pediatric patients. <i>Ann Pharmacother</i>. 2020;54(8):757-766. doi:10.1177/1060028019900650<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31958969/pubmed" id="31958969" target="_blank">31958969</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11487763">
<a name="11487763"></a>Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/11487763/pubmed" id="11487763" target="_blank">11487763</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25369238">
<a name="25369238"></a>Ahluwalia J, Abuabara K, Perman MJ, Yan AC. Human herpesvirus 6 involvement in paediatric drug hypersensitivity syndrome. <i>Br J Dermatol</i>. 2015;172(4):1090-1095. doi:10.1111/bjd.13512<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25369238/pubmed" id="25369238" target="_blank">25369238</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27891788">
<a name="27891788"></a>Ailes EC, Gilboa SM, Gill SK, et al. Association between antibiotic use among pregnant women with urinary tract infections in the first trimester and birth defects, National Birth Defects Prevention Study 1997 to 2011. <i>Birth Defects Res A Clin Mol Teratol</i>. 2016;106(11):940-949. doi:10.1002/bdra.23570<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/27891788/pubmed" id="27891788" target="_blank">27891788</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31219042">
<a name="31219042"></a>Alarcón E, Sansosti A, Navarro B, et al. Amoxicillin-induced aseptic meningitis: 2 case reports and appraisal of the literature. <i>J Investig Allergol Clin Immunol</i>. 2019;29(3):248-250. doi:10.18176/jiaci.0380<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31219042/pubmed" id="31219042" target="_blank">31219042</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-AAP.2021">
<a name="AAP.2021"></a>American Academy of Pediatrics (AAP). In: Kimberlin DW, Barnett ED, Lynfield R, Sawyer MH, eds. <i>Red Book: 2021 Report of the Committee on Infectious Diseases</i>. 32nd ed. American Academy of Pediatrics; 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32080050">
<a name="32080050"></a>American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins—Obstetrics. Prelabor rupture of membranes: ACOG Practice Bulletin, Number 217. <i>Obstet Gynecol</i>. 2020;135(3):e80-e97. doi:10.1097/AOG.0000000000003700<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32080050/pubmed" id="32080050" target="_blank">32080050</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30134425">
<a name="30134425"></a>American College of Obstetricians and Gynecologists (ACOG) Committee on Practice Bulletins—Obstetrics. ACOG Practice Bulletin No. 199: Use of prophylactic antibiotics in labor and delivery. <i>Obstet Gynecol</i>. 2018;132(3):e103-e119.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/30134425/pubmed" id="30134425" target="_blank">30134425</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31977795">
<a name="31977795"></a>American College of Obstetricians and Gynecologists (ACOG). Prevention of group B streptococcal early-onset disease in newborns: ACOG Committee Opinion, Number 797. <i>Obstet Gynecol</i>. 2020;135(2):e51-e72. doi:10.1097/AOG.0000000000003668<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31977795/pubmed" id="31977795" target="_blank">31977795</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12892448">
<a name="12892448"></a>American Dental Association (ADA); American Academy of Orthopedic Surgeons (AAOS). Antibiotic prophylaxis for dental patients with total joint replacements. J Am Dent Assoc. 2003;134(7):895-899.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/12892448/pubmed" id="12892448" target="_blank">12892448</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amoxicillin.1">
<a name="Amoxicillin.1"></a>Amoxicillin [prescribing information]. North Wales, PA: Teva Pharmaceuticals; August 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amoxicillin.2">
<a name="Amoxicillin.2"></a>Amoxicillin [prescribing information]. North Wales, PA: Teva Pharmaceuticals; January 2016.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amoxicillin.3">
<a name="Amoxicillin.3"></a>Amoxicillin [prescribing information]. Princeton, NJ: Neopharma Inc; September 2019.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Auro.1">
<a name="Auro.1"></a>Amoxicillin [product monograph]. Woodbridge, Ontario, Canada: Auro Pharma Inc; December 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amoxil.1">
<a name="Amoxil.1"></a>Amoxil (amoxicillin) [prescribing information]. Bristol, TN: Dr Reddy’s Laboratories; December 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Amoxil.2">
<a name="Amoxil.2"></a>Amoxil (amoxicillin) [prescribing information]. Bristol, TN: USAntibiotics LLC; November 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27060684">
<a name="27060684"></a>Anderson PO, Sauberan JB. Modeling drug passage into human milk. <i>Clin Pharmacol Ther</i>. 2016;100(1):42-52.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/27060684/pubmed" id="27060684" target="_blank">27060684</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9736566">
<a name="9736566"></a>Andes D, Craig WA. In vivo activities of amoxicillin and amoxicillin-clavulanate against streptococcus pneumoniae: application to breakpoint determinations. <i>Antimicrob Agents Chemother.</i> 1998;42(9):2375-2379. doi:10.1128/AAC.42.9.2375<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/9736566/pubmed" id="9736566" target="_blank">9736566</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17329990">
<a name="17329990"></a>Andrew MA, Easterling TR, Carr DB, et al. Amoxicillin pharmacokinetics in pregnant women: modeling and simulations of dosage strategies. <i>Clin Pharmacol Ther.</i> 2007;81(4):547-556.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/17329990/pubmed" id="17329990" target="_blank">17329990</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Aronoff.1">
<a name="Aronoff.1"></a>Aronoff GR, Bennett WM, Berns JS, et al. <i>Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children.</i> 5th ed. Philadelphia, PA: American College of Physicians; 2007:61, 153.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9636854">
<a name="9636854"></a>Aubier M, Verster R, Regamey C, Geslin P, Vercken JB. Once-daily sparfloxacin versus high-dosage amoxicillin in the treatment of community-acquired, suspected pneumococcal pneumonia in adults. Sparfloxacin European Study Group. <i>Clin Infect Dis</i>. 1998;26(6):1312-1320. doi:10.1086/516366<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/9636854/pubmed" id="9636854" target="_blank">9636854</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Berbari.2018">
<a name="Berbari.2018"></a>Baddour LM, Chen AF. Prosthetic joint infection: Treatment. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 14, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29292282">
<a name="29292282"></a>Balighian E, Burke M. Urinary tract infections in children. <i>Pediatr Rev</i>. 2018;39(1):3-12. doi:10.1542/pir.2017-0007<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29292282/pubmed" id="29292282" target="_blank">29292282</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26373317">
<a name="26373317"></a>Baltimore RS, Gewitz M, Baddour LM, et al. Infective endocarditis in childhood: 2015 update: a scientific statement from the American Heart Association (AHA). <i>Circulation</i>. 2015;132(15):1487-1515.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/26373317/pubmed" id="26373317" target="_blank">26373317</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Barker.2018">
<a name="Barker.2018"></a>Barker AF. Bronchiectasis in adults; maintaining lung health. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 13, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11821511">
<a name="11821511"></a>Bartlett JG. Clinical practice. Antibiotic-associated diarrhea. <i>N Engl J Med</i>. 2002;346(5):334-339. doi:10.1056/NEJMcp011603<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/11821511/pubmed" id="11821511" target="_blank">11821511</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16427220">
<a name="16427220"></a>Belarmino JM and Kogan BA. Management of neonatal hydronephrosis. <i>Early Hum Dev.</i> 2006;82(1):9-14.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/16427220/pubmed" id="16427220" target="_blank">16427220</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20653681">
<a name="20653681"></a>Ben Fredj N, Aouam K, Chaabane A, et al. Hypersensitivity to amoxicillin after drug rash with eosinophilia and systemic symptoms (DRESS) to carbamazepine and allopurinol: a possible co-sensitization. <i>Br J Clin Pharmacol</i>. 2010;70(2):273-276. doi:10.1111/j.1365-2125.2010.03685.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/20653681/pubmed" id="20653681" target="_blank">20653681</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16044108">
<a name="16044108"></a>Benyamini L, Merlob P, Stahl B, et al, "The Safety of Amoxicillin/Clavulanic Acid and Cefuroxime During Lactation," <i>Ther Drug Monit</i>, 2005, 27(4):499-502.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/16044108/pubmed" id="16044108" target="_blank">16044108</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30558872">
<a name="30558872"></a>Blumenthal KG, Peter JG, Trubiano JA, Phillips EJ. Antibiotic allergy. <i>Lancet</i>. 2019;393(10167):183-198. doi:10.1016/S0140-6736(18)32218-9<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/30558872/pubmed" id="30558872" target="_blank">30558872</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27311002">
<a name="27311002"></a>Bonnefond S, Catroux M, Melenotte C, et al. Clinical features of actinomycosis: a retrospective, multicenter study of 28 cases of miscellaneous presentations. <i>Medicine (Baltimore)</i>. 2016;95(24):e3923. doi:10.1097/MD.0000000000003923<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/27311002/pubmed" id="27311002" target="_blank">27311002</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21701406">
<a name="21701406"></a>Bontems P, Kalach N, Oderda G, et al. Sequential therapy versus tailored triple therapies for Helicobacter pylori infection in children. <i>J Pediatr Gastroenterol Nutr</i>. 2011;53(6):646-650. doi:10.1097/MPG.0b013e318229c769<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/21701406/pubmed" id="21701406" target="_blank">21701406</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26598097">
<a name="26598097"></a>Bookstaver PB, Bland CM, Griffin B, Stover KR, Eiland LS, McLaughlin M. A review of antibiotic use in pregnancy. <i>Pharmacotherapy</i>. 2015;35(11):1052-1062. doi:10.1002/phar.1649<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/26598097/pubmed" id="26598097" target="_blank">26598097</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28303587">
<a name="28303587"></a>Borges I, Faveri M, Figueiredo LC, et al. Different antibiotic protocols in the treatment of severe chronic periodontitis: a 1-year randomized trial. <i>J Clin Periodontol</i>. 2017;44(8):822-832. doi:10.1111/jcpe.12721<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28303587/pubmed" id="28303587" target="_blank">28303587</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31834290">
<a name="31834290"></a>Bower WA, Schiffer J, Atmar RL, et al; CDC ACIP Anthrax Vaccine Work Group. Use of anthrax vaccine in the United States: recommendations of the Advisory Committee on Immunization Practices, 2019. <i>MMWR Recomm Rep</i>. 2019;68(4):1-14. doi:10.15585/mmwr.rr6804a1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31834290/pubmed" id="31834290" target="_blank">31834290</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21880587">
<a name="21880587"></a>Bradley JS, Byington CL, Shah SS, et al. “The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America”, <i>Clin Infect Dis</i>, 2011, 53(7):e25-76.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/21880587/pubmed" id="21880587" target="_blank">21880587</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20975453">
<a name="20975453"></a>Bradley JS, Garonzik SM, Forrest A, Bhavnani SM. Pharmacokinetics, pharmacodynamics, and Monte Carlo simulation: selecting the best antimicrobial dose to treat an infection. <i>Pediatr Infect Dis J</i>. 2010;29(11):1043-1046. doi:10.1097/INF.0b013e3181f42a53<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/20975453/pubmed" id="20975453" target="_blank">20975453</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Bradley.1">
<a name="Bradley.1"></a>Bradley JS, Nelson JD, Kimberlin DK, et al, eds. <i>Nelson's Pocket Book of Pediatric Antimicrobial Therapy</i>. 28th ed. American Academy of Pediatrics; 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24777226">
<a name="24777226"></a>Bradley JS, Peacock G, Krug SE, et al; AAP Committee on Infectious Diseases and Disaster Preparedness Advisory Council. Pediatric anthrax clinical management. <i>Pediatrics</i>. 2014;133(5):e1411-e1436. doi:10.1542/peds.2014-0563<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/24777226/pubmed" id="24777226" target="_blank">24777226</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26120552">
<a name="26120552"></a>Brockow K, Przybilla B, Aberer W, et al. Guideline for the diagnosis of drug hypersensitivity reactions: S2K-Guideline of the German Society for Allergology and Clinical Immunology (DGAKI) and the German Dermatological Society (DDG) in collaboration with the Association of German Allergologists (AeDA), the German Society for Pediatric Allergology and Environmental Medicine (GPA), the German Contact Dermatitis Research Group (DKG), the Swiss Society for Allergy and Immunology (SGAI), the Austrian Society for Allergology and Immunology (ÖGAI), the German Academy of Allergology and Environmental Medicine (DAAU), the German Center for Documentation of Severe Skin Reactions and the German Federal Institute for Drugs and Medical Products (BfArM). <i>Allergo J Int</i>. 2015;24(3):94-105. doi:10.1007/s40629-015-0052-6<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/26120552/pubmed" id="26120552" target="_blank">26120552</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Brook.1">
<a name="Brook.1"></a>Brook I. Treatment of actinomycosis. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 12, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25157757">
<a name="25157757"></a>Brown KA, Fisman DN, Moineddin R, Daneman N. The magnitude and duration of <i>Clostridium difficile</i> infection risk associated with antibiotic therapy: a hospital cohort study. <i>PLoS One</i>. 2014;9(8):e105454. doi:10.1371/journal.pone.0105454<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25157757/pubmed" id="25157757" target="_blank">25157757</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23478961">
<a name="23478961"></a>Brown KA, Khanafer N, Daneman N, Fisman DN. Meta-analysis of antibiotics and the risk of community-associated <i>Clostridium difficile</i> infection. <i>Antimicrob Agents Chemother</i>. 2013;57(5):2326-2332. doi:10.1128/AAC.02176-12<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23478961/pubmed" id="23478961" target="_blank">23478961</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32069358">
<a name="32069358"></a>Brown KA, Langford B, Schwartz KL, Diong C, Garber G, Daneman N. Antibiotic prescribing choices and their comparative <i>C. difficile</i> infection risks: a longitudinal case-cohort study. <i>Clin Infect Dis</i>. 2021;72(5):836-844. doi:10.1093/cid/ciaa124<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32069358/pubmed" id="32069358" target="_blank">32069358</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1183221">
<a name="1183221"></a>Buckingham M, Welply G, Miller JF, Elstein M. Gastro-intestinal absorption and transplacental transfer of amoxycillin during labour and the influence of metoclopramide. <i>Curr Med Res Opin</i>. 1975;3(6):392-396. doi:10.1185/03007997509114794<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/1183221/pubmed" id="1183221" target="_blank">1183221</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25345303">
<a name="25345303"></a>Buonomo A, Nucera E, Pecora V, et al. Cross-reactivity and tolerability of cephalosporins in patients with cell-mediated allergy to penicillins. <i>J Investig Allergol Clin Immunol</i>. 2014;24(5):331-337.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25345303/pubmed" id="25345303" target="_blank">25345303</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28653787">
<a name="28653787"></a>Butenko T, Jeverica S, Orel R, Homan M. Antibacterial resistance and the success of tailored triple therapy in Helicobacter pylori strains isolated from Slovenian children. <i>Helicobacter</i>. 2017;22(5):e12400. doi:10.1111/hel.12400<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28653787/pubmed" id="28653787" target="_blank">28653787</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9493813">
<a name="9493813"></a>Canafax DM, Yuan Z, Chonmaitree T, Deka K, Russlie HQ, Giebink GS. Amoxicillin middle ear fluid penetration and pharmacokinetics in children with acute otitis media. <i>Pediatr Infect Dis J.</i> 1998;17(2):149-156. doi:10.1097/00006454-199802000-00014<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/9493813/pubmed" id="9493813" target="_blank">9493813</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24574739">
<a name="24574739"></a>Cardaropoli S, Rolfo A, Todros T. Helicobacter pylori and pregnancy-related disorders. <i>World J Gastroenterol</i>. 2014;20(3):654-664. doi:10.3748/wjg.v20.i3.654<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/24574739/pubmed" id="24574739" target="_blank">24574739</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33500632">
<a name="33500632"></a>Caruso C, Valluzzi RL, Colantuono S, Gaeta F, Romano A. β-lactam allergy and cross-reactivity: a clinician's guide to selecting an alternative antibiotic. <i>J Asthma Allergy</i>. 2021;14:31-46. doi:10.2147/JAA.S242061<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/33500632/pubmed" id="33500632" target="_blank">33500632</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.1">
<a name="CDC.1"></a>CDC and Johns Hopkins Working Group on Civilian Biodefense. Commentary on Non-Labeled Dosing of Oral Amoxicillin in Adults and Pediatrics for Post-Exposure Inhalational Anthrax. December 10, 2001. http://www.fda.gov/cder/drugprepare/amox-anthrax.htm</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6810084">
<a name="6810084"></a>Centers for Disease Control and Prevention (CDC). Neonatal deaths associated with use of benzyl alcohol—United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href="https://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm" target="_blank">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a>
<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/6810084/pubmed" id="6810084" target="_blank">6810084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-CDC.1">
<a name="CDC.1"></a>Centers for Disease Control and Prevention (CDC). FAQs for clinicians about <i>C. diff</i>. <a href="https://www.cdc.gov/cdiff/clinicians/faq.html" target="_blank">https://www.cdc.gov/cdiff/clinicians/faq.html</a>. Updated March 27, 2020. Accessed July 27, 2021<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/CDC.1/pubmed" id="CDC.1" target="_blank">CDC.1</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26893522">
<a name="26893522"></a>Chew C, Goenka A. QUESTION 2: Does amoxicillin exposure increase the risk of rash in children with acute Epstein-Barr virus infection? <i>Arch Dis Child</i>. 2016;101(5):500-502. doi:10.1136/archdischild-2015-310364<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/26893522/pubmed" id="26893522" target="_blank">26893522</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28071659">
<a name="28071659"></a>Chey WD, Leontiadis GI, Howden CW, Moss SF. ACG clinical guideline: treatment of <i>Helicobacter pylori</i> infection [published correction appears in <i>Am J Gastroenterol. </i>2018;113(7):1102]. <i>Am J Gastroenterol</i>. 2017;112(2):212-239. doi:10.1038/ajg.2016.563<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28071659/pubmed" id="28071659" target="_blank">28071659</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-cho.2020">
<a name="cho.2020"></a>Cho CB. Adverse reactions to drugs. In: Kliegman RM, St. Geme J, eds. <i>Nelson Textbook of Pediatrics</i>. 21st ed. Elsevier; 2020:chap. 177.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/cho.2020/pubmed" id="cho.2020" target="_blank">cho.2020</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30121684">
<a name="30121684"></a>Choon SE, Der YS, Lai NLJ, Yu SEE, Yap XL, Nalini NM. Clinical characteristics, culprit drugs and outcome of patients with Acute Generalised Exanthematous Pustulosis seen in Hospital Sultanah Aminah, Johor Bahru. <i>Med J Malaysia</i>. 2018;73(4):220-225.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/30121684/pubmed" id="30121684" target="_blank">30121684</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23589810">
<a name="23589810"></a>Chovel-Sella A, Ben Tov A, Lahav E, et al. Incidence of rash after amoxicillin treatment in children with infectious mononucleosis. <i>Pediatrics</i>. 2013;131(5):e1424-e1427. doi:10.1542/peds.2012-1575<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23589810/pubmed" id="23589810" target="_blank">23589810</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22438350">
<a name="22438350"></a>Chow AW, Benninger MS, Brook I, et al; Infectious Diseases Society of America. IDSA clinical practice guideline for acute bacterial rhinosinusitis in children and adults. <i>Clin Infect Dis</i>. 2012;54(8):e72-e112.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/22438350/pubmed" id="22438350" target="_blank">22438350</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Chow.2020">
<a name="Chow.2020"></a>Chow AW. Complications, diagnosis, and treatment of odontogenic infections. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed August 9, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20042912">
<a name="20042912"></a>Christian-Kopp S, Sinha M, Rosenberg DI, Eisenhart AW, McDonald FW. Antibiotic dosing for acute otitis media in children: a weighty issue. <i>Pediatr Emerg Care</i>. 2010;26(1):19-25. doi:10.1097/PEC.0b013e3181cbeb00<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/20042912/pubmed" id="20042912" target="_blank">20042912</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1147656">
<a name="1147656"></a>Cohen MD, Raeburn JA, Devine J, et al. Pharmacology of some oral penicillins in the newborn infant. <i>Arch Dis Child</i>. 1975;50(3):230-234. doi:10.1136/adc.50.3.230<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/1147656/pubmed" id="1147656" target="_blank">1147656</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22000846">
<a name="22000846"></a>Coignard-Biehler H, Lanternier F, Hot A, et al. Adherence to preventive measures after splenectomy in the hospital setting and in the community. <i>J Infect Public Health</i>. 2011;4(4):187-194. doi:10.1016/j.jiph.2011.06.004<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/22000846/pubmed" id="22000846" target="_blank">22000846</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26369973">
<a name="26369973"></a>Cole KA, Kenney RM, Perri MB, et al. Outcomes of aminopenicillin therapy for vancomycin-resistant enterococcal urinary tract infections. <i>Antimicrob Agents Chemother</i>. 2015;59(12):7362-7366.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/26369973/pubmed" id="26369973" target="_blank">26369973</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29689301">
<a name="29689301"></a>Connelly S, Subramanian P, Hasan NA, Colwell RR, Kaleko M. Distinct consequences of amoxicillin and ertapenem exposure in the porcine gut microbiome. <i>Anaerobe</i>. 2018;53:82-93. doi:10.1016/j.anaerobe.2018.04.012<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29689301/pubmed" id="29689301" target="_blank">29689301</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9455502">
<a name="9455502"></a>Craig WA. Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. <i>Clin Infect Dis.</i> 1998;26(1):1-10. doi:10.1086/516284<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/9455502/pubmed" id="9455502" target="_blank">9455502</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8852915">
<a name="8852915"></a>Craig WA, Andes D. Pharmacokinetics and pharmacodynamics of antibiotics in otitis media.<i> Pediatr Infect Dis J.</i> 1996;15(3):255-259. doi:10.1097/00006454-199603000-00015<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/8852915/pubmed" id="8852915" target="_blank">8852915</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19884587">
<a name="19884587"></a>Crider KS, Cleves MA, Reefhuis J, Berry RJ, Hobbs CA, Hu DJ. Antibacterial medication use during pregnancy and risk of birth defects: National Birth Defects Prevention Study. <i>Arch Pediatr Adolesc Med</i>. 2009;163(11):978-985. doi:10.1001/archpediatrics.2009.188<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/19884587/pubmed" id="19884587" target="_blank">19884587</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-2217684">
<a name="2217684"></a>Currie DC, Garbett ND, Chan KL, et al. Double-blind randomized study of prolonged higher-dose oral amoxycillin in purulent bronchiectasis. <i>Q J Med</i>. 1990;76(280):799-816.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/2217684/pubmed" id="2217684" target="_blank">2217684</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29222255">
<a name="29222255"></a>Curtis BR. Non-chemotherapy drug-induced neutropenia: key points to manage the challenges. <i>Hematology Am Soc Hematol Educ Program</i>. 2017;2017(1):187-193. doi:10.1182/asheducation-2017.1.187<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29222255/pubmed" id="29222255" target="_blank">29222255</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31260651">
<a name="31260651"></a>Damkier P, Brønniche LMS, Korch-Frandsen JFB, Broe A. In utero exposure to antibiotics and risk of congenital malformations: a population-based study. <i>Am J Obstet Gynecol</i>. 2019;221(6):648.e1-648.e15. doi:10.1016/j.ajog.2019.06.050<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31260651/pubmed" id="31260651" target="_blank">31260651</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3190988">
<a name="3190988"></a>Davies BE, Boon R, Horton R, Reubi FC, Descoeudres CE. Pharmacokinetics of amoxycillin and clavulanic acid in haemodialysis patients following intravenous administration of augmentin. <i>Br J Clin Pharmacol</i>. 1988;26(4):385-390. doi:10.1111/j.1365-2125.1988.tb03395.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/3190988/pubmed" id="3190988" target="_blank">3190988</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10639354">
<a name="10639354"></a>Davies TA, Kelly LM, Pankuch GA, Credito KL, Jacobs MR, Appelbaum PC. Antipneumococcal activities of gemifloxacin compared to those of nine other agents. <i>Antimicrob Agents Chemother.</i> 2000;44(2):304-310. doi:10.1128/aac.44.2.304-310.2000<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/10639354/pubmed" id="10639354" target="_blank">10639354</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33777581">
<a name="33777581"></a>De La Cruz AC, Ashraf S, Shrestha N, Saad M. Myocarditis and drug rash with eosinophilia and systemic symptoms syndrome: a deadly combination. <i>Cureus</i>. 2021;13(2):e13496. doi:10.7759/cureus.13496<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/33777581/pubmed" id="33777581" target="_blank">33777581</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32360431">
<a name="32360431"></a>de Rossi P, Cimerman S, Truzzi JC, et al. Joint report of SBI (Brazilian Society of Infectious Diseases), FEBRASGO (Brazilian Federation of Gynecology and Obstetrics Associations), SBU (Brazilian Society of Urology) and SBPC/ML (Brazilian Society of Clinical Pathology/Laboratory Medicine): recommendations for the clinical management of lower urinary tract infections in pregnant and non-pregnant women. <i>Braz J Infect Dis</i>. 2020;24(2):110-119. doi:10.1016/j.bjid.2020.04.002<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32360431/pubmed" id="32360431" target="_blank">32360431</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23620467">
<a name="23620467"></a>Deshpande A, Pasupuleti V, Thota P, et al. Community-associated <i>Clostridium difficile</i> infection and antibiotics: a meta-analysis. <i>J Antimicrob Chemother</i>. 2013;68(9):1951-1961. doi:10.1093/jac/dkt129<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23620467/pubmed" id="23620467" target="_blank">23620467</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29617685">
<a name="29617685"></a>Dibek Misirlioglu E, Guvenir H, Ozkaya Parlakay A, et al. Incidence of antibiotic-related rash in children with Epstein-Barr virus infection and evaluation of the frequency of confirmed antibiotic hypersensitivity. <i>Int Arch Allergy Immunol</i>. 2018;176(1):33-38. doi:10.1159/000481988<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29617685/pubmed" id="29617685" target="_blank">29617685</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24073903">
<a name="24073903"></a>Di Lernia V, Mansouri Y. Epstein-Barr virus and skin manifestations in childhood. <i>Int J Dermatol</i>. 2013;52(10):1177-1184. doi:10.1111/j.1365-4632.2012.05855.x<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/24073903/pubmed" id="24073903" target="_blank">24073903</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Domonoske.1">
<a name="Domonoske.1"></a>Domonoske C. Appendix A: Common neonatal intensive care unit (NICU) medication guidelines. In: Eichenwald EC, Hansen AR, Martin CR, Stark AR. <i>Cloherty and Stark's Manual of Neonatal Care</i>. 8th edition. Lippincott Williams &amp; Wilkins; 2017.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32123023">
<a name="32123023"></a>Donaldson N, Sanders J, Child J, Parker S. Acute hematogenous bacterial osteoarticular infections in children. <i>Pediatr Rev</i>. 2020;41(3):120-136. doi:10.1542/pir.2018-0201<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32123023/pubmed" id="32123023" target="_blank">32123023</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9951971">
<a name="9951971"></a>Dowell SF, Butler JC, Giebink GS, et al. Acute otitis media: management and surveillance in an era of pneumococcal resistance--a report from the Drug-resistant <i>Streptococcus pneumoniae</i> Therapeutic Working Group. <i>Pediatr Infect Dis J</i>. 1999;18(1):1-9.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/9951971/pubmed" id="9951971" target="_blank">9951971</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10904192">
<a name="10904192"></a>Dubois J, St-Pierre C. In vitro study of the post-antibiotic effect and the bactericidal activity of cefditoren and ten other oral antimicrobial agents against upper and lower respiratory tract pathogens. <i>Diagn Microbiol Infect Dis</i>. 2000;37(3):187-193. doi:10.1016/s0732-8893(00)00141-3<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/10904192/pubmed" id="10904192" target="_blank">10904192</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34293504">
<a name="34293504"></a>Exius R, Gabrielli S, Abrams EM, et al. Establishing Amoxicillin Allergy in Children Through Direct Graded Oral Challenge (GOC): Evaluating Risk Factors for Positive Challenges, Safety, and Risk of Cross-Reactivity to Cephalosporines. <i>J Allergy Clin Immunol Pract</i>. Published online July 19, 2021. doi:10.1016/j.jaip.2021.06.057<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/34293504/pubmed" id="34293504" target="_blank">34293504</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-18754699">
<a name="18754699"></a>Fallon RM, Kuti JL, Doern GV, Girotto JE, Nicolau DP. Pharmacodynamic target attainment of oral beta-lactams for the empiric treatment of acute otitis media in children. <i>Paediatr Drugs</i>. 2008;10(5):329-335. doi:10.2165/00148581-200810050-00006<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/18754699/pubmed" id="18754699" target="_blank">18754699</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27102658">
<a name="27102658"></a>Fallone CA, Chiba N, van Zanten SV, et al. The Toronto consensus for the treatment of <i>Helicobacter pylori</i> infection in adults. <i>Gastroenterology.</i> 2016;151(1):51-69.e14.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/27102658/pubmed" id="27102658" target="_blank">27102658</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-File.1">
<a name="File.1"></a>File TM. Treatment of community-acquired pneumonia in adults in the outpatient setting. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed January 23, 2023b.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-File.2">
<a name="File.2"></a>File TM. Treatment of community-acquired pneumonia in adults who require hospitalization. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 14, 2023a.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7012996">
<a name="7012996"></a>Finegold SM, Gentry LO, Mogabgab W, Campbell SC, Skatrud J. Controlled comparative trial of bacampicillin and amoxicillin in therapy of bacterial infections of the lower respiratory tract. <i>Rev Infect Dis</i>. 1981;3(1):150-153.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/7012996/pubmed" id="7012996" target="_blank">7012996</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-12604533">
<a name="12604533"></a>Fonseca W, Hoppu K, Rey LC, Amaral J, Qazi S. Comparing pharmacokinetics of amoxicillin given twice or three times per day to children older than 3 months with pneumonia.<i> Antimicrob Agents Chemother.</i> 2003;47(3):997-1001. doi:10.1128/aac.47.3.997-1001.2003<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/12604533/pubmed" id="12604533" target="_blank">12604533</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32364593">
<a name="32364593"></a>Fox MT, Amoah J, Hsu AJ, Herzke CA, Gerber JS, Tamma PD. Comparative effectiveness of antibiotic treatment duration in children with pyelonephritis. <i>JAMA Netw Open</i>. 2020;3(5):e203951. doi:10.1001/jamanetworkopen.2020.3951<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32364593/pubmed" id="32364593" target="_blank">32364593</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-445959">
<a name="445959"></a>Francke EL, Appel GB, Neu HC. Kinetics of intravenous amoxicillin in patients on long-term dialysis. <i>Clin Pharmacol Ther</i>. 1979;26(1):31-35. doi:10.1002/cpt197926131<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/445959/pubmed" id="445959" target="_blank">445959</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15286214">
<a name="15286214"></a>Garbutt J, St Geme JW 3rd, May A, Storch GA, Shackelford PG. Developing community-specific recommendations for first-line treatment of acute otitis media: is high-dose amoxicillin necessary? <i>Pediatrics</i>. 2004;114(2):342-347. doi:10.1542/peds.114.2.342<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/15286214/pubmed" id="15286214" target="_blank">15286214</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22337680">
<a name="22337680"></a>Garbutt JM, Banister C, Spitznagel E, Piccirillo JF. Amoxicillin for acute rhinosinusitis: a randomized controlled trial. <i>JAMA</i>. 2012;307(7):685-692.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/22337680/pubmed" id="22337680" target="_blank">22337680</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10493674">
<a name="10493674"></a>García-Porrúa C, González-Gay MA, López-Lázaro L. Drug associated cutaneous vasculitis in adults in northwestern Spain. <i>J Rheumatol</i>. 1999;26(9):1942-1944.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/10493674/pubmed" id="10493674" target="_blank">10493674</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-14742786">
<a name="14742786"></a>Garrison GD, Sorum PC, Hioe W, Miller MM. High-dose versus standard-dose amoxicillin for acute otitis media. <i>Ann Pharmacother</i>. 2004;38(1):15-19. doi:10.1345/aph.1D052<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/14742786/pubmed" id="14742786" target="_blank">14742786</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19246689">
<a name="19246689"></a>Gerber MA, Baltimore RS, Eaton CB, et al. Prevention of rheumatic fever and diagnosis and treatment of acute Streptococcal pharyngitis: a scientific statement from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee of the Council on Cardiovascular Disease in the Young, the Interdisciplinary Council on Functional Genomics and Translational Biology, and the Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Academy of Pediatrics. <i>Circulation</i>. 2009;119(11):1541-1551. doi:10.1161/CIRCULATIONAHA.109.191959<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/19246689/pubmed" id="19246689" target="_blank">19246689</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25404399">
<a name="25404399"></a>Gillies M, Ranakusuma A, Hoffmann T, et al. Common harms from amoxicillin: a systematic review and meta-analysis of randomized placebo-controlled trials for any indication. <i>CMAJ</i>. 2015;187(1):E21-E31. doi:10.1503/cmaj.140848<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25404399/pubmed" id="25404399" target="_blank">25404399</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23936716">
<a name="23936716"></a>Girelli F, Bernardi S, Gardelli L, et al. A new case of DRESS syndrome induced by sulfasalazine and triggered by amoxicillin. <i>Case Rep Rheumatol</i>. 2013;2013:409152. doi:10.1155/2013/409152<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23936716/pubmed" id="23936716" target="_blank">23936716</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19366316">
<a name="19366316"></a>Goldstein LH, Berlin M, Tsur L, Bortnik O, Binyamini L, Berkovitch M. The safety of macrolides during lactation. <i>Breastfeed Med</i>. 2009;4(4):197-200.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/19366316/pubmed" id="19366316" target="_blank">19366316</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Golightly.1">
<a name="Golightly.1"></a>Golightly LK, Teitelbaum I, Kiser TH, et al, eds. <i>Renal Pharmacotherapy: Dosage Adjustment of Medications Eliminated by the Kidneys. </i>New York, NY: Springer Science; 2013.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8416502">
<a name="8416502"></a>Green SM, Rothrock SG. Single-dose intramuscular ceftriaxone for acute otitis media in children. <i>Pediatrics</i>. 1993;91(1):23-30.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/8416502/pubmed" id="8416502" target="_blank">8416502</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16716788">
<a name="16716788"></a>Greenbaum LA and Mesrobian HG. Vesicoureteral reflux. <i>Pediatr Clin North Am.</i> 2006;53(3):413-427.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/16716788/pubmed" id="16716788" target="_blank">16716788</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Hooton.1">
<a name="Hooton.1"></a>Gupta K. Acute simple cystitis in females. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 14, 2023b.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Hooton.2">
<a name="Hooton.2"></a>Gupta K. Urinary tract infections and asymptomatic bacteriuria in pregnancy. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 14, 2023a.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21292654">
<a name="21292654"></a>Gupta K, Hooton TM, Naber KG, et al; Infectious Diseases Society of America; European Society for Microbiology and Infectious Diseases. International clinical practice guidelines for the treatment of acute uncomplicated cystitis and pyelonephritis in women: a 2010 update by the Infectious Diseases Society of America and the European Society for Microbiology and Infectious Diseases. <i>Clin Infect Dis</i>. 2011;52(5):e103-e120. doi:10.1093/cid/ciq257<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/21292654/pubmed" id="21292654" target="_blank">21292654</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11502511">
<a name="11502511"></a>Gustafsson I, Löwdin E, Odenholt I, Cars O. Pharmacokinetic and pharmacodynamic parameters for antimicrobial effects of cefotaxime and amoxicillin in an in vitro kinetic model. <i>Antimicrob Agents Chemother</i>. 2001;45(9):2436-2440. doi:10.1128/aac.45.9.2436-2440.2001<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/11502511/pubmed" id="11502511" target="_blank">11502511</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17522387">
<a name="17522387"></a>Halperin JJ, Shapiro ED, Logigian E, et al. Practice parameter: treatment of nervous system Lyme disease (an evidence-based review): report of the Quality Standards Subcommittee of the American Academy of Neurology. <i>Neurology</i>. 2007;69(1):91-102.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/17522387/pubmed" id="17522387" target="_blank">17522387</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26785402">
<a name="26785402"></a>Harris AM, Hicks LA, Qaseem A; High Value Care Task Force of the American College of Physicians and for the Centers for Disease Control and Prevention. Appropriate antibiotic use for acute respiratory tract infection in adults: advice for high-value care from the American College of Physicians and the Centers for Disease Control and Prevention. <i>Ann Intern Med</i>. 2016;164(6):425-434.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/26785402/pubmed" id="26785402" target="_blank">26785402</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24447897">
<a name="24447897"></a>Hendricks KA, Wright ME, Shadomy SV, et al; Workgroup on Anthrax Clinical Guidelines. Centers for Disease Control and Prevention expert panel meetings on prevention and treatment of anthrax in adults. <i>Emerg Infect Dis</i>. 2014;20(2). doi:10.3201/eid2002.130687<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/24447897/pubmed" id="24447897" target="_blank">24447897</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22146873">
<a name="22146873"></a>Hensgens MP, Goorhuis A, Dekkers OM, Kuijper EJ. Time interval of increased risk for <i>Clostridium difficile</i> infection after exposure to antibiotics. <i>J Antimicrob Chemother</i>. 2012;67(3):742-748. doi:10.1093/jac/dkr508<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/22146873/pubmed" id="22146873" target="_blank">22146873</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28002709">
<a name="28002709"></a>Hoberman A, Paradise JL, Rockette HE, et al. Shortened antimicrobial treatment for acute otitis media in young children. <i>N Engl J Med</i>. 2016;375(25):2446-2456. doi:10.1056/NEJMoa1606043<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28002709/pubmed" id="28002709" target="_blank">28002709</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31505007">
<a name="31505007"></a>Homme JH. Acute otitis media and group A streptococcal pharyngitis: a review for the general pediatric practitioner. <i>Pediatr Ann</i>. 2019;48(9):e343-e348. doi:10.3928/19382359-20190813-01<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31505007/pubmed" id="31505007" target="_blank">31505007</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Hsu.1">
<a name="Hsu.1"></a>Hsu K. Treatment of Chlamydia trachomatis infection. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 14, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Hu.1">
<a name="Hu.1"></a>Hu L. Treatment of Lyme disease. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed September 29, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31561959">
<a name="31561959"></a>Hum SW, Shaikh KJ, Musa SS, Shaikh N. Adverse events of antibiotics used to treat acute otitis media in children: a systematic meta-analysis. <i>J Pediatr</i>. 2019;215:139-143.e7.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31561959/pubmed" id="31561959" target="_blank">31561959</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9024461">
<a name="9024461"></a>"Inactive" ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/9024461/pubmed" id="9024461" target="_blank">9024461</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21334779">
<a name="21334779"></a>Isla A, Trocóniz IF, Canut A, et al. Pharmacokinetic/pharmacodynamic evaluation of amoxicillin, amoxicillin/clavulanate and ceftriaxone in the treatment of paediatric acute otitis media in Spain. <i>Enferm Infecc Microbiol Clin</i>. 2011;29(3):167-173. doi:10.1016/j.eimc.2010.05.008<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/21334779/pubmed" id="21334779" target="_blank">21334779</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8498418">
<a name="8498418"></a>Ito S, Blajchman A, Stephenson M, et al. Prospective Follow-Up of Adverse Reactions in Breast-Fed Infants Exposed to Maternal Medication. <i>Am J Obstet Gynecol. </i>1993;168(5):1393-1399.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/8498418/pubmed" id="8498418" target="_blank">8498418</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10891521">
<a name="10891521"></a>Ito S. Drug therapy for breast-feeding women. <i>N Engl J Med</i>. 2000;343(2):118-126.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/10891521/pubmed" id="10891521" target="_blank">10891521</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27629844">
<a name="27629844"></a>Iwańczak BM, Borys-Iwanicka A, Biernat M, Gościniak G. Assessment of sequential and standard triple therapy in treatment of Helicobacter pylori infection in children dependent on bacteria sensitivity to antibiotics. <i>Adv Clin Exp Med</i>. 2016;25(4):701-708. doi:10.17219/acem/38554<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/27629844/pubmed" id="27629844" target="_blank">27629844</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11408852">
<a name="11408852"></a>Jacobson GF, Autry AM, Kirby RS, Liverman EM, Motley RU. A randomized controlled trial comparing amoxicillin and azithromycin for the treatment of Chlamydia trachomatis in pregnancy. <i>Am J Obstet Gynecol</i>. 2001;184(7):1352-1354. doi:10.1067/mob.2001.115050<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/11408852/pubmed" id="11408852" target="_blank">11408852</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23457071">
<a name="23457071"></a>Jevsevar DS, Abt E. The New AAOS-ADA Clinical Practice Guideline on Prevention of Orthopaedic Implant Infection in Patients Undergoing Dental Procedures. <i>J Am Acad Orthop Surg.</i> 2013;21(3):195-197.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23457071/pubmed" id="23457071" target="_blank">23457071</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28541262">
<a name="28541262"></a>Jones NL, Koletzko S, Goodman K, et al. Joint ESPGHAN/NASPGHAN guidelines for the management of <i>Helicobacter pylori</i> in children and adolescents (update 2016). <i>J Pediatr Gastroenterol Nutr</i>. 2017;64(6):991-1003. doi:10.1097/MPG.0000000000001594<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28541262/pubmed" id="28541262" target="_blank">28541262</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7246123">
<a name="7246123"></a>Kafetzis DA, Siafas CA, Georgakopoulos PA, Papadatos CJ. Passage of cephalosporins and amoxicillin into the breast milk. <i>Acta Paediatr Scand.</i> 1981;70(3):285-288.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/7246123/pubmed" id="7246123" target="_blank">7246123</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27925427">
<a name="27925427"></a>Kanhutu K, Jones P, Cheng AC, Grannell L, Best E, Spelman D. Spleen Australia guidelines for the prevention of sepsis in patients with asplenia and hyposplenism in Australia and New Zealand.<i> Intern Med J.</i> 2017;47(8):848-855. doi:10.1111/imj.13348<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/27925427/pubmed" id="27925427" target="_blank">27925427</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34384710">
<a name="34384710"></a>Katoh Y, Natsume O, Matsunaga M, Takayanagi F, Uchida H, Yasuoka R. Diagnosis of non-immediate hypersensitivity to amoxicillin in children by skin test and drug provocation tests: a retrospective case-series study. <i>Allergol Int</i>. Published online August 9, 2021. doi:10.1016/j.alit.2021.07.009<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/34384710/pubmed" id="34384710" target="_blank">34384710</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31236572">
<a name="31236572"></a>Keij FM, Kornelisse RF, Hartwig NG, Reiss IKM, Allegaert K, Tramper-Stranders GA. Oral antibiotics for neonatal infections: a systematic review and meta-analysis. <i>J Antimicrob Chemother</i>. 2019;74(11):3150-3161. doi:10.1093/jac/dkz252<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31236572/pubmed" id="31236572" target="_blank">31236572</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26167456">
<a name="26167456"></a>Keller F, Schröppel B, Ludwig U. Pharmacokinetic and pharmacodynamic considerations of antimicrobial drug therapy in cancer patients with kidney dysfunction. <i>World J Nephrol</i>. 2015;4(3):330-344. doi:10.5527/wjn.v4.i3.330<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/26167456/pubmed" id="26167456" target="_blank">26167456</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22102391">
<a name="22102391"></a>Kim JS, Jang YR, Lee JW, et al. A case of amoxicillin-induced hepatocellular liver injury with bile-duct damage. <i>Korean J Hepatol</i>. 2011;17(3):229-232. doi:10.3350/kjhep.2011.17.3.229<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/22102391/pubmed" id="22102391" target="_blank">22102391</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21558964">
<a name="21558964"></a>Koletzko S, Jones NL, Goodman KJ, et al. Evidence-based guidelines from ESPGHAN and NASPGHAN for <i>Helicobacter pylori</i> infection in children. <i>J Pediatr Gastroenterol Nutr</i>. 2011;53(2):230-243.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/21558964/pubmed" id="21558964" target="_blank">21558964</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34306301">
<a name="34306301"></a>Koosakulchai V, Sangsupawanich P, Wantanaset D, Jessadapakorn W, Jongvilaikasem P, Yuenyongviwat A. Safety of direct oral provocation testing using the amoxicillin-2-step-challenge in children with history of non-immediate reactions to amoxicillin. <i>World Allergy Organ J</i>. 2021;14(7):100560. doi:10.1016/j.waojou.2021.100560<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/34306301/pubmed" id="34306301" target="_blank">34306301</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20824827">
<a name="20824827"></a>Kozyrskyj A, Klassen TP, Moffatt M, Harvey K. Short-course antibiotics for acute otitis media. <i>Cochrane Database Syst Rev</i>. 2010;2010(9):CD001095. doi:10.1002/14651858.CD001095.pub2<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/20824827/pubmed" id="20824827" target="_blank">20824827</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25964726">
<a name="25964726"></a>Kuehn J, Ismael Z, Long PF, Barker CI, Sharland M. Reported rates of diarrhea following oral penicillin therapy in pediatric clinical trials. <i>J Pediatr Pharmacol Ther</i>. 2015;20(2):90-104. doi:10.5863/1551-6776-20.2.90<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25964726/pubmed" id="25964726" target="_blank">25964726</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35579504">
<a name="35579504"></a>Kuitunen I, Jääskeläinen J, Korppi M, Renko M. Antibiotic treatment duration for community acquired pneumonia in outpatient children in high-income countries - a systematic review and meta-analysis. <i>Clin Infect Dis</i>. 2022;ciac374. doi:10.1093/cid/ciac374<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/35579504/pubmed" id="35579504" target="_blank">35579504</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25171023">
<a name="25171023"></a>Kutluk G, Tutar E, Bayrak A, et al. Sequential therapy versus standard triple therapy for Helicobacter pylori eradication in children: any advantage in clarithromycin-resistant strains?. <i>Eur J Gastroenterol Hepatol</i>. 2014;26(11):1202-1208. doi:10.1097/MEG.0000000000000190<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25171023/pubmed" id="25171023" target="_blank">25171023</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32211414">
<a name="32211414"></a>Lambert JS. An overview of tickborne infections in pregnancy and outcomes in the newborn: the need for prospective studies. <i>Front Med (Lausanne)</i>. 2020;7:72. doi:10.3389/fmed.2020.00072<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32211414/pubmed" id="32211414" target="_blank">32211414</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25189188">
<a name="25189188"></a>Lamont HF, Blogg HJ, Lamont RF. Safety of antimicrobial treatment during pregnancy: a current review of resistance, immunomodulation and teratogenicity. <i>Expert Opin Drug Saf</i>. 2014;13(12):1569-1581. doi:10.1517/14740338.2014.939580<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25189188/pubmed" id="25189188" target="_blank">25189188</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Lamont.2023">
<a name="Lamont.2023"></a>Lamont TJ. Treatment regimens for helicobacter pylori in adults. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 14, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33251700">
<a name="33251700"></a>Lantos PM, Rumbaugh J, Bockenstedt LK, et al. Clinical practice guidelines by the Infectious Diseases Society of America (IDSA), American Academy of Neurology (AAN), and American College of Rheumatology (ACR): 2020 guidelines for the prevention, diagnosis, and treatment of lyme disease. <i>Arthritis Care Res (Hoboken)</i>. 2021;73(1):1-9. doi:10.1002/acr.24495<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/33251700/pubmed" id="33251700" target="_blank">33251700</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34860955">
<a name="34860955"></a>Lashkar MO, Nahata MC. Antimicrobial pharmacotherapy management of urinary tract infections in pediatric patients. <i>J Pharm Technol</i>. 2018;34(2):62-81. doi:10.1177/8755122518755402<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/34860955/pubmed" id="34860955" target="_blank">34860955</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33275684">
<a name="33275684"></a>Lee GM. Preventing infections in children and adults with asplenia. <i>Hematology Am Soc Hematol Educ Program</i>. 2020;2020(1):328-335. doi:10.1182/hematology.2020000117<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/33275684/pubmed" id="33275684" target="_blank">33275684</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11128556">
<a name="11128556"></a>Lee SY. Postantibiotic effects and postantibiotic sub-MIC effects of amoxicillin on streptococcus gordonii and streptococcus sanguis.<i> J Chemother.</i> 2000;12(5):379-384. doi:10.1179/joc.2000.12.5.379<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/11128556/pubmed" id="11128556" target="_blank">11128556</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23439909">
<a name="23439909"></a>Lieberthal AS, Carroll AE, Chonmaitree T, et al. The diagnosis and management of acute otitis media. <i>Pediatrics</i>. 2013;131(3):e964-e999. doi:10.1542/peds.2012-3488<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23439909/pubmed" id="23439909" target="_blank">23439909</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Limb.1">
<a name="Limb.1"></a>Limb CJ, Lustig LR, Durand ML. Acute otitis media in adults. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 14, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22766750">
<a name="22766750"></a>Lin KJ, Mitchell AA, Yau WP, Louik C, Hernandez-Diaz S. Maternal exposure to amoxicillin and the risk of oral clefts. <i>Epidemiology.</i> 2012;23(5):699-705.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/22766750/pubmed" id="22766750" target="_blank">22766750</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8760738">
<a name="8760738"></a>Lindbaek M, Hjortdahl P, Johnsen UL. Randomised, double blind, placebo controlled trial of penicillin V and amoxycillin in treatment of acute sinus infections in adults. <i>BMJ</i>. 1996;313(7053):325-329.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/8760738/pubmed" id="8760738" target="_blank">8760738</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30020891">
<a name="30020891"></a>Litao G, Jingjing S, Yu L, Lei Z, Xiaona H, Zhijing Z. Risk factors for antibiotic-associated diarrhea in critically ill patients. <i>Med Sci Monit</i>. 2018;24:5000-5007. doi:10.12659/MSM.911308<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/30020891/pubmed" id="30020891" target="_blank">30020891</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31668170">
<a name="31668170"></a>Lockhart PB, Tampi MP, Abt E, et al. Evidence-based clinical practice guideline on antibiotic use for the urgent management of pulpal- and periapical-related dental pain and intraoral swelling: A report from the American Dental Association. <i>J Am Dent Assoc</i>. 2019;150(11):906-921.e12. doi:10.1016/j.adaj.2019.08.020<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31668170/pubmed" id="31668170" target="_blank">31668170</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-7100823">
<a name="7100823"></a>Lönnerholm G, Bengtsson S, Ewald U. Oral pivampicillin and amoxycillin in newborn infants. <i>Scand J Infect Dis</i>. 1982;14(2):127-130. doi:10.3109/inf.1982.14.issue-2.10<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/7100823/pubmed" id="7100823" target="_blank">7100823</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-850084">
<a name="850084"></a>Lusk RH, Fekety FR Jr, Silva J Jr, et al. Gastrointestinal side effects of clindamycin and ampicillin therapy. <i>J Infect Dis</i>. 1977;135 suppl:S111-S119. doi:10.1093/infdis/135.supplement.s111<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/850084/pubmed" id="850084" target="_blank">850084</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31118710">
<a name="31118710"></a>Ma H, Zhang L, Zhang Y, Liu Y, He Y, Guo L. Combined administration of antibiotics increases the incidence of antibiotic-associated diarrhea in critically ill patients. <i>Infect Drug Resist</i>. 2019;12:1047-1054. doi:10.2147/IDR.S194715<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31118710/pubmed" id="31118710" target="_blank">31118710</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8414799">
<a name="8414799"></a>Mandel EM, Kardatzke D, Bluestone CD, Rockette HE. A comparative evaluation of cefaclor and amoxicillin in the treatment of acute otitis media. <i>Pediatr Infect Dis J</i>. 1993;12(9):726-732. doi:10.1097/00006454-199309000-00005<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/8414799/pubmed" id="8414799" target="_blank">8414799</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28827186">
<a name="28827186"></a>Mantegazza C, Molinari P, D'Auria E, Sonnino M, Morelli L, Zuccotti GV. Probiotics and antibiotic-associated diarrhea in children: a review and new evidence on <i>Lactobacillus rhamnosus</i> GG during and after antibiotic treatment. <i>Pharmacol Res</i>. 2018;128:63-72. doi:10.1016/j.phrs.2017.08.001<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28827186/pubmed" id="28827186" target="_blank">28827186</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31876601">
<a name="31876601"></a>Marchisio P, Galli L, Bortone B, et al. Updated guidelines for the management of acute otitis media in children by the Italian Society of Pediatrics: treatment. <i>Pediatr Infect Dis J</i>. 2019;38(12S suppl):S10-S21. doi:10.1097/INF.0000000000002452<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31876601/pubmed" id="31876601" target="_blank">31876601</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-6584159">
<a name="6584159"></a>Martin MV. The use of oral amoxycillin for the treatment of actinomycosis. A clinical and in vitro study. <i>Br Dent J</i>. 1984;156(7):252-254.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/6584159/pubmed" id="6584159" target="_blank">6584159</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17483966">
<a name="17483966"></a>Mattoo TK. Medical management of vesicoureteral reflux - quiz within the article. Don't overlook placebos. <i>Pediatr Nephrol.</i> 2007;22(8):1113-1120.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/17483966/pubmed" id="17483966" target="_blank">17483966</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-15930204">
<a name="15930204"></a>McCormick DP, Chonmaitree T, Pittman C, et al. Nonsevere acute otitis media: a clinical trial comparing outcomes of watchful waiting versus immediate antibiotic treatment. <i>Pediatrics</i>. 2005;115(6):1455-1465. doi:10.1542/peds.2004-1665<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/15930204/pubmed" id="15930204" target="_blank">15930204</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29462280">
<a name="29462280"></a>McDonald LC, Gerding DN, Johnson S, et al. Clinical practice guidelines for <i>Clostridium difficile</i> infection in adults and children: 2017 update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA). <i>Clin Infect Dis</i>. 2018;66(7):e1-e48. doi:10.1093/cid/cix1085<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29462280/pubmed" id="29462280" target="_blank">29462280</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27003987">
<a name="27003987"></a>McFarland LV, Ozen M, Dinleyici EC, Goh S. Comparison of pediatric and adult antibiotic-associated diarrhea and <i>Clostridium difficile</i> infections. <i>World J Gastroenterol</i>. 2016;22(11):3078-3104. doi:10.3748/wjg.v22.i11.3078<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/27003987/pubmed" id="27003987" target="_blank">27003987</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24457117">
<a name="24457117"></a>Meaney-Delman D, Zotti ME, Creanga AA, et al; Workgroup on Anthrax in Pregnant and Postpartum Women. Special considerations for treatment of anthrax in pregnant and postpartum women. <i>Emerg Infect Dis</i>. 2014;20(2).<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/24457117/pubmed" id="24457117" target="_blank">24457117</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31573350">
<a name="31573350"></a>Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. <i>Am J Resp Crit Care Med</i>. 2019;200(7):e45-e67. doi:10.1164/rccm.201908-1581ST<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31573350/pubmed" id="31573350" target="_blank">31573350</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31699837">
<a name="31699837"></a>Middleton PG, Gade EJ, Aguilera C, et al. ERS/TSANZ Task Force statement on the management of reproduction and pregnancy in women with airways diseases. <i>Eur Respir J</i>. 2020;55(2):1901208. doi:10.1183/13993003.01208-2019<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31699837/pubmed" id="31699837" target="_blank">31699837</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32404437">
<a name="32404437"></a>Mir F, Pearce RE, Baig-Ansari N, et al. Serum amoxicillin levels in young infants (0-59 days) with sepsis treated with oral amoxicillin. <i>Arch Dis Child</i>. 2020;105(12):1208-1214. doi:10.1136/archdischild-2019-317342<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32404437/pubmed" id="32404437" target="_blank">32404437</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28631728">
<a name="28631728"></a>Moayyedi PM, Lacy BE, Andrews CN, Enns RA, Howden CW, Vakil N. ACG and CAG clinical guideline: management of dyspepsia. <i>Am J Gastroenterol</i>. 2017;112(7):988-1013. doi:10.1038/ajg.2017.154<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28631728/pubmed" id="28631728" target="_blank">28631728</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23722146">
<a name="23722146"></a>Moghimi M, Salentijn E, Debets-Ossenkop Y, Karagozoglu KH, Forouzanfar T. Treatment of cervicofacial actinomycosis: a report of 19 cases and review of literature. <i>Med Oral Patol Oral Cir Bucal</i>. 2013;18(4):e627-e632.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23722146/pubmed" id="23722146" target="_blank">23722146</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32653225">
<a name="32653225"></a>Mohsenzadeh A, Movahedi M, Saatchi M, et al. Serum sickness-like reactions in Iranian children: a registry-based study in a referral center. <i>Allergol Immunopathol (Madr)</i>. 2020;48(5):424-429. doi:10.1016/j.aller.2019.07.012<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32653225/pubmed" id="32653225" target="_blank">32653225</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28722171">
<a name="28722171"></a>Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and the risk of major congenital malformations: a population based cohort study. <i>Br J Clin Pharmacol</i>. 2017a;83(11):2557-2571. doi:10.1111/bcp.13364<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28722171/pubmed" id="28722171" target="_blank">28722171</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28461374">
<a name="28461374"></a>Muanda FT, Sheehy O, Bérard A. Use of antibiotics during pregnancy and risk of spontaneous abortion. <i>CMAJ</i>. 2017b;189(17):E625-E633. doi:10.1503/cmaj.161020<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28461374/pubmed" id="28461374" target="_blank">28461374</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19164154">
<a name="19164154"></a>Muller AE, Oostvogel PM, DeJongh J, et al. Pharmacokinetics of amoxicillin in maternal, umbilical cord, and neonatal sera. <i>Antimicrob Agents Chemother.</i> 2009;53(4):1574-1580.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/19164154/pubmed" id="19164154" target="_blank">19164154</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Murray.2018">
<a name="Murray.2018"></a>Murray BE. Treatment of enterococcal infections. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed February 8, 2021.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11718584">
<a name="11718584"></a>Musher DM, Bartlett JG, Doern GV. A fresh look at the definition of susceptibility of Streptococcus pneumoniae to beta-lactam antibiotics. <i>Arch Intern Med</i>. 2001;161(21):2538-2544. doi:10.1001/archinte.161.21.2538<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/11718584/pubmed" id="11718584" target="_blank">11718584</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29408016">
<a name="29408016"></a>Nasiri MJ, Goudarzi M, Hajikhani B, Ghazi M, Goudarzi H, Pouriran R. <i>Clostridioides (Clostridium) difficile</i> infection in hospitalized patients with antibiotic-associated diarrhea: a systematic review and meta-analysis. <i>Anaerobe</i>. 2018;50:32-37. doi:10.1016/j.anaerobe.2018.01.011<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29408016/pubmed" id="29408016" target="_blank">29408016</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NICE.1">
<a name="NICE.1"></a>National Institute for Health and Care Excellence. Drug allergy: diagnosis and management. Published September 3, 2014. Accessed October 5, 2021. https://www.nice.org.uk/guidance/cg183
                  </div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NICE.2">
<a name="NICE.2"></a>National Institute for Health and Care Excellence (NICE). Otitis media (acute): antimicrobial prescribing. London, UK: National Institute for Health and Care Excellence. https://www.nice.org.uk/guidance/ng91. Published March 2018. Accessed November 3, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31400244">
<a name="31400244"></a>Nguyen CT, Davis KA, Nisly SA, Li J. Treatment of Helicobacter pylori in special patient populations. <i>Pharmacotherapy</i>. 2019;39(10):1012-1022. doi:10.1002/phar.2318<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31400244/pubmed" id="31400244" target="_blank">31400244</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31506700">
<a name="31506700"></a>Nicolle LE, Gupta K, Bradley SF, et al. Clinical practice guideline for the management of asymptomatic bacteriuria: 2019 update by the Infectious Diseases Society of America. <i>Clin Infect Dis.</i> 2019;68(10):1611-1615. doi:10.1093/cid/ciz021<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31506700/pubmed" id="31506700" target="_blank">31506700</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28315732">
<a name="28315732"></a>Nishimura RA, Otto CM, Bonow RO, et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. <i>J Am Coll Cardiol</i>. 2017;70(2):252-289. doi:10.1016/j.jacc.2017.03.011<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28315732/pubmed" id="28315732" target="_blank">28315732</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Novamoxin.1">
<a name="Novamoxin.1"></a>Novamoxin (amoxicillin) [product monograph]. Toronto, Ontario, Canada: Teva Canada Limited; May 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23223583">
<a name="23223583"></a>Osmon DR, Berbari EF, Berendt AR, et al; Infectious Diseases Society of America. Diagnosis and management of prosthetic joint infection: clinical practice guideline by the Infectious Diseases Society of America. <i>Clin Infect Dis.</i> 2013;56(1):e1-e25.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23223583/pubmed" id="23223583" target="_blank">23223583</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3320613">
<a name="3320613"></a>Parry MF, “The Penicillins,” <i>Med Clin North Am</i>, 1987, 71(6):1093-112.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/3320613/pubmed" id="3320613" target="_blank">3320613</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Patel.2018">
<a name="Patel.2018"></a>Patel ZM, Hwang PH. Uncomplicated acute sinusitis and rhinosinusitis in adults: treatment. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed July 14, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29513846">
<a name="29513846"></a>Paulo CO, Jordão S, Correia-Pinto J, Ferreira F, Neves I. Actinomycosis, a lurking threat: a report of 11 cases and literature review. <i>Rev Soc Bras Med Trop</i>. 2018;51(1):7-13. doi:10.1590/0037-8682-0215-2017<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29513846/pubmed" id="29513846" target="_blank">29513846</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28965641">
<a name="28965641"></a>Pavlos R, White KD, Wanjalla C, Mallal SA, Phillips EJ. Severe delayed drug reactions: role of genetics and viral infections. <i>Immunol Allergy Clin North Am</i>. 2017;37(4):785-815. doi:10.1016/j.iac.2017.07.007<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28965641/pubmed" id="28965641" target="_blank">28965641</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17385141">
<a name="17385141"></a>Peled N, Pitlik S, Samra Z, Kazakov A, Bloch Y, Bishara J. Predicting <i>Clostridium difficile</i> toxin in hospitalized patients with antibiotic-associated diarrhea. <i>Infect Control Hosp Epidemiol</i>. 2007;28(4):377-381. doi:10.1086/513723<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/17385141/pubmed" id="17385141" target="_blank">17385141</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33683325">
<a name="33683325"></a>Pernica JM, Harman S, Kam AJ, et al. Short-course antimicrobial therapy for pediatric community-acquired pneumonia: the SAFER Randomized Clinical Trial. <i>JAMA Pediatr</i>. 2021;175(5):475-482. doi:10.1001/jamapediatrics.2020.6735<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/33683325/pubmed" id="33683325" target="_blank">33683325</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-11157603">
<a name="11157603"></a>Petitpretz P, Arvis P, Marel M, Moita J, Urueta J; CAP5 Moxifloxacin Study Group. Oral moxifloxacin vs high-dosage amoxicillin in the treatment of mild-to-moderate, community-acquired, suspected pneumococcal pneumonia in adults. <i>Chest</i>. 2001;119(1):185-195. doi:10.1378/chest.119.1.185<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/11157603/pubmed" id="11157603" target="_blank">11157603</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34271183">
<a name="34271183"></a>Piotin A, Godet J, Trubiano JA, et al. Predictive factors of amoxicillin immediate hypersensitivity and validation of PEN-FAST clinical decision rule. <i>Ann Allergy Asthma Immunol</i>. Published online July 13, 2021. doi:10.1016/j.anai.2021.07.005<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/34271183/pubmed" id="34271183" target="_blank">34271183</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28889110">
<a name="28889110"></a>Polverino E, Goeminne PC, McDonnell MJ, et al. European Respiratory Society guidelines for the management of adult bronchiectasis. <i>Eur Respir J</i>. 2017;50(3):pii:1700629. doi:10.1183/13993003.00629-2017<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28889110/pubmed" id="28889110" target="_blank">28889110</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17826619">
<a name="17826619"></a>Price VE, Blanchette VS, Ford-Jones EL. The prevention and management of infections in children with asplenia or hyposplenia. <i>Infect Dis Clin North Am</i>. 2007;21(3):697-710.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/17826619/pubmed" id="17826619" target="_blank">17826619</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3129390">
<a name="3129390"></a>Prigogine T, Glupczynski Y, Carpiaux JP, Blogie M, Yourassowsky E, Schmerber JS. Enoxacin in acute exacerbations of chronic bronchitis: a comparison with amoxycillin. <i>J Antimicrob Chemother</i>. 1988;21(suppl B):131-136.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/3129390/pubmed" id="3129390" target="_blank">3129390</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17328645">
<a name="17328645"></a>Puhó EH, Szunyogh M, Métneki J, Czeizel AE. Drug treatment during pregnancy and isolated orofacial clefts in Hungary. <i>Cleft Palate Craniofac J.</i> 2007;44(2):194-202.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/17328645/pubmed" id="17328645" target="_blank">17328645</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-8295812">
<a name="8295812"></a>Pukander JS, Jero JP, Kaprio EA, Sorri MJ. Clarithromycin vs. amoxicillin suspensions in the treatment of pediatric patients with acute otitis media. <i>Pediatr Infect Dis J</i>. 1993;12(12 suppl 3):S118-S121. doi:10.1097/00006454-199312003-00005<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/8295812/pubmed" id="8295812" target="_blank">8295812</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16628135">
<a name="16628135"></a>Pullen J, Stolk LM, Nieman FH, Degraeuwe PL, van Tiel FH, Zimmermann LJ. Population pharmacokinetics and dosing of amoxicillin in (pre)term neonates. <i>Ther Drug Monit.</i> 2006;28(2):226-231. doi:10.1097/01.ftd.0000198648.39751.11<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/16628135/pubmed" id="16628135" target="_blank">16628135</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Reboli.1">
<a name="Reboli.1"></a>Reboli AC. Erysipelothrix infection. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed September 10, 2020.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-manu.1">
<a name="manu.1"></a>Refer to manufacturer's labeling.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30051945">
<a name="30051945"></a>Rodríguez-Martín S, Martín-Merino E, Lerma V, et al. Active surveillance of severe cutaneous adverse reactions: a case-population approach using a registry and a health care database. <i>Pharmacoepidemiol Drug Saf</i>. 2018;27(9):1042-1050. doi:10.1002/pds.4622<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/30051945/pubmed" id="30051945" target="_blank">30051945</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27016799">
<a name="27016799"></a>Romano A, Gaeta F, Valluzzi RL, Maggioletti M, Caruso C, Quaratino D. Cross-reactivity and tolerability of aztreonam and cephalosporins in subjects with a T cell-mediated hypersensitivity to penicillins. <i>J Allergy Clin Immunol</i>. 2016;138(1):179-186. doi:10.1016/j.jaci.2016.01.025<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/27016799/pubmed" id="27016799" target="_blank">27016799</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29408440">
<a name="29408440"></a>Romano A, Valluzzi RL, Caruso C, Maggioletti M, Quaratino D, Gaeta F. Cross-reactivity and tolerability of cephalosporins in patients with IgE-mediated hypersensitivity to penicillins. <i>J Allergy Clin Immunol Pract</i>. 2018;6(5):1662-1672. doi:10.1016/j.jaip.2018.01.020<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29408440/pubmed" id="29408440" target="_blank">29408440</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25832968">
<a name="25832968"></a>Rosenfeld RM, Piccirillo JF, Chandrasekhar SS, et al. Clinical practice guideline (update): adult sinusitis. <i>Otolaryngol Head Neck Surg</i>. 2015;152(2)(suppl):S1-S39. doi:10.1177/0194599815572097<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25832968/pubmed" id="25832968" target="_blank">25832968</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-20516363">
<a name="20516363"></a>Rossi F, Ruggiero S, Gallo M, Simeone G, Matarese SM, Nobili B. Amoxicillin-induced hemolytic anemia in a child with glucose 6-phosphate isomerase deficiency. <i>Ann Pharmacother</i>. 2010;44(7-8):1327-1329. doi:10.1345/aph.1P030<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/20516363/pubmed" id="20516363" target="_blank">20516363</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28708801">
<a name="28708801"></a>Saavedra-Lozano J, Falup-Pecurariu O, Faust SN, et al. Bone and joint infections. <i>Pediatr Infect Dis J</i>. 2017;36(8):788-799. doi:10.1097/INF.0000000000001635<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28708801/pubmed" id="28708801" target="_blank">28708801</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24855431">
<a name="24855431"></a>Salvadori MI, Price VE; Canadian Paediatric Society, Infectious Diseases and Immunization Committee. Preventing and treating infections in children with asplenia or hyposplenia. <i>Paediatr Child Health</i>. 2014;19(5):271-278.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/24855431/pubmed" id="24855431" target="_blank">24855431</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32525203">
<a name="32525203"></a>Same RG, Amoah J, Hsu AJ, et al. The association of antibiotic duration with successful treatment of community-acquired pneumonia in children. <i>J Pediatric Infect Dis Soc</i>. 2021;10(3):267-273. doi:10.1093/jpids/piaa055<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32525203/pubmed" id="32525203" target="_blank">32525203</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1856121">
<a name="1856121"></a>Schliamser SE, Cars O, Norrby SR. Neurotoxicity of beta-lactam antibiotics: predisposing factors and pathogenesis. <i>J Antimicrob Chemother</i>. 1991;27(4):405-425.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/1856121/pubmed" id="1856121" target="_blank">1856121</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-9764549">
<a name="9764549"></a>Scholz H, Noack R. Multicenter, randomized, double-blind comparison of erythromycin estolate versus amoxicillin for the treatment of acute otitis media in children. AOM Study Group. <i>Eur J Clin Microbiol Infect Dis</i>. 1998;17(7):470-478. doi:10.1007/BF01691129<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/9764549/pubmed" id="9764549" target="_blank">9764549</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33292467">
<a name="33292467"></a>Schrüfer P, Brockow K, Stoevesandt J, Trautmann A. Predominant patterns of β-lactam hypersensitivity in a single German Allergy Center: exanthem induced by aminopenicillins, anaphylaxis by cephalosporins. <i>Allergy Asthma Clin Immunol</i>. 2020;16(1):102. doi:10.1186/s13223-020-00488-0<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/33292467/pubmed" id="33292467" target="_blank">33292467</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21407111">
<a name="21407111"></a>Schwarzer A, Urruzuno P, Iwańczak B, et al. New effective treatment regimen for children infected with a double-resistant Helicobacter pylori strain. <i>J Pediatr Gastroenterol Nutr</i>. 2011;52(4):424-428. doi:10.1097/MPG.0b013e3181fc8c58<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/21407111/pubmed" id="21407111" target="_blank">21407111</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33524402">
<a name="33524402"></a>Shah SC, Iyer PG, Moss SF. AGA clinical practice update on the management of refractory Helicobacter pylori infection: expert review. <i>Gastroenterology</i>. 2021;160(5):1831-1841. doi:10.1053/j.gastro.2020.11.059<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/33524402/pubmed" id="33524402" target="_blank">33524402</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29053792">
<a name="29053792"></a>Shane AL, Mody RK, Crump JA, et al. 2017 Infectious Diseases Society of America clinical practice guidelines for the diagnosis and management of infectious diarrhea. <i>Clin Infect Dis</i>. 2017;65(12):e45-e80. doi:10.1093/cid/cix669<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29053792/pubmed" id="29053792" target="_blank">29053792</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22965026">
<a name="22965026"></a>Shulman ST, Bisno AL, Clegg HW, et al; Infectious Diseases Society of America. Clinical practice guideline for the diagnosis and management of group A streptococcal pharyngitis: 2012 update by the Infectious Diseases Society of America [published correction appears in <i>Clin Infect Dis. </i>2014;58(10):1496]. <i>Clin Infect Dis.</i> 2012;55(10):e86-e102.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/22965026/pubmed" id="22965026" target="_blank">22965026</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23297772">
<a name="23297772"></a>Silva-Senem MX, Heller D, Varela VM, Torres MC, Feres-Filho EJ, Colombo AP. Clinical and microbiological effects of systemic antimicrobials combined to an anti-infective mechanical debridement for the management of aggressive periodontitis: a 12-month randomized controlled trial. <i>J Clin Periodontol</i>. 2013;40(3):242-251. doi:10.1111/jcpe.12052<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23297772/pubmed" id="23297772" target="_blank">23297772</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26246256">
<a name="26246256"></a>Siqueira MB, Saleh A, Klika AK, et al. Chronic suppression of periprosthetic joint infections with oral antibiotics increases infection-free survivorship. <i>J Bone Joint Surg Am</i>. 2015;97(15):1220-1232. doi:10.2106/JBJS.N.00999<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/26246256/pubmed" id="26246256" target="_blank">26246256</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24324224">
<a name="24324224"></a>Slimings C, Riley TV. Antibiotics and hospital-acquired Clostridium difficile infection: update of systematic review and meta-analysis. <i>J Antimicrob Chemother</i>. 2014;69(4):881-891. doi:10.1093/jac/dkt477<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/24324224/pubmed" id="24324224" target="_blank">24324224</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32414479">
<a name="32414479"></a>Smith GN, Moore KM, Hatchette TF, Nicholson J, Bowie W, Langley JM. Committee Opinion No. 399: Management of tick bites and Lyme disease during pregnancy. <i>J Obstet Gynaecol Can</i>. 2020;42(5):644-653. doi:10.1016/j.jogc.2020.01.001<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32414479/pubmed" id="32414479" target="_blank">32414479</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25569493">
<a name="25569493"></a>Sollecito TP, Abt E, Lockhart PB, et al. The use of prophylactic antibiotics prior to dental procedures in patients with prosthetic joints: Evidence-based clinical practice guideline for dental practitioners--a report of the American Dental Association Council on Scientific Affairs. <i>J Am Dent Assoc.</i> 2015;146(1):11-16.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25569493/pubmed" id="25569493" target="_blank">25569493</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Spelman.1">
<a name="Spelman.1"></a>Spelman D, Baddour LM. Acute cellulitis and erysipelas in adults: Treatment. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed June 17, 2022.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33419114">
<a name="33419114"></a>Spoială EL, Stanciu GD, Bild V, Ababei DC, Gavrilovici C. From evidence to clinical guidelines in antibiotic treatment in acute otitis media in children. <i>Antibiotics (Basel)</i>. 2021;10(1):52. doi:10.3390/antibiotics10010052<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/33419114/pubmed" id="33419114" target="_blank">33419114</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25477258">
<a name="25477258"></a>Stein R, Dogan HS, Hoebeke P, et al. Urinary tract infections in children: EAU/ESPU guidelines. <i>Eur Urol</i>. 2015;67(3):546-558. doi:10.1016/j.eururo.2014.11.007<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25477258/pubmed" id="25477258" target="_blank">25477258</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-24973422">
<a name="24973422"></a>Stevens DL, Bisno AL, Chambers HF, et al; Infectious Diseases Society of America. Practice guidelines for the diagnosis and management of skin and soft tissue infections: 2014 update by the Infectious Diseases Society of America. <i>Clin Infect Dis</i>. 2014;59(2):e10-e52. doi:10.1093/cid/ciu444<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/24973422/pubmed" id="24973422" target="_blank">24973422</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21653301">
<a name="21653301"></a>Stevens V, Dumyati G, Fine LS, Fisher SG, van Wijngaarden E. Cumulative antibiotic exposures over time and the risk of <i>Clostridium difficile</i> infection. <i>Clin Infect Dis</i>. 2011;53(1):42-48. doi:10.1093/cid/cir301<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/21653301/pubmed" id="21653301" target="_blank">21653301</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21308555">
<a name="21308555"></a>Swaminathan S, Alangaden GJ. Treatment of resistant enterococcal urinary tract infections. <i>Curr Infect Dis Rep</i>. 2010;12(6):455-464.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/21308555/pubmed" id="21308555" target="_blank">21308555</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19330931">
<a name="19330931"></a>Szajewska H, Albrecht P, Topczewska-Cabanek A. Randomized, double-blind, placebo-controlled trial: effect of lactobacillus GG supplementation on Helicobacter pylori eradication rates and side effects during treatment in children. <i>J Pediatr Gastroenterol Nutr</i>. 2009;48(4):431-436. doi:10.1097/mpg.0b013e318182e716<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/19330931/pubmed" id="19330931" target="_blank">19330931</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-28360365">
<a name="28360365"></a>Szeto CC, Li PK, Johnson DW, et al. ISPD Catheter-related infection recommendations: 2017 update. <i>Perit Dial Int</i>. 2017;37(2):141-154. doi:10.3747/pdi.2016.00120<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/28360365/pubmed" id="28360365" target="_blank">28360365</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30973334">
<a name="30973334"></a>Takimoto R, Honda T, Kataoka TR, Ueshima C, Otsuka A, Kabashima K. DIHS/DRESS-like eruption possibly induced by amoxicillin during treatment with nivolumab. <i>Eur J Dermatol</i>. 2019;29(2):228-229. doi:10.1684/ejd.2019.3522<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/30973334/pubmed" id="30973334" target="_blank">30973334</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-26783390">
<a name="26783390"></a>Thienvibul C, Vachiramon V, Chanprapaph K. Five-year retrospective review of acute generalized exanthematous pustulosis. <i>Dermatol Res Pract</i>. 2015;2015:260928. doi:10.1155/2015/260928<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/26783390/pubmed" id="26783390" target="_blank">26783390</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27941119">
<a name="27941119"></a>Tikmani SS, Muhammad AA, Shafiq Y, et al. Ambulatory treatment of fast breathing in young infants aged &lt;60 days: a double-blind, randomized, placebo-controlled equivalence trial in low-income settlements of Karachi. <i>Clin Infect Dis</i>. 2017;64(2):184-189. doi:10.1093/cid/ciw690<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/27941119/pubmed" id="27941119" target="_blank">27941119</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-19747629">
<a name="19747629"></a>Tomblyn M, Chiller T, Einsele H, et al; Center for International Blood and Marrow Research; National Marrow Donor program; European Blood and Marrow Transplant Group; American Society of Blood and Marrow Transplantation; Canadian Blood and Marrow Transplant Group; Infectious Diseases Society of America; Society for Healthcare Epidemiology of America; Association of Medical Microbiology and Infectious Disease Canada; Centers for Disease Control and Prevention. Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective.<i> Biol Blood Marrow Transplant.</i> 2009;15(10):1143-1238. doi:10.1016/j.bbmt.2009.06.019<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/19747629/pubmed" id="19747629" target="_blank">19747629</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25842223">
<a name="25842223"></a>Tshefu A, Lokangaka A, African Neonatal Sepsis Trial (AFRINEST) group, et al. Oral amoxicillin compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with fast breathing when referral is not possible: a randomised, open-label, equivalence trial. <i>Lancet</i>. 2015a;385(9979):1758-1766. doi:10.1016/S0140-6736(14)62285-6<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25842223/pubmed" id="25842223" target="_blank">25842223</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25842221">
<a name="25842221"></a>Tshefu A, Lokangaka A, African Neonatal Sepsis Trial (AFRINEST) group, et al. Simplified antibiotic regimens compared with injectable procaine benzylpenicillin plus gentamicin for treatment of neonates and young infants with clinical signs of possible serious bacterial infection when referral is not possible: a randomised, open-label, equivalence trial. <i>Lancet</i>. 2015b;385(9979):1767-1776. doi:10.1016/S0140-6736(14)62284-4<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25842221/pubmed" id="25842221" target="_blank">25842221</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3400652">
<a name="3400652"></a>Tu YH, Stiles ML, Allen LV Jr, Olsen KM, Barton CI, Greenwood RB. Stability of amoxicillin trihydrate-potassium clavulanate in original containers and unit dose oral syringes.. <i>Am J Hosp Pharm.</i> 1988;45(5):1092-1099.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/3400652/pubmed" id="3400652" target="_blank">3400652</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-NHLBI.1">
<a name="NHLBI.1"></a>US Department of Health and Human Services. National Heart, Lung, and Blood Institute (NHLBI). Evidence-based management of sickle cell disease: expert panel report, 2014. <a href="https://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease" target="_blank">https://www.nhlbi.nih.gov/health-topics/evidence-based-management-sickle-cell-disease</a>. Published 2014. Accessed January 3, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-FDA.1">
<a name="FDA.1"></a>US Food and Drug Administration (FDA). Compounding certain beta-lactam products in shortage under section 503A of the Federal Food Drug and Cosmetic Act. <a href="https://www.fda.gov/regulatory-information/search-fda-guidance-documents/compounding-certain-beta-lactam-products-shortage-under-section-503a-federal-food-drug-and-cosmetic" target="_blank">https://www.fda.gov/regulatory-information/search-fda-guidance-documents/compounding-certain-beta-lactam-products-shortage-under-section-503a-federal-food-drug-and-cosmetic</a>. Published November 2022. Accessed January 3, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25045274">
<a name="25045274"></a>Valour F, Sénéchal A, Dupieux C, et al. Actinomycosis: etiology, clinical features, diagnosis, treatment, and management. <i>Infect Drug Resist</i>. 2014;7:183-197. doi:10.2147/IDR.S39601<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/25045274/pubmed" id="25045274" target="_blank">25045274</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-27216385">
<a name="27216385"></a>Vardakas KZ, Trigkidis KK, Boukouvala E, Falagas ME. <i>Clostridium difficile</i> infection following systemic antibiotic administration in randomised controlled trials: a systematic review and meta-analysis. <i>Int J Antimicrob Agents</i>. 2016;48(1):1-10. doi:10.1016/j.ijantimicag.2016.03.008<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/27216385/pubmed" id="27216385" target="_blank">27216385</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-21235333">
<a name="21235333"></a>Varela VM, Heller D, Silva-Senem MX, et al. Systemic Antimicrobials Adjunctive to a Repeated Mechanical and Antiseptic Therapy for Aggressive Periodontitis: A 6-Month Randomized Controlled Trial. <i>J Periodontol. </i>2011;82(8):1121-1130.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/21235333/pubmed" id="21235333" target="_blank">21235333</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23796742">
<a name="23796742"></a>Wald ER, Applegate KE, Bordley C, et al. Clinical practice guideline for the diagnosis and management of acute bacterial sinusitis in children aged 1 to 18 years. <i>Pediatrics</i>. 2013;132(1):e262-e280.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23796742/pubmed" id="23796742" target="_blank">23796742</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-22851742">
<a name="22851742"></a>Warady BA, Bakkaloglu S, Newland J, et al. Consensus guidelines for the prevention and treatment of catheter-related infections and peritonitis in pediatric patients receiving peritoneal dialysis: 2012 update.<i> Perit Dial Int</i>. 2012;32(suppl 2):S32-S86.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/22851742/pubmed" id="22851742" target="_blank">22851742</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29272341">
<a name="29272341"></a>Watson T, Hickok J, Fraker S, Korwek K, Poland RE, Septimus E. Evaluating the risk factors for hospital-onset <i>Clostridium difficile</i> infections in a large healthcare system. <i>Clin Infect Dis</i>. 2018;66(12):1957-1959. doi:10.1093/cid/cix1112<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29272341/pubmed" id="29272341" target="_blank">29272341</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-870440">
<a name="870440"></a>Weingärtner L, Sitka U, Patsch R, Richter I. Experience with amoxycillin in neonates and premature babies. <i>Int J Clin Pharmacol Biopharm</i>. 1977;15(4):184-188.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/870440/pubmed" id="870440" target="_blank">870440</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-35040920">
<a name="35040920"></a>Williams DJ, Creech CB, Walter EB, et al. Short- vs standard-course outpatient antibiotic therapy for community-acquired pneumonia in children: the SCOUT-CAP randomized clinical trial. <i>JAMA Pediatr</i>. 2022;176(3):253-261. doi:10.1001/jamapediatrics.2021.5547<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/35040920/pubmed" id="35040920" target="_blank">35040920</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-Wilson.1">
<a name="Wilson.1"></a>Wilson KH. Prevention of anthrax. Post TW, ed. UpToDate. Waltham, MA: UpToDate Inc. <a href="http://www.uptodate.com" target="_blank">http://www.uptodate.com</a>. Accessed March 21, 2023.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-33853363">
<a name="33853363"></a>Wilson WR, Gewitz M, Lockhart PB, et al; American Heart Association Young Hearts Rheumatic Fever, Endocarditis and Kawasaki Disease Committee of the Council on Lifelong Congenital Heart Disease and Heart Health in the Young; Council on Cardiovascular and Stroke Nursing; and the Council on Quality of Care and Outcomes Research. Prevention of viridans group streptococcal infective endocarditis: a scientific statement from the American Heart Association. <i>Circulation</i>. 2021;143(20):e963-e978. doi:10.1161/CIR.0000000000000969<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/33853363/pubmed" id="33853363" target="_blank">33853363</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-17446442">
<a name="17446442"></a>Wilson W, Taubert KA, Gewitz M, et al; American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee; American Heart Association Council on Cardiovascular Disease in the Young; American Heart Association Council on Clinical Cardiology; American Heart Association Council on Cardiovascular Surgery and Anesthesia; Quality of Care and Outcomes Research Interdisciplinary Working Group. Prevention of infective endocarditis. Guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group. <i>Circulation.</i> 2007;116(15):1736-1754.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/17446442/pubmed" id="17446442" target="_blank">17446442</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34350458">
<a name="34350458"></a>Woods CR, Bradley JS, Chatterjee A, et al. Clinical practice guideline by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America (PIDS/IDSA): 2021 guideline on diagnosis and management of acute hematogenous osteomyelitis in pediatrics. <i>J Pediatric Infect Dis Soc</i>. 2021;10(8):801-844. doi:10.1093/jpids/piab027<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/34350458/pubmed" id="34350458" target="_blank">34350458</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.1">
<a name="WHO.1"></a>World Health Organization (WHO). Mastitis: Causes and Management, Publication Number WHO/FCH/CAH/00.13. World Health Organization: Geneva, Switzerland; 2000.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-WHO.2">
<a name="WHO.2"></a>World Health Organization (WHO). WHO Model Prescribing Information: Drugs Used in Bacterial Infections. Geneva, Switzerland: World Health Organization; 2001. http://apps.who.int/medicinedocs/pdf/s5406e/s5406e.pdf. Accessed November 6, 2018.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-23215911">
<a name="23215911"></a>World Health Organization (WHO). Breastfeeding and maternal medication, recommendations for drugs in the Eleventh WHO Model List of Essential Drugs. 2002. http://www.who.int/maternal_child_adolescent/documents/55732/en/
                     <span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/23215911/pubmed" id="23215911" target="_blank">23215911</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-34292926">
<a name="34292926"></a>Workowski KA, Bachmann LH, Chan PA, et al. Sexually transmitted infections treatment guidelines, 2021. <i>MMWR Recomm Rep</i>. 2021;70(4):1-187. doi:10.15585/mmwr.rr7004a1<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/34292926/pubmed" id="34292926" target="_blank">34292926</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-10090000">
<a name="10090000"></a>Wright AJ. The Penicillins. <i>Mayo Clin Proc.</i> 1999;74(3):290-307.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/10090000/pubmed" id="10090000" target="_blank">10090000</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-1812049">
<a name="1812049"></a>Wynn RL. Amoxicillin Update. <i>Gen Dent.</i> 1991;39(5):322,4,6.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/1812049/pubmed" id="1812049" target="_blank">1812049</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-31614216">
<a name="31614216"></a>Yang MS, Lee JY, Kim J, et al. Searching for the culprit drugs for Stevens-Johnson syndrome and toxic epidermal necrolysis from a nationwide claim database in Korea. <i>J Allergy Clin Immunol Pract</i>. 2020;8(2):690-695.e2. doi:10.1016/j.jaip.2019.09.032<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/31614216/pubmed" id="31614216" target="_blank">31614216</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-29369602">
<a name="29369602"></a>Zareba-Szczudlik J, Romejko-Wolniewicz E, Lewandowski Z, et al. Evaluation of the amoxicillin concentrations in amniotic fluid, placenta, umbilical cord blood and maternal serum two hours after oral administration. <i>Neuro Endocrinol Lett</i>. 2017;38(7):502-508.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/29369602/pubmed" id="29369602" target="_blank">29369602</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-30672065">
<a name="30672065"></a>Zhan Y, Si M, Li M, Jiang Y. The risk of Helicobacter pylori infection for adverse pregnancy outcomes: a systematic review and meta-analysis. <i>Helicobacter</i>. 2019;24(2):e12562. doi:10.1111/hel.12562<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/30672065/pubmed" id="30672065" target="_blank">30672065</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-32518780">
<a name="32518780"></a>Zhou H, Xu Q, Liu Y, Guo LT. Risk factors, incidence, and morbidity associated with antibiotic-associated diarrhea in intensive care unit patients receiving antibiotic monotherapy. <i>World J Clin Cases</i>. 2020;8(10):1908-1915. doi:10.12998/wjcc.v8.i10.1908<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/amoxicillin-pediatric-drug-information/abstract-text/32518780/pubmed" id="32518780" target="_blank">32518780</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 12631 Version 614.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
